<SEC-DOCUMENT>0001193125-24-118077.txt : 20240426
<SEC-HEADER>0001193125-24-118077.hdr.sgml : 20240426
<ACCEPTANCE-DATETIME>20240426161457
ACCESSION NUMBER:		0001193125-24-118077
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20240606
FILED AS OF DATE:		20240426
DATE AS OF CHANGE:		20240426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Savara Inc
		CENTRAL INDEX KEY:			0001160308
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				841318182
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32157
		FILM NUMBER:		24883933

	BUSINESS ADDRESS:	
		STREET 1:		6836 BEE CAVE ROAD
		STREET 2:		BUILDING 3, SUITE 201
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746
		BUSINESS PHONE:		51285113796

	MAIL ADDRESS:	
		STREET 1:		6836 BEE CAVE ROAD
		STREET 2:		BUILDING 3, SUITE 201
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Mast Therapeutics, Inc.
		DATE OF NAME CHANGE:	20130312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVENTRX PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20030613

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOKEYS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20010928
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d785934ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE&nbsp;14A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No.&#8195;) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&#8194;&#9746; &#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;Filed by a Party other than the Registrant&#8194;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate
box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule</B><B></B><B>&nbsp;14a</B><B><FONT
STYLE="white-space:nowrap">-6(e)(2))</FONT></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant to <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>SAVARA INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of
Registrant as Specified In Its Charter) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
<FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">April 26, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dear Fellow Stockholder, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
behalf of the Board of Directors, it is my pleasure to invite you to attend the Savara Inc. 2024 Annual Meeting of Stockholders, to be held on June&nbsp;6, 2024 at 3:00 p.m. Eastern Time via live webcast at
<U>www.virtualshareholdermeeting.com/SVRA2024</U>. The attached Notice of Annual Meeting and Proxy Statement contain important information about the meeting and matters for your consideration. Your vote is important, and regardless of whether you
plan to attend the meeting, I encourage you to review the material carefully and submit your proxy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Over the past year, we made strong
progress with the pivotal Phase 3 <FONT STYLE="white-space:nowrap">IMPALA-2</FONT> trial in autoimmune pulmonary alveolar proteinosis (aPAP) and the molgramostim development program. We over-enrolled <FONT STYLE="white-space:nowrap">IMPALA-2</FONT> <FONT
STYLE="white-space:nowrap">on-time</FONT> during the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, introduced aPAP ClearPath<SUP STYLE="font-size:75%; vertical-align:top">TM</SUP>, a simple, accurate,
<FONT STYLE="white-space:nowrap">no-cost,</FONT> <FONT STYLE="white-space:nowrap">lab-developed</FONT> autoantibody blood test that provides a definitive aPAP diagnosis, and launched a disease state awareness campaign that educates U.S.
pulmonologists about the hallmark signs and symptoms of the disease and need for earlier testing. We also strengthened our management team with key hires in Global Technical Operations, Medical Affairs, Clinical Development, and Quality Assurance.
Additionally, Savara was added to the Russell 3000<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> and Nasdaq Biotechnology Indices. Finally, we completed an $80M equity financing and, under the current operating plan, believe we are
sufficiently capitalized into 2026. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We look forward to reporting top line results from the
<FONT STYLE="white-space:nowrap">IMPALA-2</FONT> trial, which we anticipate at the end of 2Q 2024. The Savara team is working hard to bring molgramostim nebulizer solution, our investigational therapy, to market to address the significant unmet need
in aPAP. Our work has always been, and will continue to be, fueled by creating long-term value for our stockholders and our desire to dramatically improve the standard of care for people living with this rare and debilitating lung disease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Thank you for your continued support. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sincerely,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Matthew Pauls</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chair of the Board of Directors&nbsp;&amp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>SAVARA INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>One Summit Square </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1717
Langhorne Newtown Rd. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Suite 300 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Langhorne, PA 19047 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held on June&nbsp;6, 2024 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2024 Annual Meeting of Stockholders of Savara Inc. (the &#147;Annual Meeting&#148;) will be held virtually via live webcast at
<U>www.virtualshareholdermeeting.com/SVRA2024</U> on June&nbsp;6, 2024 at 3:00 p.m. Eastern Time. The meeting is being held for the following purposes, as more fully described in the proxy statement accompanying this notice: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. To elect six directors to hold office until the next annual meeting of stockholders and until their respective successors are elected and
qualified or until their earlier resignation or removal; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. To approve the Savara Inc. 2024 Omnibus Incentive Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. To approve an amendment to our Amended and Restated Certificate of Incorporation to allow for exculpation of officers as permitted by
Delaware law; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending
December&nbsp;31, 2024; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. To approve, on an advisory basis, the compensation of our named executives; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. To transact such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only stockholders of record at the close of business on April&nbsp;8, 2024 will be entitled to notice of, and to vote at, the Annual Meeting
and any adjournment or postponement thereof. A list of stockholders entitled to vote at the Annual Meeting will be available for inspection by any stockholder for any purpose relating to the meeting during ordinary business hours at our corporate
offices located at One Summit Square, 1717 Langhorne Newtown Rd., Suite 300, Langhorne, PA 19047 for ten days prior to the Annual Meeting, and will also be available for inspection at the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Your vote is important. </I></B>Whether or not you plan to attend the Annual Meeting, and no matter how many shares you own, please vote
as promptly as possible. This will help to ensure the presence of a quorum at the Annual Meeting and save us additional proxy solicitation costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All stockholders are cordially invited to attend the Annual Meeting. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Matthew Pauls</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chair of the Board of Directors&nbsp;&amp;</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Executive Officer</I></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Langhorne, PA </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;26, 2024 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Notice Regarding the
Availability of Proxy Materials for the Stockholders&#146; Meeting To Be Held on June</B><B></B><B>&nbsp;6, 2024. </B>This notice of Annual Meeting, the proxy statement for the Annual Meeting and our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2023 are available at www.proxyvote.com. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_1">General Information About the Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_2">Board of Directors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_3">Nominees for Election to the Board</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_4">Corporate Governance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_5">Corporate Responsibility</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_6">Director Nominations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_7">Communications with Directors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_8">Executive Officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_9">Security Ownership of Certain Beneficial Owners and Management</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_10">Certain Relationships and Related Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_11">Equity Compensation Plan Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_12">Compensation Discussion and Analysis</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_13">Executive Compensation Tables</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_14">Director Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_15">Audit Committee Report</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_16">Principal Accountant Fees and Services</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_17">Proposal 1 &#151; Election of Directors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_18">Proposal 2 &#151; Approval of the Savara Inc. 2024 Omnibus Incentive
Plan</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_19">Proposal 3 &#151; Approval of an amendment to our Amended and Restated Certificate
 of Incorporation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_20">Proposal 4 &#151; Ratification of Independent Registered Public Accounting Firm
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_21">Proposal 5 &#151; Advisory Vote on the Compensation of our Named Executive Officers
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_22">Other Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_23">Stockholder Proposals and Director Nominations for 2025 Annual
Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_24">Appendix A: 2024 Omnibus Incentive Plan</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc785934_25">Appendix B: Certificate of Amendment to the Amended and Restated Certificate
 of Incorporation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">B-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SAVARA INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>One Summit Square </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1717
Langhorne Newtown Rd. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Suite 300 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Langhorne, PA 19047 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2024
ANNUAL MEETING OF STOCKHOLDERS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held on June&nbsp;6, 2024 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_1"></A>GENERAL INFORMATION ABOUT THE MEETING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Savara Inc., a Delaware corporation (&#147;Savara,&#148; &#147;we,&#148; &#145;us,&#148; &#147;our,&#148; &#147;the company,&#148; &#147;the
Company&#148; or &#147;our company&#148;), is making proxy materials, including this proxy statement, available to our stockholders via the internet in connection with the solicitation of proxies by the Savara Board of Directors (the &#147;Board of
Directors&#148; or &#147;Board&#148;) for use at our 2024 Annual Meeting of Stockholders to be held virtually on June&nbsp;6, 2024 at 3:00 p.m. Eastern Time via live webcast at www.virtualshareholdermeeting.com/SVRA2024, and at any adjournment or
postponement thereof (the &#147;Annual Meeting&#148;). </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This proxy statement, the attached notice of the Annual Meeting, a proxy card
and our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2023 are collectively referred to as the &#147;proxy materials.&#148; The proxy materials are first being made available to our
stockholders on or about April&nbsp;26, 2024. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice of Internet Availability of Proxy Materials </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All stockholders have the ability to access the proxy materials on the website referred to in the attached notice of the Annual Meeting.
Pursuant to rules adopted by the U.S. Securities and Exchange Commission (the &#147;SEC&#148;), we have elected to send a Notice of Internet Availability of Proxy Materials (the &#147;Notice of Internet Availability&#148;) to our stockholders
instead of mailing printed copies of the proxy materials, unless you have previously elected to receive printed materials. The Notice of Internet Availability provides instructions on how to access the proxy materials via the internet and how to
request a printed set of the proxy materials at no charge. In addition, stockholders can elect to receive future proxy materials electronically by email or in printed form by mail, and any such election will remain in effect until terminated by the
stockholder. We encourage all stockholders to take advantage of the availability of the proxy materials on the internet to help reduce the cost and environmental impact of our annual meetings. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Purposes of the Annual Meeting </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Annual Meeting is being held for the following purposes: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. To elect six directors to hold office until the next annual meeting of
stockholders and until their respective successors are elected and qualified or until their earlier resignation or removal; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. To approve
the Savara Inc. 2024 Omnibus Incentive Plan (the &#147;2024 Plan&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. To approve an amendment to our Amended and Restated
Certificate of Incorporation to allow for exculpation of officers as permitted by Delaware law; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. To ratify the appointment of RSM US
LLP (&#147;RSM&#148;) as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2024; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. To
approve, on an advisory basis, the compensation of our named executives; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. To transact such other business as may properly come
before the Annual Meeting and any adjournment or postponement thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Record Date; Shares Outstanding and Entitled to Vote </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors has fixed April&nbsp;8, 2024 as the record date (the &#147;record date&#148;) for the determination of holders of our
common stock entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof. At the close of business on the record date, we had 138,176,641 shares of common stock issued and outstanding. Each stockholder of
record as of the record date is entitled to one vote at the Annual Meeting for each share of common stock held by such stockholder on the record date. Stockholders do not have cumulative voting rights. We had no other class of capital stock
outstanding as of the record date. No other shares are entitled to notice of, or to vote at, the Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How to Vote Your Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>If you hold your shares in your own name as the stockholder of record</B>: You may vote your shares by proxy over the internet or by
telephone by following the instructions provided in the Notice of Internet Availability, or, if you requested to receive printed proxy materials, you may vote by marking, dating and signing the enclosed proxy card and returning it in the
postage-paid envelope provided or you may vote over the internet or by telephone pursuant to the instructions provided in the proxy card. Additionally, you may vote your shares electronically during the Annual Meeting using the control number found
on your Notice of Internet Availability or proxy card and following the instructions at&nbsp;<U>www.virtualshareholdermeeting.com/SVRA2024</U>. Stockholders voting by internet or telephone should understand that, while we and the party providing the
service through which you may vote by internet or by telephone do not charge any fees to our stockholders for voting by internet or telephone, there may still be costs, such as usage charges from internet access providers and telephone companies,
for which you are responsible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>If your shares are held in the name of a broker or other nominee (typically referred to as shares being
held in &#147;street name&#148;)</B>: You will receive instructions from the holder of record that you must follow for your shares to be voted. The availability of telephonic or internet voting will depend on your broker&#146;s (or other
nominee&#146;s) voting process. Please check with your broker or other nominee and follow the voting procedure your broker or other nominee provides to vote your shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By casting your vote by proxy, you are authorizing the holders of the proxies solicited by this proxy statement to vote your shares in
accordance with your instructions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">YOUR VOTE IS VERY IMPORTANT. We encourage you to submit your vote by proxy even if you plan to attend
the Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How to Change Your Vote </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>If you hold your shares in your own name</B>: You may revoke your proxy and change your vote at any time before your proxy is exercised by:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Delivering to our corporate secretary a written notice of revocation, dated later than the proxy you wish to
revoke, before voting begins at the Annual Meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Delivering to our corporate secretary a duly executed proxy bearing a date later than the proxy you wish to
revoke, before voting begins at the Annual Meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Voting again on a later date via the internet or by telephone before 11:59&nbsp;p.m. Eastern Time on June&nbsp;5,
2024 (in which case only your latest internet or telephone proxy submitted will be counted); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Attending the Annual Meeting and voting electronically during the Annual Meeting by following the instructions at
<U>www.virtualshareholdermeeting.com/SVRA2024</U> (your attendance at the Annual Meeting, in and of itself, will not revoke your proxy). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any written notice of revocation or later dated proxy should be delivered before the close
of business on June&nbsp;5, 2024 to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Savara Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One Summit Square </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1717 Langhorne
Newtown Rd. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Suite 300 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Langhorne, PA 19047 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention:
Corporate Secretary </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>If your shares are held in street name</B>: You must follow the instructions provided by the broker or other
nominee if you wish to change your vote. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proxies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you provide specific voting instructions on your proxy card or when voting via the internet or by telephone, your shares will be voted at
the Annual Meeting in accordance with your instructions. If you hold shares in your name and execute a proxy (either by submitting it via the internet or telephone or signing and returning a proxy card) without making individual selections, your
shares will be voted in accordance with the recommendations of our Board of Directors, which are: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;For&#148; election of each of the nominees to our Board of Directors listed in the proxy materials;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;For&#148; the adoption of the 2024 Plan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;For&#148; the amendment of our Amended and Restated Certificate of Incorporation to allow for exculpation
of officers as permitted by Delaware law; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;For&#148; ratification of the appointment of RSM as our independent registered public accounting firm for
the fiscal year ending December&nbsp;31, 2024; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;For&#148; the approval of the compensation of our named executives. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At this time, we are unaware of any matters, other than those set forth above, that may properly come before the Annual Meeting. If any other
matters properly come before the Annual Meeting or any adjournment or postponement thereof, the holders of proxies solicited by this proxy statement, or their duly constituted substitutes acting at the Annual Meeting and any adjournment or
postponement thereof, will be deemed authorized to vote or otherwise act on such matters in accordance with their judgment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders
of proxies solicited by this proxy statement, or their duly constituted substitutes acting at the Annual Meeting and any adjournment or postponement thereof, may propose and vote for one or more adjournments or postponements of the Annual Meeting,
including adjournments or postponements to permit further solicitations of proxies. Proxies solicited may be voted only at the Annual Meeting and any adjournment or postponement thereof and will not be used for any other meeting of our stockholders.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Broker <FONT STYLE="white-space:nowrap">Non-Votes</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A &#147;broker <FONT STYLE="white-space:nowrap">non-vote&#148;</FONT> occurs when a nominee (typically a broker or bank) holding shares for a
beneficial owner (typically referred to as shares being held in &#147;street name&#148;) submits a proxy for those shares but indicates on the proxy that it does not have authority to vote those shares on particular proposals because it has not
received specific voting instructions from the beneficial owner for those proposals. Under the rules of the New York Stock Exchange, brokers and other nominees have discretion to vote shares held in street name on &#147;routine&#148; matters but
lack such discretion with regard to <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> matters. The ratification of the appointment of RSM as our independent registered public accounting firm for fiscal year 2024 is considered a routine
matter and, as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such, brokers and other nominees may vote on that proposal in the absence of specific instructions from the beneficial owner. The other proposals described in this proxy statement are considered <FONT
STYLE="white-space:nowrap">non-routine</FONT> matters and brokers and other nominees do not have discretionary authority to vote on such proposals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quorum and Required Votes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A majority of
the aggregate number of shares of our common stock issued and outstanding and entitled to vote at the Annual Meeting must be present or represented by proxy in order for there to be a quorum at the Annual Meeting and for any action to be taken at
the Annual Meeting. If you submit a properly executed proxy via the internet or by telephone or mail, regardless of whether you abstain from voting on one or more matters, your shares will be counted as present at the Annual Meeting for the purpose
of determining a quorum. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will also be counted as present for the purpose of determining the presence of a quorum at the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Proposal 1 &#150; Election of Directors: </I>The affirmative vote of the holders of a majority of the shares of our common stock having
voting power present or represented by proxy at the Annual Meeting is required for the election of each director nominee. This majority voting standard means that a director nominee will be elected if the number of shares voted &#147;For&#148; that
director nominee exceeds the aggregate number of shares voted &#147;Against&#148; and that &#147;Abstain&#148; from voting with respect to that director nominee. As a result, an abstention will have the same effect as a negative vote. Broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> will not be counted toward the vote total and therefore will have no effect on the outcome of this proposal. In accordance with our corporate governance guidelines, each of our incumbent directors tendered
his or her resignation in advance of being nominated for election at the Annual Meeting, with the effectiveness of such resignation subject to and contingent upon (a)&nbsp;the director&#146;s failure to receive a sufficient number of votes for <FONT
STYLE="white-space:nowrap">re-election</FONT> at the Annual Meeting and (b)&nbsp;our Board of Directors&#146; acceptance of the resignation. Accordingly, the continued service on our Board of Directors by any director who is not <FONT
STYLE="white-space:nowrap">re-elected</FONT> because such director does not receive the requisite affirmative votes at the Annual Meeting will be subject to our Board of Directors&#146; determination as to whether to accept or reject his or her
resignation. Our Board of Directors will take into account and consider the voting results at the Annual Meeting but has sole discretion to determine whether or not to accept the resignation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Proposal 2 &#150; Approval of the 2024 Plan: </I>The affirmative vote of the holders of a majority of the shares of our common stock having
voting power present or represented by proxy at the Annual Meeting is required to approve the adoption of the 2024 Plan. An abstention will have the same effect as a negative vote.
<FONT STYLE="white-space:nowrap">Broker&nbsp;non-votes&nbsp;will</FONT> not be counted toward the vote total and therefore will have no effect on the outcome of this proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Proposal 3 &#150; Amendment of our Amended and Restated Certificate of Incorporation to allow for exculpation of officers as permitted by
Delaware law: </I>The affirmative vote of the holders of a majority of the outstanding shares of our common stock on the record date is required to amend our Certificate of Incorporation to allow for exculpation of officers as permitted by Delaware
law. An abstention will have the same effect as a negative vote. <FONT STYLE="white-space:nowrap">Broker&nbsp;non-votes&nbsp;will</FONT> have the same effect as a negative vote. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Proposal 4 &#150; Ratification of Independent Registered Public Accounting Firm: </I>The affirmative vote of the holders of a majority of
the shares of our common stock having voting power present or represented by proxy at the Annual Meeting is required to ratify the appointment of RSM as our independent registered public accounting firm for the fiscal year ended December&nbsp;31,
2024. An abstention will have the same effect as a negative vote. Brokers and other nominees generally will have discretionary authority to vote on this proposal because it is considered a routine matter; therefore, we do not expect any broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> with respect to this proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Proposal 5 &#150; Advisory Vote on the Compensation of our
Named Executives: </I>The affirmative vote of the holders of a majority of the shares of our common stock having voting power present or represented by proxy at the Annual Meeting is required to approve, on an advisory basis, the compensation of our
named executives. An </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
abstention will have the same effect as a negative vote. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will not be counted toward the vote total and therefore will have no effect on
the outcome of this proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Solicitation of Proxies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are soliciting proxies from our stockholders on behalf of our Board of Directors and will pay for all costs incurred in connection with the
solicitation. In addition to solicitation by mail, our directors, officers and employees may solicit proxies from our stockholders in person or by telephone, facsimile, email or other electronic methods without additional compensation other than
reimbursement for their actual expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may retain a proxy solicitation firm to assist us in the solicitation of proxies for the
Annual Meeting. We would pay such firm, if any, customary fees, which we do not expect would exceed $20,000 and would reimburse the firm for its reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Arrangements also will be made with brokerage firms and other custodians, nominees and fiduciaries for the forwarding of
solicitation material to the beneficial owners of stock held of record by such persons, and we will reimburse such custodians, nominees and fiduciaries for their reasonable
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses in connection therewith. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If You Receive More
Than One Proxy Card </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you receive more than one proxy card, it means you hold shares that are registered in more than one account. To
ensure that all of your shares are voted, please mark your votes and date, sign and return each proxy card, or vote your proxy via internet or by telephone as instructed on each proxy card. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Householding Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC has
adopted rules that permit brokers, banks and other nominees to satisfy the delivery requirements for proxy statements, annual reports and Notice of Internet Availability, as applicable, with respect to two or more stockholders sharing the same
address by delivering a single copy of such document addressed to those stockholders. This process, which is commonly referred to as &#147;householding,&#148; potentially means extra convenience for stockholders and cost savings for companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A number of brokers and other nominees with account holders who are our stockholders may be &#147;householding&#148; the proxy materials. This
means that only one copy of this proxy statement, our annual report and Notice of Internet Availability may have been sent to multiple stockholders in a household. If, at any time, you no longer wish to participate in householding and would prefer
to receive a separate proxy statement, annual report and Notice of Internet Availability from the other stockholder(s) sharing your address, please (i)&nbsp;notify your broker or other nominee, (ii)&nbsp;direct your written request to Savara Inc.,
One Summit Square, 1717 Langhorne Newtown Rd., Suite 300, Langhorne, PA 19047, Attention: Corporate Secretary or (iii)&nbsp;contact us by phone at (512) <FONT STYLE="white-space:nowrap">614-1848.</FONT> We undertake to deliver promptly, upon any
such oral or written request, a separate copy of the proxy materials to a stockholder at a shared address to which a single copy of these documents was delivered. Stockholders who currently receive multiple copies of the proxy materials at their
address and would like to request householding of their communications should notify their broker or other nominee or contact our corporate secretary at the above address or phone number. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you have any questions about voting your shares, please contact us at (512) <FONT STYLE="white-space:nowrap">614-1848.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_2"></A>BOARD OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides summary information about each current member of our Board of Directors: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Committee Membership</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Director Since</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">None</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">April 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nevan Elam</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Compensation Committee (Chair)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Nominating&nbsp;&amp; Governance Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">February&nbsp;2009</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard J. Hawkins</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Audit Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">October 2010</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph S. McCracken</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Compensation Committee</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Nominating&nbsp;&amp;
Governance Committee (Chair)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">October 2013</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David A. Ramsay</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Audit Committee (Chair)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">April 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ricky Sun*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Nominating&nbsp;&amp; Governance Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">December&nbsp;2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">An van <FONT STYLE="white-space:nowrap">Es-Johansson</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Compensation Committee</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Audit
Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">December&nbsp;2019</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Sun is not standing for reelection following the completion of his term at the Annual Meeting.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Composition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a snapshot of the Board&#146;s current composition and the attributes of its directors: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="8" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Board Diversity Matrix (As of
April&nbsp;8, 2024)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="8"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Board Size:</B></P></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Number of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center">7</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Female</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Male</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="8"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Gender:</B></P></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="8"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Demographic Background:</B></P></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">African American or Black</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Asian</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">White</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Knowledge, Skills, and Expertise </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors is committed to ensuring the Board reflects a diverse range of viewpoints, qualifications, skills, and experience. Below
is a list of a few of the areas of knowledge and expertise reflected in the members of the Board that contribute to the Board&#146;s effectiveness. Detailed information about each individual director nominee&#146;s qualifications, skills and
experience, as well as biographical information, can be found starting on page&nbsp;8. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Chief Executive Officer Leadership</B> &#150; Service as a chief executive officer at a publicly traded or
privately-held organization. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Industry Experience</B> &#150; Experience in the pharmaceutical or life sciences industry, including
development and commercialization of pharmaceutical products. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Medical or Scientific Background</B> &#150; Medical degree or advanced degree in a scientific field.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Financial and Accounting</B> &#150; Experience at a large accounting firm or as chief financial officer, or
other professional experience in a financial oversight role. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Public Company Governance</B> &#150; Service as a board member of a publicly traded company and familiarity
with key corporate governance matters. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Global Strategy and Operations </B>&#150; Experience guiding the strategic direction and growth of a
pharmaceutical or life sciences company on a global scale. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_3"></A>NOMINEES FOR ELECTION TO THE BOARD </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Composite Amended and Restated Certificate of Incorporation and our Amended and Restated Bylaws (our &#147;Bylaws&#148;) provide that each
director elected or appointed to our Board of Directors shall hold office until the next annual meeting of stockholders following such election or appointment and until the director&#146;s successor is elected and qualified, or until the
director&#146;s earlier resignation or removal. Our Bylaws provide that vacancies on our Board of Directors, including those resulting from an increase in the authorized number of directors, may be filled by a majority of the remaining directors,
even if less than a quorum, or by a sole remaining director. Any director appointed as a result of a vacancy holds office until the next annual meeting of stockholders and until a successor is elected and qualified. Pursuant to our Bylaws, the
authorized number of directors may be not less than three nor more than nine, with the exact number, currently seven, to be fixed by resolutions adopted from time to time by our Board of Directors. Our current director, Dr.&nbsp;Ricky Sun, was
initially identified to serve as member of our Board of Directors by investors affiliated with Bain Capital Life Sciences Investors, LLC (&#147;Bain Capital Life Sciences&#148;) pursuant to the Bain Capital Life Sciences director designation right
under that certain Securities Purchase Agreement dated December&nbsp;20, 2019 among us and certain accredited and institutional investors. Following Dr.&nbsp;Sun&#146;s decision not to stand for reelection at the Annual Meeting and the waiver by
Bain Capital Life Sciences of its director designation right, our Board adopted resolutions reducing the authorized number of directors from seven to six effective as of the Annual Meeting. Accordingly, proxies cannot be voted for a greater number
of individuals than the six nominees named in this proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of our nominees for election to our Board of Directors is a
current director. The paragraphs below provide information about each such director nominee. There are no family relationships among any of our directors, director nominees, and executive officers. Service on our Board of Directors or as an
executive officer prior to April 2017 described in this proxy statement refers to service with Savara Inc., the private company with which we completed a reverse merger in April 2017 when we were operating as Mast Therapeutics, Inc. Following the
reverse merger, we changed our name to Savara Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Matthew Pauls</I></B><I>. </I>Mr.&nbsp;Pauls has served as our Chief Executive
Officer since December 2020, the Chair of our Board of Directors since September 2020, and was our Interim Chief Executive Officer from September 2020 to December 2020. Mr.&nbsp;Pauls has served as a member of our Board of Directors since April 2017
and was a member of the board of directors of Mast Therapeutics, Inc. from October 2015 to April 2017. Previously, Mr.&nbsp;Pauls was the founder of Spartan Biopharma Insights, LLC, where he provided strategic advisement to institutional investors,
and company management teams on investment thesis assessment, capitalization strategy, mergers and acquisitions, clinical execution, and commercialization from December 2019 to September 2020. Since August 2023, Mr.&nbsp;Pauls has served on the
board of directors of Soleno Therapeutics, Inc. (Nasdaq: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, as well as the board of directors of the privately held companies Amplo Biotechnology, Inc.,
a gene therapy company focused on rare neuromuscular disorders, and Pelthos Therapeutics, a biopharmaceutical company focused on dermatologic infectious diseases. Mr.&nbsp;Pauls served on the board of directors of Zyla Life Sciences (previously
Egalet Corporation) (OTCQX: ZCOR), a commercial-stage life sciences company with a portfolio of medicines for pain and inflammation, from January 2019 until its merger with Assertio Therapeutics, Inc. in May 2020. From August 2014 to November 2019,
Mr.&nbsp;Pauls served as President and Chief Executive Officer of Strongbridge Biopharma plc (Nasdaq: SBBP) (&#147;Strongbridge&#148;), a biopharmaceutical company focused on therapies that target rare diseases that Mr.&nbsp;Pauls lead through an
initial public offering. He also served as a member of the board of directors of Strongbridge from September 2015 to November 2019. From April 2013 to August 2014, Mr.&nbsp;Pauls was Chief Commercial Officer of Insmed, Inc. (Nasdaq: INSM), a
publicly traded global biopharmaceutical company focused on rare diseases. From 2007 to April 2013, Mr.&nbsp;Pauls worked at Shire Pharmaceuticals, a global specialty biopharmaceutical company, most recently as Senior Vice President, Head of Global
Commercial Operations from May 2012 to April 2013. Earlier in his career, from 1997 to 2007, Mr.&nbsp;Pauls held senior positions at Bristol-Myers Squibb in Brand Management and Payor Marketing and at Johnson&nbsp;&amp; Johnson in various U.S. and
global commercial roles. Mr.&nbsp;Pauls holds B.S. and M.B.A. degrees from Central Michigan University and a J.D. from Michigan State University College of Law. We believe Mr.&nbsp;Pauls&#146; experience as our
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Chief Executive Officer, as well as his leadership experience and extensive commercialization, strategic planning and operations experience in the biopharmaceutical industry, particularly with
therapies for rare diseases, qualify him to serve as a member of the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Nevan Elam</I></B><I>.</I> Mr.&nbsp;Elam
has served as a member of our Board of Directors since February 2009. Since February 2013, Mr.&nbsp;Elam has served as a member of the Board of Directors as well as the President and Chief Executive Officer of Rezolute, Inc. (Nasdaq: RZLT)
(&#147;Rezolute&#148;), a biopharmaceutical company focused on developing therapies for metabolic diseases with serious unmet needs. Prior to his tenure at Rezolute, Mr.&nbsp;Elam held senior executive roles within in the pharmaceutical industry,
including Senior Vice President and Head of the Pulmonary Business Unit of Nektar Therapeutics and President and Chief Executive Officer of a European medical device company. Earlier in his career, he was a
<FONT STYLE="white-space:nowrap">co-founder</FONT> and the Chief Financial Officer of E2open, Inc. and a Partner in the corporate practice of the law firm of Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C. In addition, from November 2022 to June
2023, Mr.&nbsp;Elam served on the board of directors of Peak Bio, Inc. (OTCPK: PKBO). Mr.&nbsp;Elam received his J.D. from Harvard Law School and a B.A. from Howard University. We believe Mr.&nbsp;Elam&#146;s broad experience with pharmaceutical
companies, including advising them of their unique legal and regulatory obligations, qualifies him to serve on the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Richard J. Hawkins</I></B><I>.</I> Mr.&nbsp;Hawkins has served as a member of our Board of Directors since October 2010.
Mr.&nbsp;Hawkins is currently Chief Executive Officer and Chair of the Board of Directors of Lumos Pharma, Inc. (Nasdaq: LUMO), a clinical stage biotechnology company focused on bringing novel therapies to patients with severe, rare, and genetic
diseases, whose medical needs are unmet. In addition, Mr.&nbsp;Hawkins currently serves on the board of directors of several privately held life sciences companies, as well as Plus Therapeutics Inc. (formerly Cytori Therapeutics, Inc.) (Nasdaq:
PSTV), and previously served on the board of directors of SciClone Pharmaceuticals, Inc. until its acquisition in October 2017. Prior to his tenure with Lumos Pharma, Inc., which began in September 2010, Mr.&nbsp;Hawkins founded and advised numerous
pharmaceutical companies including Sensus, where he served as <FONT STYLE="white-space:nowrap">co-founder</FONT> and Chair of the Board of Directors until it was sold to Pfizer in 2001. From 1981 to 2000, Mr.&nbsp;Hawkins was founder, President and
Chief Executive Officer of Pharmaco where he guided the company&#146;s growth to more than 2,000 employees. Pharmaco later merged with PPD of Wilmington, North Carolina to form PPD Pharmaco, one of the largest clinical contract research
organizations in the world. Mr.&nbsp;Hawkins received his B.S. in Biology from Ohio University. We believe Mr.&nbsp;Hawkins&#146; experience in the pharmaceutical and life sciences industries as well as his broad management experience qualify him to
serve on the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Joseph S. McCracken</I></B><I>.</I> Dr.&nbsp;McCracken has served as our Lead Independent Director
since December 2019 and a member of our Board of Directors since October 2013. Since September 2013, Dr.&nbsp;McCracken has advised biopharmaceutical companies on the design and implementation of corporate strategy and business development
initiatives. Dr.&nbsp;McCracken also serves on the board of directors of Lumos Pharma, Inc. (Nasdaq: LUMO) and Modalis Therapeutics Corporation (TSE: 4883.T), as well as the board of directors of the privately held company Regimmune Inc.
Dr.&nbsp;McCracken served on the board of directors of Kindred Biosciences, Inc. until its acquisition in August 2021, and on the board of directors of Alkahest, Inc. until its acquisition by Grifols SA in December of 2020. From July 2011 to
September 2013, Dr.&nbsp;McCracken was Vice President and Global Head of Business Development&nbsp;&amp; Licensing for Roche Pharma, a research-focused healthcare company, where he was responsible for Roche Pharma&#146;s global <FONT
STYLE="white-space:nowrap">in-licensing</FONT> and <FONT STYLE="white-space:nowrap">out-licensing</FONT> activities. From October 2009 until July 2011, he was General Manager, Roche Pharma Japan&nbsp;&amp; Asia Regional Head, Roche Partnering. Prior
to joining Roche Pharma, Dr.&nbsp;McCracken held the position of Vice President, Business Development at Genentech for more than nine years, and previously held similar positions at Aventis Pharma and Rhone-Poulenc Rorer. Dr.&nbsp;McCracken holds a
B.S. in Microbiology, an M.S. in Pharmacology and a D.V.M. from The Ohio State University. We believe Dr.&nbsp;McCracken&#146;s extensive experience in the biotechnology and pharmaceutical industries qualifies him to serve on the Board of Directors.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>David A. Ramsay</I></B>. Mr.&nbsp;Ramsay has served as a member of our Board of Directors since April 2017 and as a member of the
Board of Directors of Mast Therapeutics, Inc. from June 2011 to April 2017. Mr.&nbsp;Ramsay serves </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on the board of directors of Exuma Biotech, Inc., a privately held biotechnology company, and served on the board of directors of La Jolla Pharmaceutical Company from September 2019 until its
acquisition by Innoviva, Inc. in August 2022. Mr.&nbsp;Ramsay served as Senior Vice President and Chief Financial Officer of Bonti, Inc., a private, clinical stage biotechnology company focused on the development and commercialization of neurotoxin
products for therapeutic and aesthetic applications, from February 2018 until its acquisition by Allergan plc in October 2018. Mr.&nbsp;Ramsay served as Chief Financial Officer of Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biotechnology company
developing and commercializing novel oncology therapies, from 2003 to 2009 and from May 2013 until his retirement in July 2015. He also served as Halozyme&#146;s Vice President, Corporate Development from May 2009 to May 2013. From 2000 to 2003,
Mr.&nbsp;Ramsay was Vice President, Chief Financial Officer of Lathian Systems, Inc., a provider of technology-based sales solutions for the life science industry. From 1998 to 2000, he served as Vice President, Treasurer and Director, Corporate
Finance of Valeant Pharmaceuticals International, Inc. (formerly ICN Pharmaceuticals, Inc.), a multinational specialty pharmaceutical company. Mr.&nbsp;Ramsay began his career at Deloitte&nbsp;&amp; Touche, where he obtained his CPA license.
Mr.&nbsp;Ramsay holds a B.S. in business administration from the University of California, Berkeley and an M.B.A. with a dual major in finance and strategic management from The Wharton School at the University of Pennsylvania. We believe
Mr.&nbsp;Ramsay&#146;s significant experience as chief financial officer of life science companies, particularly his experiences at Halozyme during its successful development and its commercialization of its first products, and at a large audit and
financial advisory firm, qualify him to serve on the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>An van
<FONT STYLE="white-space:nowrap">Es-Johansson</FONT></I></B>. Dr.&nbsp;An van <FONT STYLE="white-space:nowrap">Es-Johansson</FONT> has served on our Board of Directors since December 2019. Since March 2021, Dr.&nbsp;van <FONT
STYLE="white-space:nowrap">Es-Johansson</FONT> has served as a senior advisor to Sinfonia Pharma, a Swedish pharmaceutical company with a primary focus on neurological diseases. She was previously the Chief Medical Officer and Head of Development
for AlzeCure Pharma from September 2018 to March 2021. From May 2005 to September 2018, Dr.&nbsp;van <FONT STYLE="white-space:nowrap">Es-Johansson</FONT> served in a range of executive roles of increasing responsibility at Sobi, an international
rare disease company headquartered in Stockholm, Sweden, including as Vice President and Head of EMENAR Medical Affairs for Specialty Care and Partner Products from March 2013 to January 2018. Prior to her time at Sobi, Dr.&nbsp;van <FONT
STYLE="white-space:nowrap">Es-Johansson</FONT> served in leadership positions at large pharmaceutical and smaller biotechnology companies, including Roche, Eli Lilly, Active Biotech, and BioStratum. From 2004 to 2016 she was a member of the
Scientific Advisory Board for Uppsala Bio and currently serves on the board of directors at Plus Therapeutics, Inc. (Nasdaq: PSTV), Lumos Pharma, Inc. (Nasdaq: LUMO), and the privately held company Agendia BV. Dr.&nbsp;van <FONT
STYLE="white-space:nowrap">Es-Johansson</FONT> received a M.D. from Erasmus University, Rotterdam, The Netherlands. We believe Dr.&nbsp;van <FONT STYLE="white-space:nowrap">Es-Johansson&#146;s</FONT> medical knowledge and experience in the
pharmaceutical industry qualifies her to serve on the Board of Directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_4"></A>CORPORATE GOVERNANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Independence </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of
Directors has determined that each of our directors other than Matthew Pauls is independent as defined under the Nasdaq Stock Market listing standards and rules and regulations of the SEC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Committees </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors
currently has an Audit Committee, Compensation Committee and Nominating and Governance Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee</I></B>. The
Audit Committee of our Board of Directors was established by our Board of Directors in accordance with Section&nbsp;3(a)(58)(A) of the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;) to oversee our corporate accounting and financial
reporting processes and audits of our financial statements. For this purpose, the Audit Committee performs several functions, including, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">selecting, appointing and providing for the compensation of the independent registered public accounting firm to
be engaged to prepare and issue an audit report and perform other audit, review or attest services; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approving any other permissible <FONT STYLE="white-space:nowrap">non-audit</FONT> services to be provided by the
independent auditor; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing the work and evaluating the performance of the independent auditor, and, if so determined by the Audit
Committee, terminating and replacing the independent auditor; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and discussing, including with management and the independent auditor, the annual and quarterly
financial statements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing any proposed significant changes to accounting principles and practices; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing any material changes to the system of internal control over financial reporting; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing management&#146;s report on effectiveness of internal control over financial reporting and the
independent auditor&#146;s audit of the effectiveness of Savara&#146;s internal control over financial reporting, if applicable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing a procedure for receipt, retention and treatment of any complaints or concerns received by Savara
about accounting, internal accounting controls or auditing matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing, approving and overseeing any related party transaction that would require disclosure pursuant to Item
404 of Regulation <FONT STYLE="white-space:nowrap">S-K;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing the implementation and enforcement of our insider trading policy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and evaluating any significant financial risk exposures facing Savara and the steps our management has
taken to control and monitor such exposures; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with management risks related to data privacy and cybersecurity facing the Company and the steps
management has taken to control and monitor such exposures; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with management (i)&nbsp;the adequacy of controls and security for the Company&#146;s information
technology systems and (ii)&nbsp;the Company&#146;s response plan in the event of a security breach impacting those systems. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Savara&#146;s management has the primary responsibility for our consolidated financial statements and the reporting process including our
system of internal accounting and financial controls. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee currently consists of Mr.&nbsp;Ramsay, who serves as its Chair,
Dr.&nbsp;van <FONT STYLE="white-space:nowrap">Es-Johansson</FONT> and Mr.&nbsp;Hawkins. Our Board of Directors reviews the Nasdaq listing standards definition of independence for Audit </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Committee members on an annual basis and has determined that all current members of the Audit Committee are independent as currently defined by listing standards and Rule <FONT
STYLE="white-space:nowrap">10A-3</FONT> of the Exchange Act. Our Board of Directors has also determined that Mr.&nbsp;Ramsay qualifies as an &#147;audit committee financial expert,&#148; as defined in applicable SEC rules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee</I></B>. The Compensation Committee of our Board of Directors acts on behalf of our Board of Directors to review,
adopt, or recommend for adoption, and oversee Savara&#146;s compensation strategy, policies, plans and programs. For this purpose, the Compensation Committee performs several functions, including, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and recommending to our Board of Directors for its determination and approval the amount, form and
terms of compensation of our Chief Executive Officer and other &#147;officers&#148; (as such term is defined under the Nasdaq listing standards); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and making recommendations to our Board of Directors regarding our overall compensation strategy and
policies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and making recommendations regarding Savara&#146;s equity and/or cash incentive plans and other benefit
plans and, to the extent as may be permitted or required under such plans, the committee has the power and authority to administer the plans, establish guidelines, interpret plan documents, select participants, and approve grants and awards
thereunder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">granting equity awards to <FONT STYLE="white-space:nowrap">non-officer</FONT> employees and consultants in
accordance with the terms of Savara&#146;s equity incentive plan and to establish compensation policies and practices applicable to <FONT STYLE="white-space:nowrap">non-officer</FONT> employees; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the relationship between executive officer compensation policies and practices and corporate risk
management to confirm those policies and practices do not incentivize excessive risk-taking; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating and making recommendations to our Board of Directors regarding the compensation of <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">retaining, obtaining the advice of, engaging, compensating, and terminating compensation consultants, legal
counsel and such other advisors as it deems necessary and advisable to assist it in carrying out its responsibilities and functions; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appointing, compensating, and overseeing the work of any of its compensation consultants, legal counsel, and
other advisors; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing, administering, and monitoring compliance with a policy with respect to the recovery or
&#147;clawback&#148; of compensation that complies with the requirements of the SEC and Nasdaq listing standards. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Compensation Committee may delegate its authority to administer, establish guidelines for, and interpret plans and similar programs, as well as its authority to determine the compensation of Savara&#146;s
<FONT STYLE="white-space:nowrap">non-officer</FONT> employees to Savara&#146;s officers and other appropriate supervisory personnel. To the extent permitted by applicable law and regulations and subject to certain limitations, the Compensation
Committee may delegate to a subcommittee or one or more officers of Savara (or other appropriate supervisory personnel) its authority to grant equity awards to qualified persons who are not officers or members of the Board, in accordance with
guidelines approved by the Compensation Committee or the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee currently consists of
Mr.&nbsp;Elam, who serves as its Chair, Dr.&nbsp;McCracken and Dr.&nbsp;van <FONT STYLE="white-space:nowrap">Es-Johansson.</FONT> All members of the Compensation Committee are independent as currently defined under the Nasdaq listing standards and
Rule <FONT STYLE="white-space:nowrap">10C-1</FONT> of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Governance Committee</I></B>. The Nominating
and Governance Committee of our Board of Directors is responsible for identifying, reviewing and evaluating candidates to serve as directors of Savara </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(consistent with criteria approved by our Board of Directors), reviewing and evaluating incumbent directors, selecting or recommending to our Board of Directors for selection candidates for
election to the Board, making recommendations to our Board of Directors regarding the membership of the committees of the Board, assessing the performance of the Board, and developing a set of corporate governance principles for Savara. The
responsibilities of the Nominating and Governance Committee relating to the nomination of directors include, among other things, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying and recommending to our Board of Directors nominees for possible election to the Board of Directors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating and making recommendations to our Board of Directors regarding its size, composition and leadership
structure; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and assessing Savara&#146;s corporate governance guidelines and recommending any proposed changes
thereto to our Board of Directors; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and making recommendations to our Board of Directors regarding issues of executive officer succession
planning and providing oversight with respect to corporate governance matters. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Governance Committee
currently consists of Dr.&nbsp;McCracken, who serves as its Chair, Mr.&nbsp;Elam and Dr.&nbsp;Sun. All members of the Nominating and Governance Committee are independent as currently defined in Nasdaq listing standards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors may from time to time establish other committees. Charters for the Audit Committee, the Compensation Committee and the
Nominating and Governance Committee, as well as our corporate governance guidelines, are posted on our corporate website at: https://savarapharma.com/investors/corporate-governance/. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Meetings of the Board and its Committees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required under applicable listing standards and our corporate governance guidelines, our Board of Directors meets on a regular basis to
fulfill its responsibilities, including at least once each quarter, and our independent directors meet at least annually in executive session outside the presence of <FONT STYLE="white-space:nowrap">non-independent</FONT> directors and management.
During 2023, our Board of Directors met four times, the Audit Committee met four times, the Compensation Committee met two times and the Nominating and Governance Committee met two times. Each member of our Board of Directors who served on our Board
during all or part of 2023 attended 75% or more of the aggregate of (i)&nbsp;the total number of Board meetings held during the period of such member&#146;s service and (ii)&nbsp;the total number of meetings of committees on which such member served
during the period of such member&#146;s service. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Leadership Structure and Role in Risk Oversight </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The leadership structure of our Board of Directors combines the positions of Chair of the Board and Chief Executive Officer and includes a Lead
Independent Director. Matthew Pauls currently serves as both the Chair of our Board of Directors and as our Chief Executive Officer. Joseph McCracken currently serves as the Lead Independent Director and undertakes the responsibilities specified in
our corporate governance guidelines, which include coordinating the activities of the independent directors and acting as principal liaison between the independent directors and the Chair, consulting with the Chair regarding the schedule and agenda
of Board meetings, overseeing the retention of consultants who report to the Board or independent directors, and consulting with the Chair regarding the flow of information from management that is necessary for the independent directors to
effectively and responsibly perform their duties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our corporate governance guidelines do not require our Board of Directors to combine
the roles of Chair and Chief Executive Officer, but our Board of Directors believes this leadership structure is the appropriate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
structure for our company at this time. Pursuant to our corporate governance guidelines, our Board of Directors may choose its chair in any manner that it deems to be in the best interests of our
company. We believe that combining the roles of Chair of our Board of Directors and Chief Executive Officer promotes unification and direction, allowing for increased operational effectiveness and strong, efficient leadership. We believe
Mr.&nbsp;Pauls is best positioned to identify strategic priorities, lead critical discussion, and execute our business plans. We believe that the leadership structure of our Board of Directors and its committees provides independent oversight that
balances Mr.&nbsp;Pauls&#146; combined role, which helps ensure a strong, independent, and active Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of
Directors is responsible for oversight of risks facing our company, while our management is responsible for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> management of risk. Our Board of Directors, as a
whole, directly administers its risk oversight function. In addition, the risk oversight function is also administered through the committees of our Board of Directors, which oversee risks inherent in their respective areas of responsibility, report
to our Board of Directors regularly and involve the Board as necessary. For example, the Audit Committee oversees our financial exposure and financial reporting related risks, and the Compensation Committee reviews risks related to our compensation
programs and practices and both such committees make recommendations to our Board regarding oversight of such risks. Our Board of Directors, as a whole, directly oversees our strategic and business risk, including product development risk and
business continuity risk, through regular interactions with our management. We believe our Board&#146;s leadership structure supports its role in risk oversight, with our executive officers responsible for assessing and managing risks facing our
company on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> basis and the members of our Board of Directors providing oversight of such risk management. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Resignation Policy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under
Delaware law, an incumbent director may remain in office notwithstanding the failure to receive the required vote for <FONT STYLE="white-space:nowrap">re-election</FONT> until the director&#146;s successor is duly elected. To address this
&#147;holdover rule,&#148; our corporate governance guidelines include a director resignation policy whereby our Board of Directors will nominate for <FONT STYLE="white-space:nowrap">re-election</FONT> only those directors who tender an irrevocable,
contingent resignation in writing to the Chair of our Board of Directors. The resignation becomes effective only if (a)&nbsp;the director fails to receive a sufficient number of votes for <FONT STYLE="white-space:nowrap">re-election</FONT> at a
meeting of stockholders at which director elections are held and (b)&nbsp;our Board of Directors accepts the resignation. If a director fails to receive the required vote for <FONT STYLE="white-space:nowrap">re-election,</FONT> the Nominating and
Governance Committee, or such other committee designated by our Board of Directors, which we refer to as the &#147;reviewing committee,&#148; will act promptly to consider the director&#146;s resignation and recommend to the full Board of Directors
whether to accept or reject the resignation, or whether other action should be taken. Our Board of Directors expects the director whose resignation is under consideration to abstain from participating in any decision regarding that resignation. In
considering whether to accept or reject a director&#146;s resignation, each of the reviewing committee and our Board of Directors may consider any factors it deems relevant. Within 90 days after the date of the certification of the election results
for the applicable stockholders&#146; meeting, our Board of Directors will act on the resignation, taking into account the reviewing committee&#146;s recommendation, and publicly disclose its decision. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prohibition on Hedging and Speculative Transactions Involving our Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of our insider trading policy, our directors and employees (including our executive officers) and designated consultants, advisors and
contractors are prohibited from engaging in speculative transactions involving our securities, including short sales, &#147;sales against the box&#148; or any equivalent transaction involving our securities (or the securities of any of our
customers, vendors, suppliers or other business partners). In addition, as part of our insider trading policy, our directors, officers and other employees and consultants, advisors and contractors to our company are prohibited from engaging in
hedging or derivative transactions involving our securities, such as &#147;cashless&#148; collars, forward sales, equity swaps and other similar or related transactions. Further, our insider trading policy states that our directors and employees
(including our executive officers) and other persons subject to the policy are not permitted to hypothecate or pledge our securities to secure a loan and that they cannot purchase our securities &#147;on margin&#148; (that is, borrow funds to
purchase securities, including in connection with exercising any stock options). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_5"></A>CORPORATE RESPONSIBILITY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Savara is committed to improving the lives of patients with rare respiratory diseases. In support of that commitment, below are a few
highlights that align that commitment with our approach to corporate responsibility. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Ethics</B><B></B><B>&nbsp;&amp; Compliance. </B>We are committed to acting with integrity in every aspect of
our business. We have adopted a Code of Conduct and require all employees to complete training on it. Additionally, we have established a toll-free hotline and <FONT STYLE="white-space:nowrap">web-based</FONT> service to enable anonymous reporting
of concerns regarding ethical issues or suspected violations of our policies. In 2023, no reports were submitted. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Work Environment. </B>We have adopted a Human Rights and Labor Standards Policy to evidence our commitment to
ensuring that each of our employees and the people with whom we interact are treated with fairness, respect, and dignity. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Diversity and Inclusion. </B>We value diverse backgrounds and viewpoints and are committed to equal
opportunity. We aim to recruit, hire, place, develop, compensate, and advance people based on the needs of our organization and the qualifications, performance, skills, and experience of our people.&nbsp;We expect to continue to enhance our
workforce diversity and advance the development of diverse talent. We consistently evaluate the opportunity for diversity for both our employee workforce and our Board of Directors.&nbsp;As part of our diversity and inclusion strategy, upon
beginning employment, all employees receive training on workplace diversity and inclusion. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Employee Engagement and Professional Development. </B>We strive to create a collaborative work environment and
encourage employee engagement, and we believe in investing in our employees. We seek to develop our employee talent within the organization through access to training, continuous learning programs and other development initiatives.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Health and Safety. </B>The health and safety of our employees is a top priority, and our goal is to provide a
safe and healthy work environment for all personnel. We aim to comply with applicable federal, state, and local laws regarding workplace safety and have adopted a Health and Safety in the Workplace Policy that is applicable to all employees.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Employee Wellbeing. </B>We are committed to supporting the wellbeing of our employees. We help employees
balance the demands of work and personal life by offering flexible work schedules and the ability to work remotely. Additionally, we offer paid parental leave to employees who have welcomed a new family member through birth, adoption, or foster
placement. In recognition of the challenges of returning to work following parental leave, our policy allows employees to work a reduced schedule during their first month back, with no decrease in compensation. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_6"></A>DIRECTOR NOMINATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Criteria for Board Membership and Process for Identifying and Evaluating Nominees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In recommending candidates for appointment or election to our Board of Directors, the Nominating and Governance Committee considers the
appropriate balance of experience, skills and characteristics required of our Board of Directors and seeks to ensure that at least a majority of the directors are independent under Nasdaq listing standards and that the Board&#146;s Audit Committee
and Compensation Committee will be comprised of directors who meet applicable Nasdaq listing standards and SEC rules regarding qualifications to serve on such committees. Candidates for director are selected on the basis of their depth and breadth
of experience, wisdom, integrity, ability to make independent analytical inquiries, understanding of our business environment, willingness to devote adequate time to board duties, the interplay of the candidate&#146;s experience and skills with
those of other directors and the extent to which the candidate would be a desirable addition to our Board and any of its committees. Directors generally will not be nominated for <FONT STYLE="white-space:nowrap">re-election</FONT> at any annual or
special meeting held after their 80th birthday. In addition, our corporate governance guidelines require that directors limit their service on boards of directors of public companies to a total of four (including service on our Board). Other than
the foregoing, there are no stated minimum criteria for director nominees, although the Nominating and Governance Committee may also consider such other factors as it may deem are in the best interests of our company and its stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Governance Committee recognizes the importance of diversity to a well-functioning board. When identifying and selecting
director nominees, it takes into account diversity of background, skills, professional experience and perspective within the pharmaceutical and biotechnology industries. The Nominating and Governance Committee is committed to ensuring that the Board
reflects a diverse range of viewpoints. The corporate governance guidelines note the importance of diversity and specify that when assessing candidates for Board membership, the Board shall strive to achieve a diverse balance of experiences, skills,
perspectives, and backgrounds among its members, including gender, age, race, ethnicity, and other attributes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of incumbent
directors whose terms of office are set to expire, the Nominating and Governance Committee reviews these directors&#146; overall service to the company during their terms, including the number of meetings attended, level of participation, quality of
performance and any other relationships and transactions that might impair the directors&#146; independence. In the case of new director candidates, the Nominating and Governance Committee also determines whether the nominee is independent for
Nasdaq purposes, which determination is based upon applicable Nasdaq listing standards and applicable SEC rules and regulations. The Nominating and Governance Committee then uses its network of contacts to compile a list of potential candidates, but
may also engage, if it deems appropriate, a professional search firm. The Nominating and Governance Committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible candidates after considering the
function and needs of our Board of Directors. The Nominating and Governance Committee meets to discuss and consider the candidates&#146; qualifications and then selects a nominee by majority vote which is then recommended to the full Board of
Directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Recommendations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Governance Committee will consider director candidates recommended by stockholders. The Nominating and Governance Committee
does not intend to alter the manner in which it evaluates candidates, including the minimum criteria set forth above, based on whether or not the candidate was recommended by a stockholder. Stockholders who wish to recommend individuals for
consideration by the Nominating and Governance Committee to become nominees for election to our Board of Directors may do so by delivering a written recommendation to the Nominating and Governance Committee at the following address: c/o Savara Inc.,
One Summit Square, 1717 Langhorne Newtown Rd., Suite 300, Langhorne, PA 19047, Attn: Corporate Secretary. Submissions must include the following information: the name, age, business address and residence address of the proposed nominee; a statement
of the proposed nominee&#146;s business experience and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
educational background; the proposed nominee&#146;s principal occupation or employment; the class and number of shares of our capital stock beneficially owned by the proposed nominee; a detailed
description of all relationships, arrangements or understandings between the proposing stockholder and the proposed nominee and any other person or persons (naming such person or persons) pursuant to which such proposed nomination is being made by
the stockholder; a detailed description of all relationships, arrangements or understandings between the proposed nominee and any service-provider or supplier to, or competitor of Savara; information regarding each of the criteria for Board
membership described above in sufficient detail to allow the Nominating and Governance Committee to evaluate the proposed nominee; and a statement from the proposed nominee that he or she is willing to be considered and willing to serve as a
director if nominated and elected. The proposing stockholder must also include the following information with respect to such stockholder: documentation supporting that the proposing stockholder is a stockholder of Savara; the proposing
stockholder&#146;s name and address, as they appear on Savara&#146;s books; and the class and number of shares of Savara&#146;s capital stock beneficially owned by the proposing stockholder. If a stockholder submits a director recommendation in
compliance with the procedure described above, the Nominating and Governance Committee will conduct an initial evaluation of the proposed nominee and, if it determines the proposed nominee may be a qualified candidate, the Nominating and Governance
Committee and one or more members of the management team will interview the proposed nominee to determine whether he or she might be suitable to be a director. If the Nominating and Governance Committee determines the proposed nominee would be a
valuable addition to our Board of Directors, based on the criteria for Board membership described above and the specific needs of the Board at the time, it will recommend to the Board of Directors such person&#146;s nomination. In connection with
its evaluation, the Nominating and Governance Committee may request additional information from the proposed nominee and/or the proposing stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Separately, our Bylaws contain provisions that address the process by which a stockholder may nominate an individual to stand for election to
the Board at Savara&#146;s annual meeting of stockholders. Such nominations may be made only if the stockholder has given timely written notice to the company&#146;s corporate secretary containing the information required by our Bylaws. To be
timely, such notice must be received at Savara&#146;s principal executive offices not earlier than the 120th day, nor later than the close of business on the 90th day, prior to the first anniversary of the date of the preceding year&#146;s annual
meeting as first specified in the notice of meeting (without regard to any postponements or adjournments of such meeting after such notice was first sent), except that if no annual meeting was held in the previous year or the date of the annual
meeting is more than 30 days earlier or later than such anniversary date, such notice must be received no earlier than the 120th day prior to the date of such annual meeting and not later than the close of business on the later of the 90th day prior
to the date of such annual meeting or the 10th day following the date on which Savara first publicly announces the date of such meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_7"></A>COMMUNICATIONS WITH DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholders who wish to communicate with our Board of Directors or an individual director may do so by sending a written communication
addressed to the Board of Directors or an individual director to: Savara Inc., One Summit Square, 1717 Langhorne Newtown Rd., Suite 300, Langhorne, PA 19047, Attention: Investor Relations. Submitting stockholders should indicate they are a
stockholder of our company. Depending on the subject matter, investor relations will: forward the inquiry to the Chair of our Board of Directors, who may forward the inquiry to a particular director if the inquiry is addressed to a particular
director; forward the inquiry to the appropriate personnel within our company (for instance, if it is primarily commercial in nature); attempt to handle the inquiry directly (for instance, if it is a request for information about our company or a
stock-related matter); or not forward the inquiry, if it relates to an improper or inappropriate topic or is otherwise irrelevant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any
stockholder who wishes to communicate with our Board of Directors to report complaints or concerns related to accounting, internal accounting controls or auditing may submit a report telephonically or through a
<FONT STYLE="white-space:nowrap">web-based</FONT> system via the toll-free telephone number or the internet address provided in our Code of Business Conduct and Ethics, which is available on our corporate website at
https://savarapharma.com/investors/corporate-governance/. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We encourage but do not require our directors to attend our annual meetings of
stockholders. Five of the directors serving on our Board at the time of our 2023 annual meeting of stockholders attended the annual meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_8"></A>EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our current executive officers, their ages and positions held as of April&nbsp;1, 2024, are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="66%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chair of the Board of Directors and Chief Executive Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond Pratt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Medical Officer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lowrance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial&nbsp;&amp; Administrative Officer and Secretary</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Lutz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Operating Officer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anne Erickson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Business Officer</TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Biographical Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Matthew Pauls</I></B><I>. </I>For biographical information regarding Mr.&nbsp;Pauls, see &#147;Nominees for Election to the Board&#148;
above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Raymond Pratt</I></B>.<I> </I>Dr.&nbsp;Pratt has served as our Chief Medical Officer since November 2022. Dr.&nbsp;Pratt was
previously employed by Rockwell Medical, Inc. (Nasdaq: RMTI) (&#147;Rockwell Medical&#148;), where he served as Chief Development Officer from November 2019 to March 2022 and Chief Medical Officer from April 2012 to November 2019. Prior to his
positions at Rockwell Medical, Dr.&nbsp;Pratt held senior roles at Shire PLC (&#147;Shire&#148;), including Vice President of R&amp;D, Scientific Leader of Emerging Business and Renal Business Units, Vice President of Global Clinical Medicine and
Global Clinical Affairs, and Head of U.S. Clinical Development. Prior to his time at Shire, he was Senior Director of Clinical Research and Development and Head of Central Nervous System and Internal Medicine Clinical Development at Eisai Medical
Research for nine years. Since December 2021, Dr.&nbsp;Pratt has served on the board of directors of Xortx Therapeutics Inc. (Nasdaq: XRTX), a biotechnology company primarily focused on therapies for progressive kidney disease. Dr.&nbsp;Pratt is a
graduate of the University of Illinois College of Medicine and completed his nephrology fellowship at the Walter Reed Army Medical Center where he practiced nephrology and served as the assistant chief of nephrology services and director of dialysis
services from 1983 to 1985. Dr.&nbsp;Pratt was the recipient of a physician scientist training grant at Johns Hopkins School of Medicine and the recipient of a James Shannon New Investigator award from the NIH. He served as an assistant professor in
the John Hopkins Department of Medicine and Nephrology from 1989 to 1993. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>David Lowrance</I></B>.<I> </I>Mr.&nbsp;Lowrance has
served as our Chief Financial&nbsp;&amp; Administrative Officer since December 2022 and Secretary since July 2017, and he served as our Chief Financial Officer from November 2016 to December 2022. From September 2014 to October 2016,
Mr.&nbsp;Lowrance served as the Chief Financial Officer and Treasurer of Edgemont Pharmaceuticals, a fully-integrated specialty pharmaceutical company with multiple marketed products in the CNS space. From April 2011 to September 2014,
Mr.&nbsp;Lowrance served as the Chief Financial Officer and Secretary of Acucela Inc. (&#147;Acucela&#148;), a clinical stage biotechnology company that specializes in ophthalmic therapeutics, where he was responsible for overseeing all aspects of
Acucela&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations, business development and growth endeavors, investor relations and corporate communications. While at Acucela, Mr.&nbsp;Lowrance
helped lead a $162&nbsp;million international initial public offering, with a listing on the Tokyo Stock Exchange. From March 2003 to April 2011, Mr.&nbsp;Lowrance was Vice President and Chief Financial Officer of Cumberland Pharmaceuticals Inc.
(Nasdaq: CPIX), a specialty pharmaceutical company focused on commercializing branded prescription products, where he oversaw all aspects of finance and accounting, business and growth strategy and product development. Mr.&nbsp;Lowrance, a CPA,
holds a B.B.A. in Accounting from the University of Georgia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Robert Lutz</I></B>.<I> </I>Mr.&nbsp;Lutz has served as our Chief
Operating Officer since February 2023. From March 2021 to February 2023, he served as the Chief Financial and Business Officer of iBio, Inc. a biotechnology company developing precision antibody immunotherapies using
<FONT STYLE="white-space:nowrap">an&nbsp;AI-driven&nbsp;platform.</FONT> Previously, Mr.&nbsp;Lutz was employed by Strongbridge Biopharma plc (&#147;Strongbridge&#148;), a biopharmaceutical company focused on therapies that target rare diseases,
where he served as Chief Financial Officer from August 2019 to March 2021 and as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Chief Business Officer from October 2014 to August 2019. Prior to joining Strongbridge, Mr.&nbsp;Lutz worked from December&nbsp;2004 to May&nbsp;2014 at Shire Plc, a publicly traded specialty
biopharmaceutical company prior to being purchased by Takeda Pharmaceutical Company&nbsp;Ltd., where he most recently served as Vice President and held key leadership positions in the Specialty Pharmaceutical division. Prior to Shire Plc,
Mr.&nbsp;Lutz worked in a variety of roles, including Vice President of Finance, for Cinergy Corp., an electric and gas utility company. Mr.&nbsp;Lutz also worked as a Senior Analyst at Alan B. Slifka and Co., a hedge fund, after having started his
career at Goldman Sachs Group&nbsp;Inc., where he served as a Financial Analyst in its principal investment area. He holds a B.A. in Economics and Computer Science from Amherst College and an M.B.A. from the Kellogg School of Management. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Anne Erickson</I></B>. Ms.&nbsp;Erickson has served as our Chief Business Officer since August 2023. Prior to her appointment as Chief
Business Officer, Ms. Erickson served in various roles of increasing responsibility with Savara, including as our SVP of Global Business Operations from September 2022 to August 2023, SVP and Chief of Staff from October 2020 to September 2022, VP
and Head of Investor Relations &amp; Corporate Communications from May 2019 to October 2022, and Director of Investor Relations &amp; Corporate Communications from October 2018 to May 2019. Prior to joining Savara, she held leadership roles within
corporate, consulting, and agency settings at companies such as Mirati Therapeutics, Inc., Halozyme Therapeutics, Inc. (Nasdaq: HALO), Pfizer Inc. (NYSE: PFE), and Ogilvy. Ms. Erickson holds a B.A. in English from the University of Minnesota. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_9"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding beneficial ownership of our common stock as of April&nbsp;8, 2024 (the
&#147;Evaluation Date&#148;), or an earlier date for information based on filings with the SEC, by (a)&nbsp;each person known to us to beneficially own more than 5% of the outstanding shares of our common stock, (b)&nbsp;each director and nominee
for director, (c)&nbsp;each of the named executive officers (&#147;NEOs&#148;) listed in the summary compensation table included in this proxy statement, and (d)&nbsp;all of our current directors and executive officers as a group. Percent of
beneficial ownership is based on 138,176,641 shares of our common stock outstanding as of the Evaluation Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is
determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities. Shares of common stock that may be acquired by an individual or group within 60 days of the Evaluation Date, pursuant to the
exercise of options or warrants, are deemed to be outstanding for the purpose of computing the percentage ownership of such individual or group but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other
person shown in the table. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as indicated in footnotes to this table, we believe that the stockholders named in this table have sole
voting and investment power with respect to all shares of common stock shown to be beneficially owned by them, based on information provided to us by such stockholders. Unless otherwise indicated, the address for each stockholder listed is: c/o
Savara Inc., One Summit Square, 1717 Langhorne Newtown Rd., Suite 300, Langhorne, PA 19047. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and Address of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B><br><B>Beneficially</B><br><B>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent of</B><br><B>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Principal Stockholders:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Bain Capital Life Sciences, L.P.&nbsp;(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,568,622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.99</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Persons and entities affiliated with New Enterprise Associates (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,471,264</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17.71</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Persons and entities affiliated with Farallon Capital Management, LLC&nbsp;(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,641,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.99</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Persons and entities affiliated with TCG Crossover&nbsp;(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.24</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Persons and entities affiliated with Prudential Financial (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,788,303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.08</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Persons and entities affiliated with Jennison Associates LLC (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,815,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.38</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Persons and entities affiliated with Adage Capital Partners, L.P. (7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,637,930</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.53</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Blackrock, Inc. (8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,261,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.26</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Directors and NEOs:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls (9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,271,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.64</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nevan Elam (10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard J. Hawkins (11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">178,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph S. McCracken (12)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">317,894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David A. Ramsay (13)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,348,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.70</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ricky Sun (14)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">An van <FONT STYLE="white-space:nowrap">Es-Johansson</FONT> (15)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond Pratt (16)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">153,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lowrance (17)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">861,164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Lutz (18)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anne Erickson (19)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">467,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current executive officers and directors as a group (11 persons) (20)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,086,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.13</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents beneficial ownership of less than 1% of the shares of common stock of Savara. </P></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information as to beneficial ownership is based on a Schedule 13D/A filed on July&nbsp;19, 2023 with the
SEC on behalf of Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, and BCLS II Investco, LP (collectively, the &#147;Bain Reporting Persons&#148;). The Schedule 13D/A states that, collectively, the Bain Reporting Persons
have shared voting and dispositive power over 6,913,208 shares of common stock of Savara and warrants to purchase 26,457,355 shares of common stock of Savara; however, the warrants can only be exercised to the extent such exercise would not cause
the Bain Reporting Persons to beneficially own more than 9.99% of the total number of shares of common stock of Savara outstanding immediately after giving effect to the exercise. The address of the Bain Reporting Persons is 200 Clarendon Street,
Boston, MA 02116. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information as to beneficial ownership is based on a Schedule 13D/A filed on July&nbsp;26, 2023 with the
SEC on behalf of Growth Equity Opportunities 17, LLC (&#147;GEO&#148;) and the following associated persons and entities: New Enterprise Associates 17, L.P. (&#147;NEA 17&#148;), NEA Partners 17, L.P. (&#147;NEA Partners 17&#148;), NEA 17 GP, LLC
(&#147;NEA 17 LLC&#148;), Forest Baskett (&#147;Baskett&#148;), Ali Behbahani (&#147;Behbahani&#148;), Carmen Chang (&#147;Chang&#148;), Anthony A. Florence, Jr. (&#147;Florence&#148;), Mohamad H. Makhzoumi (&#147;Makhzoumi&#148;), Edward T. Mathers
(&#147;Mathers&#148;), Scott D. Sandell (&#147;Sandell&#148;), Paul Walker (&#147;Walker&#148;), and Rick Yang (&#147;Yang&#148;) (collectively, the &#147;NEA Reporting Persons&#148;). The Schedule 13D/A states that, collectively, the NEA Reporting
Persons have shared voting and dispositive power over 24,471,264 shares of common stock of Savara. The address of the principal business office of GEO, NEA 17, NEA Partners 17, NEA 17, LLC and Sandell is New Enterprise Associates, 1954 Greenspring
Drive, Suite 600, Timonium, MD 21093. The address of the principal business office of Behbahani and Mathers is New Enterprise Associates, 5425 Wisconsin Avenue, Suite 800, Chevy Chase, MD 20815. The address of the principal business office of
Baskett, Chang, Makhzoumi, Walker and Yang is New Enterprise Associates, 2855 Sand Hill Road, Menlo Park, California 94025. The address of the principal business office of Florence is New Enterprise Associates, 104 5<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>&nbsp;Avenue, 19<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>&nbsp;Floor, New York, NY 10001. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information as to beneficial ownership is based on a Schedule 13G/A filed on February&nbsp;1, 2024 with the
SEC on behalf of Farallon Capital Partners, L.P. and the following associated persons and entities: Farallon Capital Institutional Partners, L.P., Farallon Capital Institutional Partners II, L.P., Farallon Capital Institutional Partners III, L.P.,
Four Crossings Institutional Partners V, L.P., Farallon Capital Offshore Investors II, L.P., Farallon Capital (AM) Investors, L.P., Farallon Capital F5 Master I, L.P., Farallon Partners, L.L.C., Farallon Institutional (GP) V, L.L.C., and Farallon F5
(GP), L.L.C., Joshua J. Dapice, Philip D. Dreyfuss, Hannah E. Dunn, Richard B. Fried, Varun N. Gehani, Nicolas Giauque, David T. Kim, Michael G. Linn, Rajiv A. Patel, Thomas G. Roberts, Jr., Edric C. Saito, William Seybold, Daniel S. Short, Andrew
J. M. Spokes, John R. Warren and Mark C. Wehrly (collectively, the &#147;Farallon Reporting Persons&#148;). The 13G/A states that, collectively, the Farallon Reporting Persons have shared voting and dispositive power over 6,255,406 shares of common
stock of Savara and warrants to purchase 17,940,021 shares of common stock of Savara; however, the warrants can only be exercised to the extent such exercise would not cause the Farallon Reporting Persons to beneficially own more than 9.99% of the
total number of shares of common stock of Savara outstanding immediately after giving effect to the exercise. The address of the Farallon Reporting Persons is c/o Farallon Capital Management, L.L.C., One Maritime Plaza, Suite 2100, San Francisco,
California 94111. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information as to beneficial ownership is based on a Schedule 13G filed July&nbsp;25, 2023 with the SEC on
behalf of TCG Crossover GP I, LLC, TCG Crossover Fund I, L.P. and Chen Yu (collectively, the &#147;TCG Reporting Persons&#148;). The Schedule 13G states that the TCG Reporting Persons have shared voting and dispositive power over 10,000,000 shares
of common stock of Savara. The address of each of the TCG Reporting Persons is 705 High St., Palo Alto, CA 94301. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information as to beneficial ownership is based on a Schedule 13G filed February&nbsp;13, 2024 with the SEC
on behalf of Prudential Financial, Inc. (&#147;Prudential&#148;). The Schedule 13G states that Prudential may be deemed the beneficial owner of the same securities as the following subsidiaries of Prudential: Jennison Associates, LLC
(&#147;Jennison&#148;), PGIM Quantitative Solutions LLC and PRUCO Securities, LLC. 8,815,358 of the shares being reported by Prudential are also being reported by its subsidiary, Jennison (see footnote 6 below). The Schedule 13G states that
Prudential has sole voting power over 6,345 shares of common stock, shared voting power over 9,781,958 shares of common stock, sole dispositive power over 6,345 shares of </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
common stock and shared dispositive power over 9,781,958 shares of common stock. The address of the principal business office of Prudential is 751 Broad Street, Newark, New Jersey 07102-3777.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information as to beneficial ownership is based on a Schedule 13G filed February&nbsp;8, 2024 with the SEC
on behalf of Jennison. The Schedule 13G states that Jennison has sole voting and shared dispositive power over 8,815,358 shares of common stock of Savara. Jennison furnishes investment advice to several investment companies, insurance separate
accounts and institutional clients (&#147;Managed Portfolios&#148;). As a result of its role as investment adviser of the Managed Portfolios, Jennison may be deemed to be the beneficial owner of the shares of Savara&#146;s common stock held by such
Managed Portfolios. Prudential indirectly owns 100% of equity interests of Jennison. As a result, Prudential may be deemed to have the power to exercise or to direct the exercise of such voting and/or dispositive power that Jennison may have with
respect to shares of common stock of Savara held by the Managed Portfolios. Jennison does not file jointly with Prudential, as such, shares of common stock of Savara reported on Jennison&#146;s Schedule 13G may be included in the shares reported on
any Schedule 13G that may be filed by Prudential. Prudential may be deemed the beneficial owner of 8,815,358 shares of common stock of Savara. The address of Jennison is 466 Lexington Avenue, New York, NY 10017. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information as to beneficial ownership is based on a Schedule 13G/A filed February&nbsp;7, 2024 with the
SEC on behalf of Adage Capital Partners, L.P. and the following associated persons and entities: Adage Capital Partners GP, L.L.C., Adage Capital Management, L.P., Robert Atchinson and Phillip Gross (collectively, the &#147;Adage Reporting
Persons&#148;). The Schedule 13G/A states that the Adage Reporting Persons have shared voting and dispositive power over 7,637,930 shares of common stock of Savara. The address of each of the Adage Reporting Persons is 200 Clarendon Street, 52nd
Floor, Boston, Massachusetts 02116. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information as to beneficial ownership is based on a Schedule 13G filed January&nbsp;31, 2024 with the SEC
on behalf of Blackrock, Inc. (&#147;Blackrock&#148;). The Schedule 13G states that Blackrock has sole voting power over 7,121,108 shares of common stock of Savara and dispositive power over 7,261,530 shares of common stock of Savara. The address of
Blackrock is 50 Hudson Yards, New York, NY 10001. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 1,762,327 shares of common stock of Savara issuable upon the exercise of options or vesting of RSUs
within 60 days of the Evaluation Date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 112,451 shares of common stock of Savara issuable upon the exercise of options or vesting of RSUs
within 60 days of the Evaluation Date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 166,209 shares of common stock of Savara issuable upon the exercise of options or vesting of RSUs
within 60 days of the Evaluation Date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 149,557 shares of common stock of Savara issuable upon the exercise of options or vesting of RSUs
within 60 days of the Evaluation Date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 147,750 shares of common stock of Savara issuable upon the exercise of options or vesting of RSUs
within 60 days of the Evaluation Date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Does not include shares of common stock of Savara held by the Bain Reporting Persons. Ricky Sun is a Managing
Director with Bain Capital Life Sciences, LP. Consists of 132,000 shares of common stock of Savara issuable upon the exercise of options or vesting of RSUs within 60 days of the Evaluation Date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 132,000 shares of common stock of Savara issuable upon the exercise of options or vesting of RSUs
within 60 days of the Evaluation Date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 143,125 shares of common stock of Savara issuable upon the exercise of options or vesting of RSUs
within 60 days of the Evaluation Date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(17)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 778,809 shares of common stock of Savara issuable upon the exercise of options or vesting of RSUs
within 60 days of the Evaluation Date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(18)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 111,875 shares of common stock of Savara issuable upon the exercise of options or vesting of RSUs
within 60 days of the Evaluation Date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(19)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 352,625 shares of common stock of Savara issuable upon the exercise of options or vesting of RSUs
within 60 days of the Evaluation Date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(20)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 3,097,640 shares of common stock of Savara held of record by our directors and executive officers and
3,988,728 shares of common stock of Savara issuable upon the exercise of options or vesting of RSUs within 60 days of the Evaluation Date. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_10"></A>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Audit Committee&#146;s charter (which can be found at <U>https://savarapharma.com/investors/corporate-governance/)</U> requires that the
Audit Committee review and approve any proposed related-party transaction that would require disclosure pursuant to Item 404 of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Savara had no related party transactions requiring disclosure under applicable SEC rules for the years ended December&nbsp;31, 2022 and 2023.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_11"></A>EQUITY COMPENSATION PLAN INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below provides information about our common stock that, as of December&nbsp;31, 2023, may be issued upon the exercise of options and
the vesting of RSUs under the following equity compensation plans (which are all our equity compensation plans; provided, however, that currently new equity awards may only be issued under the 2015 Omnibus Incentive Plan and the 2021 Inducement
Plan): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2015 Omnibus Incentive Plan (the &#147;2015 Plan&#148;) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Savara Inc. Stock Option Plan (the &#147;2008 Plan&#148;) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2021 Inducement Equity Incentive Plan (the &#147;2021 Inducement Plan&#148;) </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Plan Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(a)&nbsp;Number&nbsp;of&nbsp;securities<BR>to be issued upon<BR>exercise of outstanding<BR>options, warrants and<BR>rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(b)&nbsp;Weighted<BR>average exercise<BR>price&nbsp;of&nbsp;outstanding<BR>options, warrants<BR>and rights (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(c)&nbsp;Number&nbsp;of&nbsp;securities<BR>remaining available for<BR>future issuance under<BR>equity compensation<BR>plans (excluding<BR>securities
reflected in<BR>column (a))</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Compensation Plans Approved by Stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,232,879&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;2.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,061,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Compensation Plans Not Approved by Stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,888,438&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,121,317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,331,694</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The weighted average exercise price does not take into account the shares issuable upon vesting of outstanding
RSUs, which have no exercise price. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 7,242,443 shares issuable upon the exercise of outstanding options granted under the 2015 Plan,
2,828,250 shares issuable upon the vesting of RSUs granted under the 2015 Plan, and 162,186 shares issuable upon the exercise of outstanding options granted under the 2008 Plan. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 2,228,438 shares issuable upon the exercise of options granted under the 2021 Inducement Plan, and
660,000 shares issuable upon the vesting of RSUs granted under the 2021 Inducement Plan. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_12"></A>COMPENSATION DISCUSSION AND ANALYSIS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Introduction </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following Compensation Discussion and Analysis describes our compensation philosophy and the material elements of compensation in 2023 for our executive officers identified in the Summary Compensation Table below, who are referred to as our
&#147;NEOs.&#148; For the year ended December&nbsp;31, 2023, our NEOs were: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Matthew Pauls, Chief Executive Officer </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Robert Lutz, Chief Operating Officer </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">David Lowrance, Chief Financial&nbsp;&amp; Administrative Officer and Secretary </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Hiring
and retaining well-performing executives is important to our ongoing success.<B> </B>Our executive compensation program is intended to attract and retain qualified executive officers and to align the interests of our executive officers with those of
our stockholders by incentivizing and rewarding achievement of business objectives that will enhance Savara&#146;s value and by promoting commitment to long-term success. As a clinical-stage biopharmaceutical company, these objectives are to be
accomplished primarily by positioning us to successfully execute our drug product development and regulatory approval efforts and to translate those efforts, over time, into revenues and income from commercialization of, or strategic collaborations
with respect to, our product candidates. To that end, our executive compensation packages include a base salary to provide an element of income stability and security that compensates our executive officers for expected <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> performance, annual performance-based cash incentives to motivate our executive officers to achieve near-term corporate goals that are set by our Board of Directors
and intended to enhance the value of our company, and significant long-term incentives in the form of stock-based compensation to further align the interests of our executive officers with those of our stockholders, reward long-term value-creation,
and increase retention. The components of our executive compensation program are also intended to complement each other and offset risk of overemphasis on short-term goals to the detriment of long-term value creation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither our Board of Directors nor the Compensation Committee has adopted any formal or informal policies or guidelines for allocating
compensation between cash and <FONT STYLE="white-space:nowrap">non-cash</FONT> compensation, or among different forms of <FONT STYLE="white-space:nowrap">non-cash</FONT> compensation. The determination of the Board of Directors or Compensation
Committee as to the appropriate use and weight of each component of executive compensation has been historically subjective, based on its view of the relative importance of each component in meeting our overall objectives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee is responsible for designing our executive compensation program each year and recommending it for approval by our
Board of Directors. The Compensation Committee considers a number of factors, including the input of our Chief Executive Officer related to the compensation of executives other than himself. Additionally, our Compensation Committee engaged Aon
(formerly Radford, &#147;Aon&#148;), an independent executive compensation consultant, to assist in evaluating our compensation practices, including measuring the competitiveness of our compensation practices against an appropriate peer group. Prior
to engaging Aon, our Compensation Committee conducted a specific review of its relationship with Aon and determined that Aon&#146;s work for the Compensation Committee did not raise any conflicts of interest, consistent with the guidance provided
under the&nbsp;Dodd-Frank Act, and by the SEC and Nasdaq rules. Aon reports directly to our Compensation Committee Chair, takes direction from our Compensation Committee, and does not provide Savara with any services other than the services provided
at the request of our Compensation Committee. Our Compensation Committee continues to monitor the independence of its compensation consultant on a periodic basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee and Aon reviewed data from the Aon Global Life Sciences Survey as well as the compensation practices of a peer
group of comparable companies. The Compensation Committee also considered the company&#146;s performance and the performance of each of the executive officers. Based on that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
review, in December 2022,&nbsp;our Compensation Committee recommended, and our Board of Directors approved, compensation packages for our executive officers that included base salary and annual
performance-based cash compensation targets for 2023. In December 2023, our Board of Directors, upon the recommendation of our Compensation Committee, (i)&nbsp;evaluated the achievement of the performance-based targets and (ii)&nbsp;approved equity
awards to each of our NEOs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Factors for Determining 2023 Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Performance </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the
primary objectives of our executive compensation program is to motivate our executive officers to achieve strategic goals that our Board of Directors believes will lead to short-term and long-term value creation for our stockholders. As discussed
above, given the nature of our business and our life-cycle stage, these goals are largely tied to advancement of our product pipeline through the attainment of clinical and regulatory milestones, securing adequate funding, and managing our cash
resources consistent with forecast and strategic plans. Although our Board of Directors establishes <FONT STYLE="white-space:nowrap">pre-approved</FONT> goals in connection with setting the bonus targets, our Board retains significant discretion to
assess performance in a subjective, <FONT STYLE="white-space:nowrap">non-formulaic</FONT> manner. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Competitive Assessment </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors and Compensation Committee believe that examining data from similarly situated companies in our industry and
establishing a peer group and reviewing compensation packages offered and paid to similar positions of that peer group provide useful information in evaluating our executive compensation practices, including the structure and levels of compensation
that will allow us to attract, retain and motivate our executive officers and also align their interests with those of our stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the third quarter of 2022, in consultation with Aon, our Compensation Committee reviewed the peer group of publicly traded companies in the
biotechnology and biopharmaceutical industries used in its compensation assessment from the prior year and refined the peer group to more closely align with our market capitalization at the time of the selection and to replace peer companies that
had been acquired. The following peer group was recommended by Aon and approved by the Compensation Committee and our management for consideration when evaluating equity awards granted to executive officers in December 2022, and for other decisions
relating to 2023 compensation: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;89Bio, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;aTyr Pharma, Inc.*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Galecto, Inc.*</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Actinium Pharmaceuticals, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;BioAtla, Inc.*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;MEI Pharma, Inc.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Aerovate Therapeutics, Inc.*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Checkpoint Therapeutics, Inc.*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Pliant Therapeutics, Inc.*</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;AN2 Therapeutics, Inc.*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Curis, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Reata Pharmaceuticals Inc.*</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Annexon, Inc.*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;DICE Therapeutics, Inc.*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Sesen Bio, Inc.*</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Arcturus Therapeutics Holdings Inc.*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Evelo Biosciences, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Viridian Therapeutics, Inc.*</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Ardelyx, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-0.85em; font-size:10pt; font-family:Times New Roman">&#149;&#8201;&#8201;Galectin Therapeutics Inc.*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Added to the peer group in 2022. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In anticipation of its 2023 annual review of compensation, in the third quarter of 2023, again in consultation with Aon, our Compensation
Committee reviewed the above peer group and made certain adjustments to align more closely with our organizational complexity and market capitalization. Specifically, Checkpoint Therapeutics, Inc., Curis, Inc., DICE Therapeutics, Inc., Galectin
Therapeutics Inc., Galecto, Inc., MEI Pharma, Inc., Reata Pharmaceuticals Inc., Sesen Bio, Inc. were removed, and Anavex Life Sciences Corp., Edgewise Therapeutics, Inc., Fulcrum Therapeutics, Inc., KalVista Pharmaceuticals, Inc., Keros
Therapeutics, Inc., Reneo Pharmaceuticals, Inc., Vera Therapeutics, Inc., and Verona Pharma plc were added. This updated peer group was considered by the Compensation Committee when evaluating the equity awards granted to our executive officers in
2023. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To effectively recruit, retain and motivate key employees, we believe our executive
compensation must be competitive within the peer group in which we compete, while also aligned with the interest of our stockholders. Our Compensation Committee used the compensation data from the peer group as well as available survey data to
assist in its evaluation of the compensation of our executive officers and as a factor in its recommendations. However, we do not benchmark executive compensation to the compensation at the peer group. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Executive Compensation Components </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Base Salary </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose
of the base salary component of our executive compensation program is to provide a level of income that allows us to attract and retain executive talent and mitigate pressure to focus on stock price performance to the detriment of other important
aspects of our business by providing an element of income stability and security. The base salary represents fixed cash compensation recognizing individual performance, scope of responsibility, leadership skills and experience, and it compensates an
executive for performing his or her job responsibilities on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> basis. The base salaries of our executive officers are initially established through <FONT
STYLE="white-space:nowrap">arm&#146;s-length</FONT> negotiation at the time of hire. Base salaries are then reviewed at least annually by the Compensation Committee and may be adjusted to realign with market levels after taking into account
individual responsibilities, performance and experience. The Compensation Committee also evaluates an executive officer&#146;s base salary in the context of the executive&#146;s other compensation components to ensure that the executive&#146;s
compensation package is in line with our overall compensation philosophy and objectives as discussed above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2023 base salary for
Mr.&nbsp;Lutz was established at his time of hire. Mr.&nbsp;Lutz entered into an Executive Employment Agreement with us upon his appointment as Chief Operating Officer in February 2023. The agreement with Mr.&nbsp;Lutz was approved by the
Compensation Committee and the Board following the review of market data <FONT STYLE="white-space:nowrap">and&nbsp;arm&#146;s-length&nbsp;negotiation</FONT> with the executive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2022, our Compensation Committee assessed the base salary levels of our other NEOs. The Compensation Committee considered the
recommendations of Aon and reviewed data from the Aon Global Life Sciences Survey for publicly traded biopharmaceutical companies with headcounts between 15 and 120 employees and between $150&nbsp;million and $1.5&nbsp;billion in market value and
the compensation practices of the peer group of comparable companies described above. Following its review and consideration of the Aon recommendations and data, as well as individual performance, the Compensation Committee recommended approval of
the 2023 base salary of each of our NEOs to the Board of Directors, which the Board of Directors approved. The 2023 base salaries for the NEOs were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Executive Officer</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;Increase</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">595,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.4%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Lutz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">437,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lowrance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">437,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Annual Cash Incentives </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we do not have a written bonus plan, the Board of Directors sets performance targets annually for each of the NEOs, and the NEOs
receive bonuses at the end of each year based on achievement against those targets. These bonuses are designed to motivate our executive officers to achieve near-term goals and are intended to reward the attainment of annual corporate and individual
goals that we believe will enhance the long-term value of our company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2023 target bonus amount for Mr.&nbsp;Lutz was established in
his employment agreement that was negotiated and entered into at his time of hire. In December 2022, the Compensation Committee recommended, and the Board of Directors approved, the target bonus amounts and performance targets for 2023 for the other
NEOs. After considering market data and input from Aon and the practices of the peer group, the Compensation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Committee recommended, and the Board of Directors approved, that the 2023 target bonus amounts would remain the same percent of base salary as 2022 for each of the other NEOs. The approved 2023
target bonus amounts as a percent of salary for each of the NEOs were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="21%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Executive Officer</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus Target</B><br><B>(%&nbsp;of&nbsp;base&nbsp;salary)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Lutz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lowrance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The total bonus opportunity for each executive was based on the achievement of certain performance goals. For
the Chief Executive Officer, the Board determined that the achievement of companywide goals established by the Chief Executive Officer and the Board of Directors would represent 100% of the bonus award. For each of Mr.&nbsp;Lutz and
Mr.&nbsp;Lowrance, the Board determined that the achievement of the companywide goals would represent 75% of the bonus award and the achievement of individual performance measures would represent 25% of the award. For Mr.&nbsp;Lutz, due to a change
in his responsibilities during the year, it was determined the 25% for individual performance measures should instead be based on the recommendation of the Chief Executive Officer based on Mr.&nbsp;Lutz&#146;s contributions to Savara during 2023.
For Mr.&nbsp;Lowrance, the individual performance measures consisted of objectives related to financial reporting metrics and budgeting, contract negotiations, the corporate offices, human resources activities, and IT and administrative activities
and support. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The companywide goals for 2023 were intended to focus the management team on completing trial enrollment and advancing our
molgramostim nebulizer solution program. Specifically, the fiscal 2023 corporate performance goals were: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Complete <FONT STYLE="white-space:nowrap">IMPALA-2</FONT> enrollment by end of May (100%), June (95%), July
(90%), or August (85%) (50% weighting); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Launch aPAP antibody testing in the U.S. by the end of 2023 (15% weighting); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Internally approve PPQ protocols for both drug substance and drug product by Q3 2023 (10% weighting);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Internally approve comparability protocols for both drug substance and drug product by Q3 2023 (10% weighting);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Support GEMA FDA <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspection (PAI) readiness via completion
of first mock PAI in Q4 2023 (10% weighting); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Operate within 5% of the 2023 approved budget (5% weighting). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2023, the Compensation Committee met to review performance against the 2023 corporate goals and to recommend bonus amounts to our
Board of Directors. The Compensation Committee determined that the companywide goals had been fully met and it recommended that an additional amount be paid in recognition of the company&#146;s performance during 2023, which resulted in a payout of
120% of the portion of the amount of the bonus award that was based on the achievement of the companywide goals. In addition, it was determined that the individual achievement portion of the bonus for Mr.&nbsp;Lutz should be paid at the 105% level
and for Mr.&nbsp;Lowrance at the 115% level. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the total awards recommended by the Compensation Committee
and approved by our Board of Directors in December 2023 for the executives serving at that date: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Executive Officer</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus</B><br><B>Award</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">357,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Lutz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">203,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lowrance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">207,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Long-Term Incentive Awards &#150; Stock Options and Restricted Stock Units </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that stock-based compensation, such as stock options and restricted stock units (&#147;RSUs&#148;), serves to further align the
interests of our executive officers with those of our stockholders, reward long-term value-creation, and increase retention, and it is therefore a significant element of our executive compensation. We typically grant options and/or RSUs to our
employees, including executives, upon the commencement of their employment and make additional grants on an annual basis as part of the annual review of performance and compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because vesting occurs over multiple years and only if the employee continues to be employed with us at the time of vesting, and because the
realized value of the equity awards is directly related to our stock price, our Board of Directors believes these equity awards encourage our employees to remain with our company, promote a long-term perspective on corporate success, directly
incentivize the NEOs to build long-term value, and align the interests of our employees, including the NEOs, with our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
generally make an initial equity award to our executive officers in connection with the commencement of their employment.&nbsp;In connection with the appointment of Mr.&nbsp;Lutz as Chief Operating Officer in February 2023, our Board of Directors
granted Mr.&nbsp;Lutz an option to purchase 350,000 shares of our common stock, which vests quarterly over four years, and an RSU award for 140,000 shares of our common stock, which vests in full upon the
<FONT STYLE="white-space:nowrap">two-year</FONT> anniversary of the commencement of his employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2023, our Compensation
Committee and our Board of Directors considered equity awards to our employees, including our NEOs, in connection with the annual performance and compensation review process. After considering the performance of the executives and the market data
provided by Aon, the Compensation Committee recommended, and the Board of Directors approved, the following equity awards to the NEOs: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Executive Officer</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>Options<SUP STYLE="font-size:75%; vertical-align:top">&nbsp;(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>RSUs<SUP STYLE="font-size:75%; vertical-align:top">&nbsp;(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">225,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">450,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Lutz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lowrance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">The options have an exercise price of $4.45 per share and vest over a four-year period in equal quarterly
installments beginning on the first quarterly anniversary of December&nbsp;14, 2023. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">The RSUs vest in full on December&nbsp;14, 2025. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Other Elements of Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain broad-based benefits that are provided to all regular, full-time employees (including the NEOs), including health, dental and
vision insurance, health savings accounts with company contribution, disability insurance, paid time off, and a 401(k) plan with company match potential. We believe these benefits enable us to offer competitive compensation packages and support
employee focus and productivity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We did not provide any of the NEOs with perquisites in 2023 that exceeded $10,000 in the aggregate for
any person. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>NEO Employment Agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that concerns about potential job loss or the possibility or occurrence of a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">change-in-control</FONT></FONT> can create uncertainty for our NEOs that may negatively affect their performance. Accordingly, we have entered into employment agreements with each of our executive officers, which provide
for severance benefits upon a qualifying termination of employment and the executive&#146;s compliance with certain post-termination obligations, including delivery of a general release of claims. Those severance benefits are described below under
&#147;Potential Payments upon Termination or Change in Control.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Results of &#147;Say on Pay&#148; Advisory Vote on Executive Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At our 2023 annual meeting of stockholders, approximately 91% of shares that voted or abstained on the &#147;say on pay&#148; proposal
approved, on an advisory basis, the compensation paid to our NEOs as disclosed in our definitive proxy statement for that meeting. By the time of the 2023 annual meeting in June 2023, the Compensation Committee had already recommended, and the Board
of Directors had approved, a majority of the components of 2023 compensation for the NEOs; however, the Compensation Committee considered the results of the 2022 advisory vote when making their recommendations. Additionally, the Compensation
Committee considered the results of the 2023 advisory vote when recommending the remaining elements of executive compensation for 2023. Our Compensation Committee intends to monitor the results of advisory votes in making future recommendations.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Prohibition on Hedging the Economic Risk of Ownership in Our Securities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a description of restrictions related to hedging, please see the section entitled &#147;Prohibition on Hedging and Speculative Transactions
Involving our Securities.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Clawback Policy </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2023, our Compensation Committee adopted a clawback policy to comply with NASDAQ and SEC rules. Under the policy, if the Company is required
to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the U.S. federal securities laws, the Compensation Committee shall, subject to limited exceptions, seek to recover &#147;excess
incentive-based compensation&#148; from each individual who is a Section&nbsp;16 officer or was a Section&nbsp;16 officer during the performance period for such incentive-based compensation. For this purpose, excess incentive-based compensation
generally is the amount of incentive-based compensation that is based on a financial performance measure that is in excess of the amount that otherwise would have been received had such incentive-based compensation been determined based on restated
amounts in the accounting restatement. The clawback policy applies to incentive-based compensation for which the financial performance metric was attained during the three-year period preceding the date of the accounting restatement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Risk Assessment </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee evaluates our executive compensation program on an annual basis to confirm that it does not incentivize excessive
risk-taking. Our executive compensation program includes a mix of different types of compensation (base salary, annual performance-based cash bonuses, and long-term equity incentive awards), which provides balance between fixed and performance-based
compensation and as to the timing of pay realization. We also believe that our compensation program encourages and rewards prudent business judgment and incentivizes our executive officers to achieve near-term goals but not to the detriment of
long-term value creation, which further aligns the interests of the executive officers with those of our stockholders. Based on its latest review, the Compensation Committee concluded that our executive compensation program does not create risks
that are reasonably likely to have a material adverse impact on our company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Conclusion </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attracting, retaining, and motivating key employees is essential to creating stockholder value. We believe offering a competitive compensation
program with the appropriate mix of base salary and performance-based compensation, including a substantial equity component, and providing for post-termination compensation in certain circumstances, helps us achieve our business objectives and
aligns the interest of our executive officers with those of our stockholders. We believe that our 2023 executive compensation was appropriate in that regard. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2023, the Compensation Committee consisted of Mr.&nbsp;Elam, Dr.&nbsp;McCracken and Dr.&nbsp;van
<FONT STYLE="white-space:nowrap">Es-Johansson.</FONT> No member of the Compensation Committee has ever been an executive officer or employee of Savara. None of our executive officers currently serve, or served during 2023, on the compensation
committee or board of directors of a company that has an executive officer serving as a member of our Board of Directors or Compensation Committee. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPENSATION COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee of the Board of Directors has reviewed and discussed with management the Compensation Discussion and Analysis
contained in this proxy statement and, based on such review and discussions, has recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">COMPENSATION COMMITTEE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Nevan Elam
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Joseph McCracken </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">An van <FONT
STYLE="white-space:nowrap">Es-Johansson</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The material in the foregoing Compensation Committee Report is not &#147;soliciting
material,&#148; shall not be deemed &#147;filed&#148; with the U.S. Securities and Exchange Commission, and shall not be incorporated by reference in any filing of Savara Inc. under the Securities Act of 1933, as amended, or the Securities Exchange
Act of 1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_13"></A>EXECUTIVE COMPENSATION TABLES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following
table sets forth compensation information for the NEOs for the years ended December&nbsp;31, 2023 and 2022: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8.5pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name&nbsp;and&nbsp;Principal&nbsp;Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Awards<BR>($) (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option&nbsp;Awards</B><br><B>($) (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT></B><br><B>Incentive Plan</B><br><B>Compensation</B><br><B>($) (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other</B><br><B>Compensation</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Matthew Pauls (3)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">595,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,002,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">787,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">297,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,759,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">580,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">490,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">810,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,537&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,195,542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Robert Lutz</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">387,341</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">143,405</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,066,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">874,534</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,664,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Chief Operating Officer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">David Lowrance</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">437,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">712,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,519,354</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Chief Financial&nbsp;&amp; Administrative Officer&nbsp;&amp; Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">289,377</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,054,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman; " ALIGN="left">Amounts shown in this column do not reflect compensation actually received by the NEO. The amounts in this
column represent the aggregate grant date fair value of stock awards or option awards granted to the NEO in the year indicated, calculated in accordance with the provisions of Financial Accounting Standards Board, or FASB, Accounting Standards
Codification, or ASC, Topic 718, <I>Stock Compensation</I>, except that any estimate of forfeitures was disregarded. For a description of the assumptions used to calculate these amounts, see Note 12 to our audited consolidated financial statements
included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman; " ALIGN="left">Amounts in this column represent annual cash incentive awards paid to each executive officer under our annual
cash incentive program. For further information, see &#147;Compensation Discussion and Analysis&#151;Executive Compensation Components&#151;Annual Cash Incentives.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Pauls did not receive any additional compensation for his service as a director.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman; " ALIGN="left">Includes $18,000 in employer 401(k) plan matching contributions. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Grants of Plan-Based Awards </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following table sets forth information regarding grants of plan-based awards to the NEOs for the year ended December&nbsp;31, 2023: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Estimated&nbsp;Future&nbsp;Payouts&nbsp;Under&nbsp;Non-Equity</FONT></B><br><B>Incentive Plan
Awards&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All&nbsp;Other</B><br><B>Stock</B><br><B>Awards:</B><br><B>Number&nbsp;of</B><br><B>Shares of<BR>Stock or<BR>Units (#)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other</B><br><B>Option</B><br><B>Awards:</B><br><B>Number of</B><br><B>Securities</B><br><B>Underlying</B><br><B>Options (#)</B></TD>

<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;or</B><br><B>Base Price<BR>of&nbsp;Option</B><br><B>Awards</B><br><B>($/Sh)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date</B><br><B>Fair Value</B><br><B>of Stock<BR>and Option</B><br><B>Awards</B><br><B>($)&nbsp;(2)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Matthew Pauls</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">297,500&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/14/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">225,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">4.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">787,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/14/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">450,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">2,002,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Robert Lutz</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174,800&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/24/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">734,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/24/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">354,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/14/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/14/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">160,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">712,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lowrance</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">175,024&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/14/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">4.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">289,377</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/14/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">160,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">&#151;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:10pt">151,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The annual incentive plan provides only for a target payment amount, and not a threshold or maximum amount.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts shown in this column do not reflect compensation actually received by the NEO. The amounts in this
column represent the aggregate grant date fair value of RSU and option awards granted to the NEO in the year indicated, calculated in accordance with the provisions of FASB ASC Topic 718, <I>Stock Compensation</I>, except that any estimate of
forfeitures was disregarded. For a description of the assumptions used to calculate these amounts, see Note 12 to our audited consolidated financial statements included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for
the year ended December&nbsp;31, 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts reported represent the performance-based incentive cash awards each NEO could earn pursuant to our
executive bonus plan for the year ended December&nbsp;31, 2023, as described above under &#147;Compensation Discussion and Analysis&#151;Executive Compensation Components&#151;Annual Cash Incentives&#148; above. The actual amounts earned for the
year ended December&nbsp;31, 2023 are set forth in the <FONT STYLE="white-space:nowrap">&#147;Non-Equity</FONT> Incentive Plan Compensation&#148; column in the Summary Compensation Table above. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at Fiscal <FONT STYLE="white-space:nowrap">Year-End</FONT> 2023 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding outstanding equity awards held by the NEOs as of December&nbsp;31, 2023. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B><br><B>of&nbsp;Securities</B><br><B>Underlying</B><br><B>Unexercised&nbsp;Options</B><br><B>(#)&nbsp;Exercisable&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Securities</B><br><B>Underlying</B><br><B>Unexercised&nbsp;Options</B><br><B>(#)&nbsp;Unexercisable&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Exercise</B><br><B>Price&nbsp;($/sh)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Expiration</B><br><B>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;shares</B><br><B>or units of stock</B><br><B>that have not</B><br><B>vested (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market&nbsp;value of</B><br><B>shares or units of</B><br><B>stock that</B><br><B>have&nbsp;not&nbsp;vested&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/25/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/13/2028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/20/2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">898,639</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/15/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">375,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/16/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/14/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">525,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/13/2032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">325,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,527,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">225,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/14/2033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">450,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,115,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Lutz</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">284,375&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(8)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/24/2033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(9)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">658,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/14/2033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">752,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lowrance</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/25/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/2/2028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/20/2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">195,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/16/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/14/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,500&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">187,500&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/13/2032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">470,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/14/2033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">752,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The vesting schedules described for each option in this table are subject to the NEO&#146;s continued service
to our company and to acceleration in connection with an involuntary termination in connection with a change of control, as described below under &#147;Potential Payments upon Termination or Change in Control&#151;Executive Employment
Agreements.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This option vests and becomes exercisable in 16 substantially equal installments on each quarterly anniversary
of December&nbsp;16, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This option vests and becomes exercisable in 16 substantially equal installments on each quarterly anniversary
of December&nbsp;14, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This option vests and becomes exercisable in 16 substantially equal installments on each quarterly anniversary
of December&nbsp;13, 2022. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The RSUs vest in full on December&nbsp;13, 2024. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The option vests and becomes exercisable in 16 substantially equal installments on each quarterly anniversary
of December&nbsp;14, 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The RSUs vest in full on December&nbsp;14, 2025. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The option vests and becomes exercisable in 16 substantially equal installments on each quarterly anniversary
of February&nbsp;13, 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The RSUs vest in full on February&nbsp;13, 2025. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Option Exercises and Stock Vested in Fiscal Year 2023 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides, for each of the NEOs, information with respect to the exercise of stock options and, on an aggregate basis, stock
awards that vested during 2023: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares<BR>Acquired&nbsp;on<BR>Exercise (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value&nbsp;Realized&nbsp;on<BR>Exercise ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;shares<BR>acquired&nbsp;on&nbsp;vesting</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value&nbsp;realized&nbsp;on<BR>vesting ($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,780,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Lutz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dave Lowrance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">556,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Value realized on vesting of stock awards does not represent proceeds from any sale of any common stock upon
its vesting but is determined by multiplying the number of shares vested by the closing price of our common stock on the Nasdaq Global Select Market on the vesting date. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pension Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not maintain any
plan that provides for payments or other benefits at, following, or in connection with retirement, other than a 401(k) plan, which all eligible employees participate in on the same basis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nonqualified Deferred Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do
not maintain any defined contribution or other plan that provides for the deferral of compensation on a basis that is not <FONT STYLE="white-space:nowrap">tax-qualified.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Potential Payments upon Termination or Change in Control </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>NEO Employment Agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As discussed above under &#147;Compensation Discussion and Analysis,&#148; we have entered into executive employment agreements with each of
the NEOs. Those executive employment agreements require us to make specified payments and provide specified benefits related to their outstanding stock option awards in the event of a qualifying termination of employment, subject to the
officer&#146;s compliance with the terms and conditions in the agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mr.&nbsp;Pauls </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The executive employment agreement with Mr.&nbsp;Pauls provides that if Mr.&nbsp;Pauls&#146; employment is terminated (i)&nbsp;by Savara
without &#147;cause&#148; (as defined in the agreement), (ii) due to resignation by Mr.&nbsp;Pauls for &#147;good reason&#148; (as defined in the agreement), or (iii)&nbsp;due to his death or disability, and, in the case of (i)&nbsp;and (ii), such
termination occurs outside of the period beginning three months prior to, and ending 12 months following, a &#147;change of control&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(as defined in the agreements) (the &#147;change of control period&#148;), then, subject to him timely signing and not revoking a separation agreement and release of claims agreement,
Mr.&nbsp;Pauls would be entitled to receive: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a lump sum payment equal to (i)&nbsp;18 months of his then-current base salary, plus (ii) 100% of his target
bonus, plus (iii)&nbsp;a <FONT STYLE="white-space:nowrap">pro-rated</FONT> portion of his target bonus based on the number of days he was employed by our company during the relevant performance period; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reimbursements for payments the executive makes for continued healthcare coverage pursuant to COBRA until the
earlier of (i)&nbsp;the date 18 months from the termination date or (ii)&nbsp;the date upon which he and his eligible dependents become covered under similar plans; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accelerated vesting as to 100% of his equity awards and an extension of the exercise period of the awards until
the earlier of (i)&nbsp;the <FONT STYLE="white-space:nowrap">18-month</FONT> anniversary of the termination date and (ii)&nbsp;the original expiration date of the applicable award. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The executive employment agreement also provides that if Mr.&nbsp;Pauls&#146; employment is terminated (i)&nbsp;by Savara without cause, or
(ii)&nbsp;due to resignation by Mr.&nbsp;Pauls for good reason and such termination occurs during the change of control period, then, subject to him timely signing and not revoking a separation agreement and release of claims agreement,
Mr.&nbsp;Pauls would be entitled to receive: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a lump sum payment equal to (i) 24 months of his then-current base salary plus (ii) 100% of his target bonus,
plus (iii)&nbsp;a <FONT STYLE="white-space:nowrap">pro-rated</FONT> portion of his target bonus based on the number of days he was employed by our company during the relevant performance period; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reimbursements for payments the executive makes for continued healthcare coverage pursuant to COBRA until the
earlier of (i)&nbsp;the date 24 months from the termination date or (ii)&nbsp;the date upon which he and his eligible dependents become covered under similar plans; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accelerated vesting as to 100% of his equity awards and an extension of the exercise period of the awards until
the earlier of (i)&nbsp;the <FONT STYLE="white-space:nowrap">24-month</FONT> anniversary of the termination date and (ii)&nbsp;the original expiration date of the applicable award. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mr.&nbsp;Lutz and Mr.&nbsp;Lowrance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
executive employment agreement with each of Mr.&nbsp;Lutz and Mr.&nbsp;Lowrance provide that if Mr.&nbsp;Lutz&#146;s or Mr.&nbsp;Lowrance&#146;s employment is terminated (i)&nbsp;by Savara without &#147;cause&#148; (as defined in the agreement),
(ii) due to resignation by Mr.&nbsp;Lutz or Mr.&nbsp;Lowrance for &#147;good reason&#148; (as defined in the agreement), or (iii)&nbsp;due to death or disability, and, in the case of (i)&nbsp;and (ii), such termination occurs outside of the period
beginning three months prior to, and ending 12 months following, a &#147;change of control&#148; (as defined in the agreements) (the &#147;change of control period&#148;), then, subject to him timely signing and not revoking a separation agreement
and release of claims agreement, each of Mr.&nbsp;Lutz and Mr.&nbsp;Lowrance would be entitled to receive: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a lump sum payment equal to (i)&nbsp;12 months of his then-current base salary plus (ii)&nbsp;a <FONT
STYLE="white-space:nowrap">pro-rated</FONT> portion of his target bonus based on the number of days he was employed by our company during the relevant performance period; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reimbursements for payments the executive makes for continued healthcare coverage pursuant to COBRA until the
earlier of (i)&nbsp;the date 12 months from the termination date or (ii)&nbsp;the date upon which he and/or his eligible dependents becomes covered under similar plans; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accelerated vesting as to the number of shares that would have otherwise vested pursuant to his equity awards had
he remained employed by our company for 12 months following his termination date. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The executive employment agreements
also provide that if Mr.&nbsp;Lutz or Mr.&nbsp;Lowrance&#146;s employment is terminated (i)&nbsp;by Savara without cause, or (ii)&nbsp;due to resignation by Mr.&nbsp;Lutz or Mr.&nbsp;Lowrance for good reason
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and such termination occurs during the change of control period, then, subject to him timely signing and not revoking a separation agreement and release of claims agreement, each of Mr.&nbsp;Lutz
and Mr.&nbsp;Lowrance would be entitled to receive: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a lump sum payment equal to (i) 18 months of his then-current base salary, plus (ii) 100% of his target bonus,
plus (iii)&nbsp;a <FONT STYLE="white-space:nowrap">pro-rated</FONT> portion of his target bonus based on the number of days he was employed by our company during the relevant performance period; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a taxable lump sum payment equal to the amount he would pay for continued healthcare coverage pursuant to COBRA
for 18 months from the termination date; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accelerated vesting as to 100% of his equity awards. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Potential Payments Upon a Qualifying Termination of Employment </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth quantitative estimates of the benefits that would have accrued to each of Mr.&nbsp;Pauls, Mr.&nbsp;Lutz, and
Mr.&nbsp;Lowrance pursuant to their respective employment agreements if there had been a qualifying termination of his employment on December&nbsp;31, 2023. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash</B><br><B>Severance</B><br><B>Based on</B><br><B>Salary and</B><br><B>Bonus&nbsp;($)&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cost to</B><br><B>Continue</B><br><B>Health</B><br><B>Insurance</B><br><B>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value of</B><br><B>Accelerated</B><br><B>Equity</B><br><B>Awards</B><br><B>($)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value of<BR>Accrued<BR>Vacation&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,547,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,442</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,435,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,044,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Lutz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">640,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">192,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,087</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">874,055</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lowrance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">645,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">987,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,698,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Calculated using the annual base salary in effect as of December&nbsp;31, 2023. As described above under
&#147;Potential Payments upon Termination or Change in Control,&#148; in the event of a qualifying termination on that date each of the NEOs would have been entitled to a <FONT STYLE="white-space:nowrap">pro-rated</FONT> portion of his target bonus
based on the number of days he was employed by us during the relevant performance period. As of December&nbsp;31, 2023, the 2023 bonus amounts had been determined but not yet paid and are therefore included; the 2024 performance period had not yet
begun. Additionally, Mr.&nbsp;Pauls would have been entitled to an amount equal to 100% of his target bonus. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Calculated using insurance premiums in effect as of December&nbsp;31, 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Calculated using the closing sale price of our common stock on December&nbsp;29, 2023. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Potential Payments upon a Qualifying Termination of Employment due to Change in Control </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth quantitative estimates of the benefits that would have accrued to each of Mr.&nbsp;Pauls, Dr.&nbsp;Pratt, and
Mr.&nbsp;Lowrance pursuant to their respective employment agreements if there had been a change in control of our company and qualifying termination of the NEOs&#146; employment on December&nbsp;31, 2022. The Company does not provide single trigger
change in control benefits. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash</B><br><B>Severance</B><br><B>Based on</B><br><B>Salary&nbsp;and</B><br><B>Bonus&nbsp;($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cost to</B><br><B>Continue</B><br><B>Health</B><br><B>Insurance</B><br><B>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value of</B><br><B>Accelerated</B><br><B>Equity</B><br><B>Awards</B><br><B>($)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value of<BR>Accrued<BR>Vacation&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Pauls</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,844,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,435,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,347,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Lutz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">858,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,037,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,087</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,954,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lowrance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">864,183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,235,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,181,730</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Calculated using the annual base salary in effect as of December&nbsp;31, 2023. As described above under
&#147;Potential Payments upon Termination or Change in Control,&#148; in the event of a qualifying termination. For the bonus amounts, as of December&nbsp;31, 2023, the 2023 bonus amounts had been determined but not yet paid
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
and are therefore included; the 2024 performance period had not yet begun. Additionally, each of the NEOs would have been entitled to an amount equal to 100% of his target bonus.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Calculated using insurance premiums in effect as of December&nbsp;31, 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Calculated using the closing sale price of our common stock on December&nbsp;29, 2023. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pay Ratio Disclosure </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required by Item
402(u) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> we are providing the following pay ratio information with respect to the year ended December&nbsp;31, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The median of the annual total compensation of all employees of our company, except our Chief Executive Officer, for 2023 was $543,949, and
the annual total compensation basis for our Chief Executive Officer, Mr.&nbsp;Pauls, for 2023 was $3,759,723. As a result, our Chief Executive Officer&#146;s 2023 annual total compensation was approximately 6.9 times that of the median annual total
compensation of all employees of our company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We identified the median employee based on the total annual compensation, as determined
using the Summary Compensation Table methodology set out in item 402(c)(2)(x) of regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> of all full-time and part-time employees as of December&nbsp;31, 2023. In accordance with item 402(u) we
identified our median&nbsp;employee&nbsp;as the employee utilized for the year ended December&nbsp;31, 2021 and the year ended December&nbsp;31, 2022, since there has been no change in our&nbsp;employee&nbsp;population
or&nbsp;employee&nbsp;compensation arrangements that would materially affect our calculation. In making the calculation, we used an annualized compensation amount for employees who were employed less than the full year. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Median&nbsp;Employee&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Chief&nbsp;Executive<BR>Officer ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,957</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">595,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bonus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,002,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Option Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,462</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">787,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Equity</FONT> Incentive Plan Compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">297,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Compensation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">543,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,759,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pay Versus Performance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required by Item 402(v) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> we are providing the following information about the
relationship between executive &#147;compensation actually paid&#148; and the financial performance of our company. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Summary<BR>Compensation<BR>Table Total<BR>for PEO (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Compensation<BR>Actually Paid<BR>to PEO (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average&nbsp;Summary<BR>Compensation<BR>Table Total for<BR><FONT STYLE="white-space:nowrap">Non-PEO</FONT><BR>NEOs&nbsp;(3), (4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>Compensation<BR>Actually&nbsp;Paid&nbsp;to<BR><FONT STYLE="white-space:nowrap">Non-PEO</FONT><BR>NEOs (5)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value&nbsp;of&nbsp;Initial&nbsp;Fixed<BR>$100 Investment<BR>Based on: Total<BR>Shareholder Return</B><br><B>(6)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Net Loss</B><br><B>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,759,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,656,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,091,817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,355,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(54,698</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,195,542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,506,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 876,409</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 656,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(38,150</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,640,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,703,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 931,620</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 774,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(43,014</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the total compensation reported for Mr.&nbsp;Pauls, our Chief Executive Officer, for each
corresponding year in the &#147;Total&#148; column of the Summary Compensation Table. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the &#147;compensation actually paid&#148; to Mr.&nbsp;Pauls, as computed in accordance with Item
402(v) of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT> The dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr.&nbsp;Pauls during the applicable year. In accordance with the requirements of Item 402(v)
of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
the following adjustments were made to Mr.&nbsp;Pauls&#146; total compensation as reported in the Summary Compensation Table to determine the &#147;compensation actually paid&#148;:
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Summary<BR>Compensation<BR>Table Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Deductions<BR>for Reported<BR>Grant Date<BR>Fair Value of<BR>Equity<BR>Awards&nbsp;(A)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity Award<BR>Adjustments&nbsp;(B)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Compensation<BR>Actually Paid</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,759,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2,789,723</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,686,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,656,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,195,542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,301,005</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,612,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,506,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,640,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(729,545</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 793,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,703,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the sum of the totals of the amounts reported in the &#147;Stock Awards&#148; and &#147;Option
Awards&#148; columns in the Summary Compensation Table for the applicable year. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of
the following: (i)&nbsp;the <FONT STYLE="white-space:nowrap">year-end</FONT> fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii)&nbsp;the amount of change as of the end of
the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii)&nbsp;for awards that are granted and vest in same applicable
year, the fair value as of the vesting date; (iv)&nbsp;for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)&nbsp;for
awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi)&nbsp;the dollar value of
any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the
applicable year. The amounts deducted or added in calculating the equity award adjustments are as follows: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;End&nbsp;Fair<BR>Value of<BR>Outstanding<BR>and Unvested<BR>Equity<BR>Awards<BR>Granted in<BR>the Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;over&nbsp;Year<BR>Change in Fair<BR>Value of<BR>Outstanding<BR>and Unvested<BR>Equity Awards<BR>Granted in<BR>Prior Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value&nbsp;as<BR>of Vesting<BR>Date&nbsp;of&nbsp;Equity<BR>Awards<BR>Granted and<BR>Vested in the<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;over&nbsp;Year<BR>Change in Fair<BR>Value of<BR>Equity&nbsp;Awards</B><br><B>Granted in<BR>Prior Years<BR>that Vested in<BR>the
Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value&nbsp;at the<BR>End of the Prior<BR>Year of Equity<BR>Awards&nbsp;that&nbsp;Failed<BR>to Meet Vesting<BR>Conditions in
the<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value of<BR>Dividends or<BR>other Earnings<BR>Paid on Stock<BR>or Option<BR>Awards not<BR>Otherwise<BR>Reflected in<BR>Fair Value
or<BR>Total<BR>Compensation)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total Equity<BR>Award<BR>Adjustments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,689,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,100,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(102,741</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,686,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,343,676</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 239,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 28,919</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,612,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 776,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(26,027</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 42,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 793,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The NEOs included for purposes of calculating the average amounts in each applicable year are:
</P></TD></TR></TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">2023: Mr.&nbsp;Lutz and Mr.&nbsp;Lowrance </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">2022: Dr.&nbsp;Pratt and Mr.&nbsp;Lowrance </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">2021: Dr.&nbsp;Chowdhury and Mr.&nbsp;Lowrance </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the total compensation reported for the average of the amounts reported for our NEOs as a group
(excluding Mr.&nbsp;Pauls) in the &#147;Total&#148; column of the Summary Compensation Table. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the average amount of &#147;compensation actually paid&#148; to our NEOs as a group (excluding
Mr.&nbsp;Pauls), as computed in accordance with Item 402(v) of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT> The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group (excluding
Mr.&nbsp;Pauls) during the applicable year. In accordance with the requirements of Item 402(v) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> the following adjustments were made to average total compensation for the NEOs as a group
(excluding Mr.&nbsp;Pauls) total </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
compensation as reported in the Summary Compensation Table to determine the &#147;compensation actually paid,&#148; using the same methodology described above in Note 2: </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>Reported<BR>Summary<BR>Compensation<BR>Table Total<BR>for <FONT STYLE="white-space:nowrap">Non-PEO</FONT><BR>NEOs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Deductions<BR>for&nbsp;Average<BR>Reported<BR>Grant Date<BR>Fair Value<BR>of&nbsp;Equity<BR>Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average&nbsp;Equity<BR>Award<BR>Adjustments&nbsp;(A)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>Compensation<BR>Actually Paid<BR>to <FONT STYLE="white-space:nowrap">Non-PEO</FONT><BR>NEOs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,091,817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,396,343</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,660,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,355,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">876,409</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(523,589</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">304,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">656,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">931,620</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(220,334</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">63,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">774,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts deducted or added in calculating the total average equity award adjustments are as follows:
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>Year End<BR>Fair&nbsp;Value&nbsp;of<BR>Outstanding<BR>and&nbsp;Unvested<BR>Equity<BR>Awards<BR>Granted in<BR>the Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year over<BR>Year<BR>Average<BR>Change in<BR>Fair&nbsp;Value&nbsp;of<BR>Outstanding<BR>and&nbsp;Unvested<BR>Equity<BR>Awards<BR>Granted in<BR>Prior
Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>Fair<BR>Value<BR>as of<BR>Vesting<BR>Date of<BR>Equity<BR>Awards<BR>Granted<BR>and<BR>Vested<BR>in the<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year over<BR>Year<BR>Average<BR>Change in<BR>Fair Value<BR>of Equity<BR>Awards<BR>Granted in<BR>Prior Years<BR>that Vested<BR>in the Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>Fair Value<BR>at the End<BR>of the<BR>Prior Year<BR>of Equity<BR>Awards<BR>that Failed<BR>to Meet<BR>Vesting<BR>Conditions<BR>in
the<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average Value<BR>of Dividends<BR>or other<BR>Earnings Paid<BR>on Stock or<BR>Option<BR>Awards not<BR>Otherwise<BR>Reflected in<BR>Fair Value
or<BR>Total<BR>Compensation)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Average<BR>Equity<BR>Award<BR>Adjustments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,833,235</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">170,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(343,046</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,660,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">556,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">33,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(286,510</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">304,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">235,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,852</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(214,370</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">63,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Total shareholder return is calculated by dividing the sum of the amount of dividends for the measurement
period, assuming dividend reinvestment, and the difference between our company&#146;s share price at the end and the beginning of the measurement period by our company&#146;s share price at the beginning of the measurement period. No dividends were
paid on stock or option awards in 2021, 2022 or 2023. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Analysis of the Information Presented in the Pay versus
Performance Table </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described in more detail in the section &#147;Compensation Discussion and Analysis,&#148; our executive
compensation program is intended to align the interests of our executive officers with those of our stockholders, and as a clinical-stage biopharmaceutical company, that is accomplished by positioning the company to successfully execute our drug
product development and regulatory approval efforts and to translate those efforts, over time, into revenues and income from commercialization of, or strategic collaborations with respect to, our product candidates. For that reason, we do not
specifically align our performance measures with &#147;compensation actually paid&#148; (as computed in accordance with Item 402(v) of Regulation <FONT STYLE="white-space:nowrap">S-K)</FONT> for a particular year, and we have not historically looked
to net income (loss) as a performance measure for our executive compensation program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following graphs visually describe the relationship between (1) &#147;compensation
actually paid&#148; to our PEO and the average &#147;compensation actually paid&#148; to our <FONT STYLE="white-space:nowrap">non-PEO</FONT> NEOs and cumulative total shareholder return and (2) &#147;compensation actually paid&#148; to our PEO and
the average &#147;compensation actually paid&#148; to our <FONT STYLE="white-space:nowrap">non-PEO</FONT> NEOs and net loss. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g785934g41g41.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g785934g25o54.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_14"></A>DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows compensation information for the individuals who served as <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors during the year ended December&nbsp;31, 2023. Mr.&nbsp;Pauls did not receive any additional compensation for his service as a director. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Director Compensation for Fiscal Year 2023 </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;Earned</B><br><B>or Paid in</B><br><B>Cash ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock</B><br><B>Awards</B><br><B>($)&nbsp;(1)&nbsp;(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nevan Elam (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rick Hawkins (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">149,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joe McCracken (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">155,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David A. Ramsay (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">158,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ricky Sun (7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">An van <FONT STYLE="white-space:nowrap">Es-Johansson</FONT> (8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">155,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts in this column do not reflect compensation actually received by the directors. The amounts in this
column represent the aggregate grant date fair value of stock awards granted to the directors in 2023, calculated in accordance with the provisions of FASB ASC Topic 718,<I> Stock Compensation</I>, except that any estimate of forfeitures was
disregarded. For a description of the assumptions used to calculate these amounts, see Note 12 to our audited consolidated financial statements included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended
December&nbsp;31, 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December&nbsp;31, 2023, each of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors held
22,500 unvested RSUs. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December&nbsp;31, 2023, Mr.&nbsp;Elam held options to purchase a total of 112,451 shares of our common
stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December&nbsp;31, 2023, Mr.&nbsp;Hawkins held options to purchase a total of 166,209 shares of our common
stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December&nbsp;31, 2023, Dr.&nbsp;McCracken held options to purchase a total of 149,557 shares of our
common stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December&nbsp;31, 2023, Mr.&nbsp;Ramsay held options to purchase a total of 147,750 shares of our common
stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December&nbsp;31, 2023, Dr.&nbsp;Sun held options to purchase a total of 132,000 shares of our common
stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December&nbsp;31, 2023, Dr.&nbsp;van <FONT STYLE="white-space:nowrap">Es-Johansson</FONT> held options to
purchase a total of 132,000 shares of our common stock. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Overview of <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director
Compensation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With the assistance of the Compensation Committee, our Board of Directors periodically reviews and evaluates the
director compensation policy and adopts changes designed to allow us to recruit and retain individuals with the requisite experience, skills, and characteristics for membership on our Board of Directors. Under the policy, <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors are compensated through a combination of cash fees and equity awards. In December 2023, following a review of market data provided by Aon, our Compensation Committee recommended that annual
equity awards to directors be in the form of RSUs, which the Board of Directors approved. Additionally, we reimburse <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for travel and other reasonable <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses related to attendance at meetings of the Board of Directors and its committees. Our current <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation policy is further
described below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Cash Fees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each <FONT STYLE="white-space:nowrap">non-employee</FONT> director receives an annual fee of $40,000 in cash for serving on the Board of
Directors. In addition, the lead independent director is entitled to an annual cash fee of $30,000, and the chairs and members of the three standing committees of the Board of Directors are entitled to the following annual cash fees: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Board Committee</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Chair&nbsp;Fee*($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Member&nbsp;Fee&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any <FONT STYLE="white-space:nowrap">non-employee</FONT> director who serves as chair of a committee shall not
be entitled to a member fee for the same committee. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Equity Awards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the cash compensation, on December&nbsp;14, 2023, each <FONT STYLE="white-space:nowrap">non-employee</FONT> director received an
annual grant of 22,500 RSUs, which vest in full on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the grant date. Each RSU award was granted under the 2015 Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_15"></A>AUDIT COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management has the primary responsibility for our financial reporting process, accounting principles and internal controls as well as the
preparation of our financial statements. Under its charter, the Audit Committee oversees our accounting and financial reporting process and audits of our financial statements on behalf of our Board of Directors. Each of the members of the Audit
Committee meets the applicable independence standards and qualification requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee appointed RSM US LLP
(&#147;RSM&#148;), an independent registered public accounting firm, as our independent auditor for fiscal year ended December&nbsp;31, 2023. As such, RSM was responsible for expressing an opinion on our annual financial statements based on an audit
conducted in accordance with the standards established by the Public Company Accounting Oversight Board (the &#147;PCAOB&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this
context and in connection with the audited financial statements contained in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2023, the Audit Committee: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed and discussed the audited financial statements as of and for the fiscal year ended December&nbsp;31,
2023 with our management; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">discussed with RSM the matters required to be discussed by the applicable requirements of the PCAOB and the U.S.
Securities and Exchange Commission (the &#147;SEC&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed and discussed with RSM any communications between RSM&#146;s team and RSM&#146;s national office with
respect to auditing or accounting issues presented by the external audit engagement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed the written disclosures and the letter from RSM required by applicable requirements of the PCAOB
regarding the independent accountant&#146;s communications with the Audit Committee concerning independence, and has discussed with RSM its independence; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">based on the foregoing reviews and discussions, recommended to our Board of Directors that the audited financial
statements be included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2023 filed with the SEC on March&nbsp;7, 2024. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">AUDIT COMMITTEE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">David A. Ramsay, Chair </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Richard J. Hawkins </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">An van <FONT STYLE="white-space:nowrap">Es-Johansson</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The preceding &#147;Audit Committee Report&#148; shall not be deemed soliciting material or filed with the SEC, nor shall any information
in this report be incorporated by reference into any past or future filing of Savara Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent Savara Inc. specifically incorporates it
by reference into such filing. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_16"></A>PRINCIPAL ACCOUNTANT FEES AND SERVICES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee has appointed RSM, an independent registered public accounting firm, as our independent auditor for the fiscal year ending
December&nbsp;31, 2024. We are asking our stockholders to ratify this appointment. See &#147;Proposal 4 &#151; Ratification of Independent Registered Public Accounting Firm&#148; below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fees of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee of our Board of Directors selected RSM as our independent registered public accounting firm for the fiscal years ended
December&nbsp;31, 2023 and December&nbsp;31, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents the fees for professional services rendered by RSM for
the fiscal years ended December&nbsp;31, 2023 and December&nbsp;31, 2022. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees (RSM) (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">387,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">320,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">405,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">361,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Audit Fees&#148; were principally for audit work performed on our consolidated financial statements and
internal control over financial reporting, but also include fees for professional services provided in connection with the review of financial statements included in our quarterly reports and our registration statements filed with the SEC, and
related services normally provided in connection with statutory and regulatory filings and engagements, such as providing comfort and consent letters. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Tax Fees&#148; were principally related to performance and calculation pursuant to Internal Revenue Code
Section&nbsp;382 &#147;Limitation on net operating loss carryforwards and certain <FONT STYLE="white-space:nowrap">built-in</FONT> losses following ownership change.&#148; </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Pre-Approval</FONT> Policies and Procedures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2022 and 2023, the Audit Committee <FONT STYLE="white-space:nowrap">pre-approved</FONT> all audit and other services performed by RSM.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to its charter, the Audit Committee must approve, in advance, all audit, review and attest services and all permissible <FONT
STYLE="white-space:nowrap">non-audit</FONT> services (including any permissible tax or internal control-related services) to be provided by our independent registered public accounting firm. The Audit Committee may
<FONT STYLE="white-space:nowrap">pre-approve</FONT> services as part of its approval of the scope of the engagement of the independent registered public accounting firm or on an individual <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis. The Audit Committee considers whether the provision of any <FONT STYLE="white-space:nowrap">non-audit</FONT> service is compatible with maintaining the independence of our auditors. The
Audit Committee&#146;s charter provides that it may adopt policies and procedures for the <FONT STYLE="white-space:nowrap">pre-approval</FONT> of permissible services, which may include delegation of authority to a designated member or members of
the Audit Committee to approve permissible services so long as any such approvals are disclosed to the full Audit Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_17"></A>PROPOSAL 1 &#151; ELECTION OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, our stockholders will vote on the election of six directors to serve for
<FONT STYLE="white-space:nowrap">one-year</FONT> terms until the 2025 annual meeting of stockholders and until their successors are elected and qualified, or until their earlier death, retirement, resignation or removal. Our Board of Directors has
nominated Matthew Pauls, Nevan Elam, Richard J. Hawkins, Joseph S. McCracken, David A. Ramsay, and An van <FONT STYLE="white-space:nowrap">Es-Johansson</FONT> for election to our Board of Directors at the Annual Meeting. Dr.&nbsp;Ricky Sun will not
stand for reelection following the completion of his term at the Annual Meeting. The director nominees have indicated that they are willing and able to serve as directors. If any of the nominees becomes unable or unwilling to serve, the proxies
being solicited by this proxy statement will be voted for the election of any substitute nominee who shall be designated by our Board of Directors to fill the vacancy. The proxies being solicited by this proxy statement will be voted for no more
than six nominees at the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming a quorum is present at the Annual Meeting, each director nominee who receives an
affirmative vote of the holders of a majority of the shares of common stock having voting power present or represented by proxy at the Annual Meeting will be elected. Abstentions will have the same effect as negative votes. Broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> will not be counted toward the vote total and therefore will have no effect on the outcome of this proposal. Stockholders do not have cumulative voting rights in the election of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Our Board of Directors unanimously recommends a vote &#147;FOR&#148; the election of Matthew Pauls, Nevan Elam, Richard J. Hawkins, Joseph
S. McCracken, David A. Ramsay, and An van <FONT STYLE="white-space:nowrap">Es-Johansson</FONT> as directors. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_18"></A>PROPOSAL 2 &#151; APPROVAL OF OUR 2024 OMNIBUS INCENTIVE PLAN
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, we are asking our stockholders to approve the adoption of the 2024 Omnibus Incentive Plan (the &#147;2024
Plan&#148;). Subject to stockholder approval, the Board of Directors adopted the 2024 Plan on March&nbsp;21, 2024, upon the recommendation of the Compensation Committee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reasons for Voting for this Proposal </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are
requesting approval of the 2024 Plan because the Savara Inc. Amended and Restated 2015 Omnibus Incentive Plan (the &#147;2015 Plan&#148;) is set to expire in 2025. If stockholders do not approve the 2024 Plan, it will not be implemented, and the
Company will not be able to grant equity or equity-based compensation under a stockholder approved plan after the 2015 Plan expires. The Board is therefore recommending that stockholders approve the 2024 Plan to ensure that the Board and the
Compensation Committee will be able to make the types of awards desirable to meet the Company&#146;s compensatory needs going forward. Our Board of Directors believes that the effective use of stock-based long-term incentive compensation is
essential for our company to maintain a balanced and competitive compensation program and important to our ability to achieve long-term business objectives. We typically grant equity awards to our employees upon the commencement of their employment
and make additional grants as part of their ongoing compensation packages. Because vesting occurs over multiple years and only if the employee continues to be employed with us at the time of vesting and because the realized value of the equity
awards is directly related to our stock price, we believe these awards help to align the interests of participants with those of our stockholders, reward long-term value-creation, and increase retention. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2024 Plan is intended to replace the 2015 Plan. If stockholders approve the 2024 Plan, no further grants will be made under the 2015 Plan
on the day immediately following the date the 2024 Plan is approved by the Company&#146;s stockholders (i.e., the 2015 Plan will terminate on the Effective Date of the 2024 Plan).<I>&nbsp;See &#147;Effective Date&#148; below.</I>&nbsp;All
outstanding awards under the 2015 Plan will continue in accordance with the 2015 Plan and any award agreement executed in connection with such outstanding awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholder approval of the 2024 Plan is also necessary to ensure that the 2024 Plan meets the requirements under section 422 of the Internal
Revenue Code for issuing incentive stock options and the Nasdaq approval requirements for equity compensation plans. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Key
Considerations and Historical Equity Granting Practices </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares available for grant under the 2024 Plan would consist of 11,700,000
shares of common stock plus (i)&nbsp;any shares remaining available for grant under the 2015 Plan (987,502 shares as of the record date), and (ii)&nbsp;any shares subject to awards granted under the 2015 Plan that are outstanding as of the Effective
Date but that expire, terminate, or are cancelled for any reason without being exercised in full (other than shares withheld as a result of net exercise or settlement or shares used to pay any exercise price or tax withholding obligation) (with
shares subject to awards under the 2015 Plan other than stock options or stock appreciation rights added to the share pool under the 2024 Plan as 1.34 shares). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors currently expects that the shares currently remaining available under the 2015 Plan plus the additional 11,700,000
shares of common stock under the 2024 Plan will likely be sufficient to meet our anticipated equity compensation needs for at least the next three years. In addition to our Company&#146;s planned growth and the need to retain and motivate key
employees and service providers, our Board of Directors considered the following principal factors when determining the appropriate number of shares: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Number of Shares Available for Grant under 2015 Plan:</I></B>&nbsp;As of the record date,
987,502&nbsp;shares remained reserved and available for issuance under the 2015 Plan. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Number of Awards Outstanding:</I></B>&nbsp;As of the record date, the following awards were outstanding
under the 2015 Plan: options with respect to 7,249,693 shares with a weighted-average exercise price of $2.58 and a weighted average remaining term of 7.52 years, and full value awards with respect to 2,866,687 shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Burn Rate:</I></B>&nbsp;Burn rate measures the usage of shares for our stock plans as a percentage of our
outstanding shares, which some stockholders view as a useful measure to compare the rates at which peer companies have granted equity. The more equity that a company grants in relation to the total number of its shares of common stock outstanding,
the higher that company&#146;s burn rate will be. For each of 2021, 2022, and 2023, our burn rate was <FONT STYLE="white-space:nowrap">2-3%.</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on 138,176,641 shares outstanding as of the record date, if all 11,700,000 new shares under the 2024 Plan, all 10,116,380 shares subject
to outstanding awards under the 2015 Plan and all 987,502 shares available for future awards under the 2015 Plan are ultimately issued, the shareholder dilution would be 14.17%.The Board believes that this level of potential dilution is reasonable
for a company of our size in our industry and gives the Company the ability to retain and motivate key employees and service providers. Expectations regarding future share usage under the 2024 Plan are naturally based on a number of assumptions
regarding factors such as future growth in the population of eligible participants, the rate of future compensation increases, the rate at which shares are returned to the 2024 Plan through forfeitures, cancellations and the like, the level at which
performance-based awards pay out, and our future stock price performance. While the Compensation Committee believes that the assumptions utilized are reasonable, future share usage will differ from current expectations to the extent that actual
events differ from the assumptions utilized. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary of the 2024 Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the material terms of the 2024 Plan. This summary does not purport to be a complete description of all provisions
of the 2024 Plan and is qualified in its entirety by reference to the complete text of the 2024 Plan, a copy of which is attached as Appendix A to this Proxy Statement. You may also obtain a copy of the 2024 Plan, free of charge, by writing to the
Company, Savara Inc., at One Summit Square, 1717 Langhorne Newtown Rd., Suite 300, Langhorne, PA 19047, Attention: Investor Relations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Corporate Governance Provisions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2024 Plan contains several provisions intended to make awards under the 2024 Plan comply with established principles of good corporate
governance. These provisions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>No Discounted Stock Options.</I></B>&nbsp;Except for certain substitute awards, stock options may not be
granted with an exercise price of less than the fair market value of our common stock on the date the stock option is granted (or in the case of an incentive stock option, the exercise price may not be less than 110% of the fair market value of our
common stock on the date the stock option is granted). This restriction may not be changed without stockholder approval. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>No Stock Option Repricings.</I></B><B><I></I></B>&nbsp;Stock options may not be repriced without
stockholder approval, whether by lowering the exercise price of an outstanding option or by cancelling an outstanding option and granting cash, a replacement stock option with a lower exercise price, or another award. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>No Liberal Share Recycling.</I></B><B><I></I></B>&nbsp;The 2024 Plan allows shares to be recycled only if
an award terminates or expires, or is canceled or forfeited for any reason. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Cap
on</I></B><B><I></I></B><B><I><FONT STYLE="white-space:nowrap">&nbsp;Non-Employee</FONT></I></B><B><I></I></B><B><I>&nbsp;Director Compensation</I></B>. The total compensation paid to a
<FONT STYLE="white-space:nowrap">single&nbsp;non-employee&nbsp;director</FONT> in any calendar year, including the cash compensation and cash value of all equity awards granted to
<FONT STYLE="white-space:nowrap">such&nbsp;non-employee&nbsp;director,</FONT> cannot exceed $1,000,000. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>No Evergreen Provision</I></B>. The 2024 Plan does not contain an automatic provision to replenish the
shares of common stock authorized for issuance. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>No Dividends on Unvested Awards.</I></B><B><I></I></B>&nbsp;Dividends and dividend equivalents that may
accrue with respect to awards under the 2024 Plan may not be paid until the underlying award vests. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Clawback Policies.</I></B><B><I></I></B>&nbsp;Awards made under the 2024 Plan will be subject to the
Company&#146;s clawback or recoupment policies. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Administration </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee will administer the 2024 Plan. The Compensation Committee is authorized to grant awards to eligible employees,
officers, consultants, advisors, <FONT STYLE="white-space:nowrap">and&nbsp;non-employee&nbsp;directors.</FONT> All members of the Compensation Committee <FONT STYLE="white-space:nowrap">are&nbsp;&#147;non-employee&nbsp;directors&#148;</FONT> within
the meaning of <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3&nbsp;under</FONT> the Exchange Act, and &#147;independent directors&#148; under applicable NYSE rules. The Compensation Committee has the full authority and discretion to grant and
administer awards under the 2024 Plan, including, but not limited to, the authority to: select eligible employees, officers, consultants, advisors, <FONT STYLE="white-space:nowrap">and&nbsp;non-employee&nbsp;directors</FONT> to whom awards may from
time to time be granted; determine the number of shares of common stock to be covered by each award; determine the type and terms and conditions of each award; condition the grant, vesting or payment of any award on the attainment of performance
criteria over a performance period, set such goals and certify the attainment of such goals; and construe and interpret the terms and provisions of the 2024 Plan and any award agreements thereunder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Eligibility </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards under the 2024 Plan may be made to consultants,&nbsp;officers, advisors,
<FONT STYLE="white-space:nowrap">non-employee&nbsp;directors,</FONT> and eligible employees. As of the record date, there were approximately 39 employees and <FONT STYLE="white-space:nowrap">six&nbsp;non-employee&nbsp;directors</FONT> eligible to
participate in the 2024 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Award Types, Available Shares, and Award Limits </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock options (both incentive stock options <FONT STYLE="white-space:nowrap">and&nbsp;non-qualified&nbsp;stock</FONT> options), stock
appreciation rights, restricted stock, restricted stock units, and other awards, including common stock and awards valued in whole or in part by reference to the fair market value of common stock, are available for grant under the 2024 Plan. The
maximum number of shares of Company common stock that may be issued in connection with awards made under the 2024 Plan is 11,700,000 shares plus (i)&nbsp;any shares remaining available for grant under the 2015 Plan (987,502 shares as of the record
date), and (ii)&nbsp;any shares subject to awards granted under the 2015 Plan that are outstanding as of the Effective Date but that expire, terminate, or are cancelled for any reason without being exercised in full (other than shares withheld as a
result of net exercise or settlement or shares used to pay any exercise price or tax withholding obligation). Shares subject to awards granted under the 2015 Plan other than stock options or stock appreciation rights that expire, terminate, or are
cancelled will be added to the share pool under the 2024 Plan as 1.34 shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Adjustments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number and kind of shares authorized for grant under the 2024 Plan, the number of shares subject to an award, and the exercise price of
awards, shall be adjusted by the Board as it determines, in good faith, to be necessary or advisable to prevent substantial dilution or enlargement of the rights of participants under the 2024 Plan in the event of any change in the number or kind of
shares of Company stock outstanding by reason of any stock split, reverse stock split, stock dividend, combination or reclassification of shares, recapitalization, merger,
<FONT STYLE="white-space:nowrap">consolidation,&nbsp;spin-off,&nbsp;reorganization,</FONT> reclassification or change in par value, or other extraordinary or unusual events affecting the outstanding shares of Company common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Transferability&nbsp;of</FONT> Awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as the Compensation Committee may permit, at the time of grant or thereafter, awards granted under the 2024 Plan are generally not
transferable by a participant other than by will or the laws of descent and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
distribution. Shares of our common stock acquired by a permissible transferee will continue to be subject to the terms of the 2024 Plan and the applicable award agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Effect of Certain Transactions; Change in Control </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a change of control, except as otherwise provided in the particular award agreement, where the Company is not the surviving
corporation (or survives only as a subsidiary of another corporation), unless the Compensation Committee determines otherwise, all outstanding awards shall be assumed by, or replaced with comparable awards by, the surviving corporation (or a parent
or subsidiary of the surviving corporation). Upon a change of control where the surviving corporation (or a parent or subsidiary of the surviving corporation) does not assume or replace the awards with comparable awards, except as otherwise provided
in the particular award agreement, (i)&nbsp;all options and stock appreciation rights shall become immediately exercisable with respect to 100% of the shares or rights subject thereto, (ii)&nbsp;the restricted stock and restricted stock units that
are subject to time-based vesting shall become fully vested, and (iii)&nbsp;the restricted stock and restricted stock units that are subject to achievement of performance goals and not subject to time-based vesting shall become vested, in such
amounts as determined by the Compensation Committee as if the applicable performance goals had been achieved at least at the target level and the corresponding number of shares of restricted stock shall vest. Notwithstanding any provision in the
2024 Plan or an award agreement to the contrary, in the event of a termination without cause that occurs in the twenty-four (24)-month period following a change of control, such terminated participant&#146;s unvested awards shall become fully
vested. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of the foregoing, a &#147;change of control&#148; generally means the occurrence of one of the following events:
(i)&nbsp;any person is or becomes the beneficial owner, directly or indirectly, of 50% or more of either the outstanding shares of common stock or the combined voting power of the Company&#146;s then outstanding voting securities entitled to vote
generally, (ii)&nbsp;during any twelve (12)-month period, individuals who constitute the Board at the beginning of such period cease to constitute at least a majority thereof, unless the election or the nomination was approved by a vote of at least
three-quarters of the directors then still in office who were directors at the beginning of the period, or (iii)&nbsp;the Company undergoes a liquidation or dissolution or a sale of all or substantially all of the assets of the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Term </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming
that the 2024 Plan is approved by the stockholders at the Annual Meeting, awards under the 2024 Plan may not be made after June&nbsp;7, 2034, but awards granted prior to such date may extend beyond that date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Amendment and Termination </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may at any time amend, in whole or in part, any or all of the provisions of the 2024 Plan, or suspend or terminate it entirely,
retroactively or otherwise. Except as required to comply with applicable law, no such amendment may reduce the rights of a participant with respect to awards previously granted without the consent of such participant. In addition, without the
approval of our stockholders, no amendment may be made that would: increase the aggregate number of shares of our common stock that may be issued under the 2024 Plan; extend the maximum option term; amend the terms of any outstanding stock option or
other stock appreciation award to reduce the exercise price thereof (i.e., reprice); cancel any outstanding &#147;in-the-money&#148; stock option or other stock appreciation award in exchange for cash, other awards or stock option or other stock
appreciation award with a lower exercise price; or require stockholder approval under the rules of any exchange or system on which the Company&#146;s securities are listed or traded. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>U.S. Federal Income Tax Considerations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the principal U.S. federal income tax consequences to the Company and to participants subject to U.S. taxation
with respect to awards granted under the 2024 Plan. This summary is not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
intended to be exhaustive and does not discuss the income tax laws of any city, state or foreign jurisdiction in which a participant may reside. Participants are advised to consult with their own
tax advisors with respect to the tax consequences inherent in the ownership and/or exercise of the awards, and the ownership and disposition of any underlying securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-Qualified</FONT></I><I></I><I>&nbsp;Stock Options</I>. A participant who is granted a nonqualified
stock option under the 2024 Plan will not recognize any income for federal income tax purposes on the grant of the option. Generally, on the exercise of the option, the participant will recognize taxable ordinary income equal to the excess of the
fair market value of the shares on the exercise date over the option price for the shares. Upon disposition of the shares purchased pursuant to the stock option, the participant will recognize long-term or short-term capital gain or loss, as the
case may be, equal to the difference between the amount realized on such disposition and the basis for such shares, which basis includes the amount paid for the shares and the amount previously recognized by the participant as ordinary income. If
the common stock received upon exercise of an option is restricted stock, the rules regarding restricted stock will apply. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Incentive
Stock Options</I>. A participant who is granted an incentive stock option, or ISO, will not recognize any taxable income for federal income tax purposes either on the grant or exercise of the ISO. The aggregate fair market value of common stock
(determined at the grant date) with respect to which ISOs can be exercisable for the first time during any calendar year cannot exceed $100,000. Any excess will be treated as <FONT STYLE="white-space:nowrap">a&nbsp;non-qualified&nbsp;stock</FONT>
option. If the participant disposes of the shares purchased pursuant to the ISO more than two years after the date of grant and more than one year after the issuance of the shares to the participant (the required statutory &#147;holding
period&#148;), (a) the participant will recognize long-term capital gain or loss, as the case may be, equal to the difference between the selling price and the option price; and (b)&nbsp;the Company will not be entitled to a deduction with respect
to the shares of stock so issued. If the holding period requirements are not met, any gain realized upon disposition will be taxed as ordinary income to the extent of the excess of the lesser of (i)&nbsp;the excess of the fair market value of the
shares at the time of exercise over the option price, and (ii)&nbsp;the gain on the sale. Also in that case, the Company will be entitled to a deduction in the year of disposition in an amount equal to the ordinary income recognized by the
participant. Any additional gain will be taxed as short-term or long-term capital gain depending upon the holding period for the stock. A sale for less than the option price results in a capital loss. The excess of the fair market value of the
shares on the date of exercise over the option price is, however, includable in the option holder&#146;s income for alternative minimum tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock</I>. A participant will not be taxed at the date of grant of an award of restricted stock, but will be taxed at ordinary
income rates on the fair market value of any shares of restricted stock as of the date that the restrictions lapse and the shares vest, unless the participant elects under Section&nbsp;83(b) of the Internal Revenue Code to include in income the fair
market value of the restricted stock as of the date of such grant. Any disposition of shares after restrictions lapse will be subject to the regular rules governing long-term and short-term capital gains and losses, with the basis for this purpose
equal to the fair market value of the shares at the end of the restricted period (or on the date of the grant of the restricted shares, if the participant has made an election under Section&nbsp;83(b) of the Internal Revenue Code). To the extent
unrestricted dividends are paid during the restricted period under the applicable award agreement, any such dividends will be taxable to the participant at ordinary income tax rates and will be deductible by the company unless the participant has
made a Section&nbsp;83(b) election, in which case the dividends will thereafter be taxable to the participant as dividends and will not be deductible by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Other Stock-Based Awards</I>. A participant generally will not recognize taxable income upon the grant of another stock-based award. When
the conditions and requirements for the grants have been satisfied and the award is settled, any cash received or the fair market value of any common stock received will constitute ordinary income to the participant. If a participant sells any
shares of stock acquired pursuant to the grant of another stock-based award, the difference between the amount realized on the sale and the participant&#146;s tax basis </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with respect to those shares (which, generally, will be equal to the amount of income the participant reported with respect to the payment of the shares of common stock) will be taxed as short-or
long-term capital gain or loss, depending on whether <FONT STYLE="white-space:nowrap">the&nbsp;one-year&nbsp;capital</FONT> gain holding period is met. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Cash Awards</I>. A participant generally will not recognize taxable income upon the grant of a cash award. When the conditions and
requirements for the awards have been satisfied and the award is settled, the cash received will constitute ordinary income to the participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Company Tax Deduction</I>. To the extent that a participant recognizes ordinary income in the circumstances described above, the Company or
affiliate for which the participant performs services will generally be entitled to a corresponding federal income tax deduction, provided that, among other things, the income meets the test of reasonableness, is an ordinary and necessary business
expense, is not an &#147;excess parachute payment&#148; within the meaning of Internal Revenue Code Section&nbsp;280G. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Effective
Date </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2024 Plan will become effective on the day immediately following its approval by the Company&#146;s stockholders (the
&#147;Effective Date&#148;). Assuming that the 2024 Plan is approved by the stockholders at the Annual Meeting, the Effective Date of the 2024 Plan will be June&nbsp;7, 2024. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>New Plan Benefits </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Future grants under the 2024 Plan will be made at the discretion of the 2024 Plan administrator and, accordingly, are not yet determinable. In
addition, benefits under the 2024 Plan will depend on a number of factors, including the fair market value of our common stock on future dates and the exercise decisions made by participants. Consequently, at this time, it is not possible to
determine the future benefits that might be received by participants receiving discretionary grants under the 2024 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Required Vote and
Recommendation of the Board </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming a quorum is present at the Annual Meeting, the affirmative vote of the holders of a majority of
the shares of common stock having voting power present or represented by proxy at the Annual Meeting is required to approve this proposal. Abstentions will have the same effect as negative votes.
<FONT STYLE="white-space:nowrap">Broker&nbsp;non-votes&nbsp;will</FONT> not be counted toward the vote total and therefore will have no effect on the outcome of this proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Our Board of Directors unanimously recommends a vote &#147;FOR&#148; the proposal to approve the adoption of the 2024 Plan. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_19"></A>PROPOSAL 3 &#151; AMENDMENT OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OUR AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO ALLOW FOR EXCULPATION OF OFFICERS AS PERMITTED BY DELAWARE LAW </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the recommendation of the Nominating and Governance Committee, our Board of Directors has unanimously approved an amendment (&#147;the
Amendment&#148;) to our Amended and Restated Certificate of Incorporation (our &#147;Certificate of Incorporation&#148;) to allow for exculpation of officers as permitted by Delaware law, subject to stockholder approval. Our board of directors has
declared the proposed Amendment advisable and in the best interests of our company and our stockholders and is submitting it for stockholder approval at the Annual Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Background </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are incorporated in the
State of Delaware and subject to the Delaware General Corporation Law (&#147;DGCL&#148;). Effective August&nbsp;1, 2022, Section&nbsp;102(b)(7) of the DGCL was amended to permit a corporation to include a provision in its certificate of
incorporation eliminating or limiting the personal liability of certain officers to the corporation or its stockholders for monetary damages for breach of fiduciary duty. Previously, the DGCL only allowed a corporation to include such a provision in
its certificate of incorporation pertaining to the exculpation of its directors. Section&nbsp;102(b)(7) of the DGCL, as amended, does not permit officer exculpation for claims that involve breaches of the duty of loyalty, acts or omissions not in
good faith or that involve intentional misconduct or a knowing violation of law, any transaction in which the officer derived an improper personal benefit, or claims brought by or in the right of the corporation, such as derivative claims. The
officer exculpation provisions apply to the following officers of a corporation: the president, chief executive officer, chief operating officer, chief financial officer, chief legal officer, controller, treasurer or chief accounting officer, any
other officer that is a &#147;named executive officer&#148; identified in the corporation&#146;s SEC filings, and any other individuals who have agreed to be identified as officers of the corporation for purposes of service of process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Certificate of Incorporation currently provides for exculpation of our directors from personal liability to the extent permitted by the
DGCL. In light of the amendments to Section&nbsp;102(b)(7) of the DGCL, our Board is recommending the adoption of the Amendment in order to better align the protections available to our officers under our Certificate of Incorporation and Delaware
law with those available to our directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rationale for the Proposed Amendment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board believes it is important to extend the exculpation protection to officers in order to allow the Company to attract and retain
qualified individuals to serve as officers. By the nature of their role, officers are frequently required to make decisions on crucial and time-sensitive matters, which can create significant risk of lawsuits seeking to impose substantial personal
liability. Defending such lawsuits is a distraction and can cause an officer to expend considerable resources, regardless of merit. Without the protection of exculpation, qualified individuals may be deterred from serving as officers of the Company.
Such lawsuits also often result in substantial costs to the Company, either through indemnification or higher insurance premiums. Additionally, the Amendment will avoid the practice among plaintiff&#146;s lawyers of bringing certain claims that
would be exculpated if brought against directors against individual officers in order to avoid dismissal. Given the limited types of claims for which officers can be exculpated under the DGCL, the Board believes the Amendment strikes the appropriate
balance between the stockholders&#146; interest in accountability and the Company&#146;s interest in attracting and retaining qualified and experienced officers and avoiding the distraction of frivolous litigation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Text of the Proposed Amendment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Certificate of Incorporation currently provides for the exculpation of directors and does not include a provision allowing for the
exculpation of officers. We propose to amend Paragraph (A)&nbsp;of Article VII of our Certificate of Incorporation so that it would state in its entirety as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(A) To the fullest extent permitted by the DGCL, as the same exists or as may hereafter be amended, no director or officer shall be
personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, as applicable.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Other than the amendments to Paragraph (A)&nbsp;of Article VII of our Certificate of Incorporation, the remainder of our Certificate of
Incorporation will remain unchanged after the effectiveness of the Amendment. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Effectiveness of the Amendment and Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the proposed amendment is adopted, it will become effective upon the filing of a certificate of amendment to our Certificate of
Incorporation with the Secretary of State of the State of Delaware. The adoption of this Amendment requires the approval of the holders of a majority of our outstanding shares of common stock as of the record date. Abstentions and broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> will have the same effect as votes against the proposal. If this proposal is not approved by our stockholders, our Certificate of Incorporation will continue as currently in effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our stockholders approve this proposal, our Board of Directors currently intends to file an amendment to our Certificate of Incorporation
substantially in the form of Appendix B to this Proxy Statement with the Secretary of State of the State of Delaware as soon as practicable following stockholder approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Our Board of Directors unanimously recommends a vote &#147;FOR&#148; the amendment of our Certificate of Incorporation to allow for
exculpation of officers as permitted by Delaware law. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_20"></A>PROPOSAL 4 &#151; RATIFICATION OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, our stockholders will be asked to ratify the appointment of RSM as our independent registered public accounting firm
for the fiscal year ending December&nbsp;31, 2024. Stockholder ratification of the appointment of RSM is not required by our Bylaws or otherwise. Our Board of Directors is submitting the appointment of RSM to our stockholders for ratification as a
matter of good corporate practice. If our stockholders do not ratify the appointment of RSM, the Audit Committee will reconsider this appointment. Even if the appointment is ratified, the Audit Committee, in its discretion, may appoint a different
independent registered public accounting firm at any time during the year if the Audit Committee determines that such a change would be in the best interests of our company and our stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A representative of RSM is expected to be present at the Annual Meeting, will have an opportunity to make a statement if that representative
so desires, and will be available to respond to appropriate questions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming a quorum is present at the Annual Meeting, the
affirmative vote of the holders of a majority of the shares of our common stock having voting power present or represented by proxy at the Annual Meeting is required to approve this proposal. Abstentions will have the same effect as negative votes.
Brokers and other nominees generally will have discretionary authority to vote on this proposal because it is considered a routine matter, and therefore we do not expect broker <FONT STYLE="white-space:nowrap">non-votes</FONT> with respect to this
proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Our Board of Directors unanimously recommends a vote &#147;FOR&#148; the ratification of the appointment of RSM as our
independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2024. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_21"></A>PROPOSAL 5 &#151; ADVISORY VOTE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our goal for our executive compensation program is to attract, motivate and retain qualified executives in a way that establishes an
appropriate relationship between executive pay and the creation of stockholder value on a long-term basis. We believe that our executive compensation program accomplishes this goal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our executive compensation program and the 2023 compensation of our NEOs are described in this proxy statement in the Compensation Discussion
and Analysis, compensation tables and narrative discussion above. We are requesting that our stockholders vote to approve the compensation of our NEOs as disclosed in this proxy statement pursuant to the SEC&#146;s compensation disclosure rules,
which disclosures include the compensation tables and the narrative discussion following the compensation tables. This advisory vote is generally referred to as a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay</FONT></FONT> vote&#148; and is being provided pursuant to Section&nbsp;14A of the Exchange Act. In accordance with the results of the 2019 stockholder vote on the
frequency of holding <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay</FONT></FONT> votes,&#148; our Board of Directors has determined that the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay</FONT></FONT> vote&#148; shall be held on an annual basis through the date of the next stockholder vote on the frequency of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">&#147;say-on-pay</FONT></FONT> votes.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors is asking our stockholders to indicate
their support for the compensation of our NEOs as described in this proxy statement by voting &#147;FOR&#148; the following resolution: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, that the compensation paid to the company&#146;s NEOs as disclosed in this proxy statement pursuant to Item 402 of Regulation <FONT
STYLE="white-space:nowrap">S-K,</FONT> including the Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby APPROVED.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As an advisory vote, this proposal will not be binding upon our Board of Directors or us. However, the views expressed by our stockholders are
important to us and, accordingly, our Board of Directors and the Compensation Committee intend to consider the outcome of this vote when evaluating and making future decisions regarding executive compensation arrangements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Our Board of Directors unanimously recommends a vote &#147;FOR&#148; the approval of the compensation of our NEOs as disclosed in this
proxy statement. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_22"></A>OTHER MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the time of preparation of this proxy statement, neither our Board of Directors nor our management knows of any matter to be presented
at the Annual Meeting that is not listed in the Notice of Annual Meeting accompanying this proxy statement and described in this proxy statement. If any other matters should properly come before the Annual Meeting or any adjournment or postponement
thereof, however, the holders of proxies solicited by this proxy statement will vote on such matters in accordance with their judgment. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc785934_23"></A>STOCKHOLDER PROPOSALS AND DIRECTOR NOMINATIONS FOR 2025 ANNUAL MEETING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The deadline for submitting a stockholder proposal for inclusion in our proxy materials for the 2025 annual meeting of stockholders (the
&#147;2025 Annual Meeting&#148;) is December 27, 2024, which is 120 days prior to the anniversary date that we released this proxy statement to our stockholders for the Annual Meeting, unless the date of the 2025 Annual Meeting is changed by more
than 30 days from June&nbsp;6, 2025, which is the first anniversary date of the Annual Meeting, in which case the proposal must be received a reasonable time before the company begins to print and send its proxy materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholders who wish to nominate persons for election to our Board of Directors or make a stockholder proposal at the 2025 Annual Meeting
without including the proposal in our proxy materials relating to such meeting must notify us in writing at our principal executive offices no earlier than February&nbsp;6, 2025 which is 120 days prior to the first anniversary of the date of the
Annual Meeting, and no later than March&nbsp;8, 2025, which is 90 days prior to the first anniversary of the date of the Annual Meeting. In the event the Board of Directors increases the number of directors to be elected to the Board of Directors
and the public announcement of such increase is not made on or before February&nbsp;26, 2025, which is 100 days prior to the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Annual Meeting, stockholder nominees for the new
directorships will be considered timely if provided to our corporate secretary within ten days of the public announcement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to
the notice and information requirements contained in the Bylaws, to comply with the SEC universal proxy rules, stockholders who, in connection the 2025 Annual Meeting, intend to solicit proxies in support of director nominees other than the
company&#146;s nominees must provide notice to the company that sets forth the information required by the SEC&#146;s Rule <FONT STYLE="white-space:nowrap">14a-19</FONT> no later than April&nbsp;7, 2025, unless the date of the 2025 Annual Meeting
has changed by more than 30 days from June&nbsp;6, 2025, which is the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Annual Meeting, in which case such notice must be provided by the later of 60 days prior to the 2025 Annual
Meeting date or the tenth day following the public announcement of 2025 Annual Meeting date by the company. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Rule
14a-4(c)(1) promulgated under the Exchange Act, the proxies designated by us for the 2025 Annual Meeting will have discretionary authority to vote on any matters for which notice is not timely received as described above. In addition, our Bylaws
provide that any matter to be presented at an annual meeting of stockholders must be proper business to be transacted at such meeting or a proper nomination to be decided on at the meeting and must have been properly brought before such meeting
pursuant to our Bylaws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Corporate Secretary must receive notices of stockholder proposals or nominations in
writing at our principal executive offices at Savara Inc., One Summit Square, 1717 Langhorne Newtown Rd., Suite 300, Langhorne, PA 19047, Attention: Corporate Secretary, and such notices of stockholder proposals must comply with the applicable
requirements as to form and substance established by the SEC, including Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> of the Exchange Act and our Bylaws for such proposals. Stockholders are advised to review our Bylaws, which contain additional
advance notice requirements. A copy of our Bylaws is available to stockholders upon written request to our Corporate Secretary and was also filed as Exhibit 3.1 to our Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the
SEC on March&nbsp;30, 2023. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">/s/ Matthew Pauls</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Matthew Pauls</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Chair of the Board of Directors&nbsp;&amp;</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Chief Executive Officer</I></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Langhorne, PA </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;26, 2024 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>YOUR VOTE IS IMPORTANT! </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>You are cordially invited to attend the Annual Meeting. However, to ensure the presence of a quorum and that your shares are represented at
the Annual Meeting, as well as to save us additional proxy solicitation costs, we encourage you to submit your proxy or voting instructions as soon as possible. For specific instructions as to how to vote your shares, please refer to the
instructions in the Notice of Internet Availability you received in the mail, or, if you&#146;ve requested and received printed proxy materials, please refer to the instructions in the enclosed proxy card. Even if you have voted by proxy, you may
still vote electronically if you attend the Annual Meeting. Please note, however, that if your shares are held of record by a broker or other nominee, you will need to follow the voting procedure your broker or other nominee provides to vote your
shares. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="toc785934_24"></A>Appendix A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SAVARA INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2024
OMNIBUS INCENTIVE PLAN </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(as approved by the Board, subject to stockholder approval) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.</B> <B>PURPOSE OF THE PLAN</B>. The purpose of the 2024 Omnibus Incentive Plan (the &#147;<B><I>Plan</I></B>&#148;) is to provide
favorable opportunities for directors, officers, employees, consultants or advisors employed by or providing services to Savara Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;) or any of its Subsidiaries, to acquire shares of
common stock of the Company (&#147;<B><I>Common Stock</I></B>&#148;) or to benefit from the appreciation thereof. Such opportunities should provide an increased incentive for these individuals to contribute to the future success and prosperity of
the Company, thus enhancing the value of the Company&#146;s Common Stock for the benefit of the stockholders, and increase the ability of the Company to attract and retain individuals of exceptional skill upon whom, in large measure, its sustained
progress, growth and profitability depend. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEFINITIONS. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B><I>Award</I></B><B></B>&nbsp;means any (i)&nbsp;Options, (ii) Stock Appreciation Rights, (iii)&nbsp;Restricted Shares,
(iv)&nbsp;Restricted Stock Units, or (v)&nbsp;Other Awards, granted under the Plan, whether granted singly, in combination or in tandem to a Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B><I>Award Agreement</I></B>&nbsp;means the written agreement between the Company and a Participant that sets forth the terms,
conditions, performance requirements, limitations and restrictions applicable to an Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>
<B><I>Board</I></B><B></B>&nbsp;means the Board of Directors of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B><I>Cause</I></B> means, with respect to a
Participant&#146;s Termination, &#147;Cause&#148; as defined in any written agreement between Participant and the Company, or if no such agreement exists, unless otherwise set forth in the applicable Award Agreement, termination due to (a)&nbsp;the
Participant&#146;s conviction of, or plea of guilty or<I>&nbsp;nolo contendere</I>&nbsp;to, a felony; (b)&nbsp;perpetration by the Participant of an illegal act, dishonesty or fraud that could have a significant adverse effect on the Company or its
assets or reputation; or (c)&nbsp;the Participant&#146;s willful misconduct with regard to the Company, as determined by the Committee. With respect to a Participant who is a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director,
&#147;Cause&#148; means an act or failure to act that constitutes cause for removal of a director under Delaware law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B>
<B><I>Change of Control</I></B>&nbsp;means the occurrence of any of the following events: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any &#147;person&#148; (as that term is used in Sections 13 and 14(d)(2) of the Exchange Act) other than a
Permitted Holder (as defined below) is or becomes the beneficial owner (as that term is used in Section&nbsp;13(d) of the Exchange Act), directly or indirectly, of 50% or more of either the outstanding shares of Common Stock or the combined voting
power of the Company&#146;s then outstanding voting securities entitled to vote generally, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">during any twelve (12)-month period, individuals who constitute the Board at the beginning of such period cease
for any reason to constitute at least a majority thereof, unless the election or the nomination for election by the Company&#146;s stockholders of each new director was approved by a vote of at least three-quarters of the directors then still in
office who were directors at the beginning of the period, or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company undergoes a liquidation or dissolution or a sale of all or substantially all of the assets of the
Company. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">No merger, consolidation or corporate reorganization in which the owners of the combined voting power of the
Company&#146;s then outstanding voting securities entitled to vote generally prior to said </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
combination, own 50% or more of the resulting entity&#146;s outstanding voting securities shall, by itself, be considered a Change of Control. As used herein, &#147;<B><I>Permitted
Holder</I></B>&#148; means (A)&nbsp;the Company, (B)&nbsp;any corporation, partnership, trust or other entity controlled by the Company and (C)&nbsp;any employee benefit plan (or related trust) sponsored or maintained by the Company or any such
controlled entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B><I>Code</I></B>&nbsp;means the Internal Revenue Code of 1986, as amended. All section references to the
Code in this Plan are intended to include any amendments or substitutions thereof or subsequent to the adoption of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(g)</B>
<B><I>Common Stock</I></B>&nbsp;means the Company&#146;s common stock, $0.001 par value per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(h)</B>
<B><I>Committee</I></B><B></B>&nbsp;means the Compensation Committee of the Board, each of whom shall be an &#147;independent director&#148; as defined in the listing standards of the exchange on which the Common Stock is principally traded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> <B><I>Company Group</I></B> means, collectively, the Company and its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> <B><I>Effective Date </I></B>means the date that the Plan is first approved by the stockholders of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> <B><I>Eligible Individuals</I></B>&nbsp;means any of the following individuals: (i)&nbsp;directors, officers and employees of the
Company or any of its Subsidiaries, or (ii)&nbsp;consultants or advisors to the Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(l)</B>
<B><I>Exchange Act</I></B>&nbsp;means the Securities Exchange Act of 1934, as amended. References to any specific section of the Exchange Act shall be deemed to include such regulations and guidance issued thereunder, as well as any successor
section, regulations or guidance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(m)</B> <B><I>Exercise Price</I></B>&nbsp;means the exercise price per share of Common Stock
specified in an Option or Stock Appreciation Right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(n)</B> <B><I>Fair Market Value</I></B>&nbsp;means, with respect to shares of
Common Stock, (i)&nbsp;if the Common Stock is listed on a national securities exchange, the closing sales price of the Common Stock reported on the primary exchange on which the Common Stock is listed and traded on such date, or, if there are no
such sales on that date, then on the last preceding date on which such sales were reported; (ii)&nbsp;if the Common Stock is not listed on any national securities exchange but is quoted in an inter-dealer quotation system on a last-sale basis, the
average between the closing bid price and ask price reported on such date, or, if there is no such sale on that date, then on the last preceding date on which a sale was reported; or (iii)&nbsp;if the Common Stock is not listed on a national
securities exchange or quoted in an inter-dealer quotation system on a last-sale basis, the amount determined by the Committee in good faith to be the fair market value of the Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(o)</B> <B><I>Incentive Stock Option</I></B>&nbsp;means an Option intended, as expressed in the Award Agreement, to meet the requirements
of an &#147;incentive stock option&#148; as defined in Section&nbsp;422(b) of the Code and the regulations thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(p)</B> <B><I><FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director</I></B> means a member of the Board who is not an employee of any member of the Company Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(q)</B> <B><I><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option</I></B>&nbsp;means an Option that is not an Incentive
Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(r)</B> <B><I>Option</I></B><B></B>&nbsp;means a right to purchase shares of Common Stock at a stated price. An Option
may either be an Incentive Stock Option or a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(s)</B> <B><I>Other Award</I></B>&nbsp;means an Award designated as an Other Award
pursuant to this Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(t)</B> <B><I>Participant</I></B><B></B>&nbsp;means an Eligible Individual to whom one or more Awards are or
have been granted under this Plan and have not been fully settled or cancelled and, following the death of any such person, his successors, heirs, executors and administrators, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(u)</B> <B><I>Person </I></B>means any individual, entity or group (within the meaning of Section&nbsp;13(d)(3) or 14(d)(2) of the Exchange
Act). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> <B><I>Plan</I></B><B></B>&nbsp;means this Savara Inc. 2024 Omnibus Incentive Plan, as set forth herein and as it may be
amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(w)</B> <B><I>Prior Plan</I></B> shall mean the Company&#146;s Amended and Restated 2015 Omnibus Incentive
Plan. Outstanding awards granted under the Prior Plan continue to be governed under the terms of the Prior Plans and, as of the Effective Date, no Awards may be granted under the Prior Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(x)</B> <B><I>Qualifying Director </I></B>means a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; within the
meaning of <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(y)</B> <B><I>Restricted
Stock</I></B>&nbsp;means a share of Common Stock that may be subject to certain transferability and other restrictions and to a risk of forfeiture (including by reason of not satisfying certain performance goals). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(z)</B> <B><I>Restricted Stock Unit</I></B>&nbsp;means a right to receive a share of Common Stock at a future date, which may be
conditioned on the satisfaction of certain requirements (including the satisfaction of certain performance goals). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(aa)</B>
<B><I>Stock Appreciation Right</I></B>&nbsp;means a right to receive, with respect to each share of Common Stock subject to such Stock Appreciation Right, value in an amount equal to the excess, if any, of (i)&nbsp;the Fair Market Value of a share
of Common Stock on the day of exercise or the trading day immediately preceding the date of exercise, as determined by the Committee in its reasonable discretion over (ii)&nbsp;the Exercise Price of such Stock Appreciation Right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(bb)</B> <B><I><FONT STYLE="white-space:nowrap">Sub-Plan</FONT> </I></B>means any <FONT STYLE="white-space:nowrap">sub-plan</FONT> to the
Plan that has been adopted by the Board or the Committee for the purpose of permitting or facilitating the offering of Awards to employees of certain designated Subsidiaries organized under the laws of any jurisdiction other than the United States
of America or otherwise outside the jurisdiction of the United States of America, with each such <FONT STYLE="white-space:nowrap">Sub-Plan</FONT> designed to comply with applicable law in such foreign jurisdictions. Although any <FONT
STYLE="white-space:nowrap">Sub-Plan</FONT> may be designated a separate and independent plan from the Plan in order to comply with applicable law, the Plan&nbsp;Share Reserve and the other limits specified in Section&nbsp;4 of the Plan shall apply
in the aggregate to the Plan and any <FONT STYLE="white-space:nowrap">Sub-Plan</FONT> adopted hereunder.<B><I> </I></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(cc)</B>
<B><I>Subsidiaries</I></B><B></B>&nbsp;has the meaning given to such term by Section&nbsp;424 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(dd)</B> <B><I>Termination
</I></B>means the termination of a Participant&#146;s employment or service, as applicable, with the Company or Subsidiary with which such Participant was principally employed or to which such Participant provided services, for any reason (including
death or disability). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B><B> ADMINISTRATION. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>General</B>. The Committee shall administer the Plan. To the extent required to comply with the provisions of <FONT
STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> promulgated under the Exchange Act (if the Board is not acting as the Committee under the Plan) it is intended that each member of the Committee shall, at the time such member takes any action with
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respect to an Award under the Plan that is intended to qualify for the exemptions provided by <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> promulgated under the Exchange Act be a
Qualifying Director. However, the fact that a Committee member shall fail to qualify as a Qualifying Director shall not invalidate any Award granted by the Committee that is otherwise validly granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Committee Authority</B>. Subject to the provisions of the Plan and applicable law, the Committee shall have the sole and plenary
authority, in addition to other express powers and authorizations conferred on the Committee by the Plan, to (i)&nbsp;designate Participants; (ii)&nbsp;determine the type or types of Awards to be granted to a Participant; (iii)&nbsp;determine the
number of shares of Common Stock to be covered by, or with respect to which payments, rights, or other matters are to be calculated in connection with, Awards; (iv)&nbsp;determine the terms and conditions of any Award; (v)&nbsp;determine whether, to
what extent, and under what circumstances Awards may be settled in, or exercised for, cash, shares of Common Stock, other securities, other Awards or other property, or canceled, forfeited, or suspended and the method or methods by which Awards may
be settled, exercised, canceled, forfeited, or suspended; (vi)&nbsp;determine whether, to what extent, and under what circumstances the delivery of cash, shares of Common Stock, other securities, other Awards, or other property and other amounts
payable with respect to an Award shall be deferred either automatically or at the election of the Participant or of the Committee; (vii)&nbsp;interpret, administer, reconcile any inconsistency in, correct any defect in and/or supply any omission in
the Plan and any instrument or agreement relating to, or Award granted under, the Plan; (viii) establish, amend, suspend, or waive any rules and regulations and appoint such agents as the Committee shall deem appropriate for the proper
administration of the Plan; (ix)&nbsp;adopt <FONT STYLE="white-space:nowrap">Sub-Plans;</FONT> and (x)&nbsp;make any other determination and take any other action that the Committee deems necessary or desirable for the administration of the Plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Delegation</B>. Except to the extent prohibited by applicable law, the Committee may allocate all or any portion of its
responsibilities and powers to any one or more of its members and may delegate all or any part of its responsibilities and powers to any Person or Persons selected by it. Any such allocation or delegation may be revoked by the Committee at any time.
Without limiting the generality of the foregoing, the Committee may delegate to one or more officers of the Company the authority to act on behalf of the Committee with respect to any matter, right, obligation, or election which is the
responsibility of, or which is allocated to, the Committee herein, and which may be so delegated in accordance with applicable law, except with respect to grants of Awards to Persons (i)&nbsp;who are
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors, or (ii)&nbsp;who are subject to Section&nbsp;16 of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Finality of Decisions</B>. Unless otherwise expressly provided in the Plan, all designations, determinations, interpretations,
and other decisions under or with respect to the Plan, any Award or any Award Agreement shall be within the sole discretion of the Committee, may be made at any time and shall be final, conclusive and binding upon all Persons, including, without
limitation, the Company Group, any Participant, any holder or beneficiary of any Award, and any stockholder of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B>
<B>Indemnification</B>. No member of the Board or the Committee or any employee or agent of any member of the Company (each such Person, an &#147;<B><I>Indemnifiable Person</I></B>&#148;) shall be liable for any action taken or omitted to be taken
or any determination made with respect to the Plan or any Award hereunder (unless constituting fraud or a willful criminal act or omission). Each Indemnifiable Person shall be indemnified and held harmless by the Company against and from any loss,
cost, liability, or expense (including attorneys&#146; fees) that may be imposed upon or incurred by such Indemnifiable Person in connection with or resulting from any action, suit or proceeding to which such Indemnifiable Person may be a party or
in which such Indemnifiable Person may be involved by reason of any action taken or omitted to be taken or determination made with respect to the Plan or any Award hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B>Board Authority</B>. Notwithstanding anything to the contrary contained in the Plan, the Board may, in its sole discretion, at
any time and from time to time, grant Awards and administer the Plan with respect to such Awards. Any such actions by the Board shall be subject to the applicable rules of the securities exchange or </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
inter-dealer quotation system on which the Common Stock is listed or quoted. In any such case, the Board shall have all the authority granted to the Committee under the Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4. AWARDS, IN GENERAL.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Number of Shares</B>. Subject to adjustment provided in Section&nbsp;10, the aggregate number of shares of Common Stock which may
be issued under the Plan and with respect to which Awards may be made is (i) 11,700,000 shares, plus (ii)&nbsp;the number of shares remaining available for issuance under the Prior Plan as of the Effective Date, plus (iii)&nbsp;any shares subject to
awards granted under the Prior Plan that are outstanding as of the Effective Date but that expire, terminate, or are cancelled for any reason without being exercised in full (other than shares withheld as a result of net exercise or settlement or
shares used to pay any exercise price or tax withholding obligation) (the &#147;<B><I>Plan Share Reserve</I></B>&#148;). The shares may be authorized and unissued or issued and reacquired shares, as the Board from time to time may determine. If any
shares subject to an Award are forfeited or an Award expires, such shares shall again be available for Awards under this Plan, in accordance with Section&nbsp;4(b) below. Shares with respect to which Options or Stock Appreciation Rights are not
exercised prior to termination of the Option or Stock Appreciation Right, shares that are subject to Restricted Stock Units which expire without converting to Common Stock, shares of Restricted Stock which are forfeited before the restrictions
lapse, and shares subject to Awards that are settled in cash pursuant to their terms (and were not eligible to be settled in shares), shall be available for issuance under the Plan. Notwithstanding the foregoing, neither (i)&nbsp;shares accepted or
withheld by the Company in payment of the Exercise Price of any Option, if permitted under the terms of such Option, (ii)&nbsp;any shares withheld from a Participant, or delivered to the Company in satisfaction of required withholding taxes arising
from Awards under the Plan, (iii)&nbsp;the difference between the total number of shares with respect to which a Stock Appreciation Right is awarded and the number of shares actually delivered upon exercise of such Stock Appreciation Right, nor
(iv)&nbsp;shares reacquired by the Company on the open market or otherwise using cash proceeds from the exercise of Options or options exercised under the Prior Plan, shall be available for reissuance under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Any share that again becomes available for grant pursuant to this Section&nbsp;4 shall be added back as (i)&nbsp;one (1) share if
such share was subject to an option or a stock appreciation right granted under the Prior Plan, and (ii) 1.34 shares if such share was subject to an award other than an option or a stock appreciation right granted under the Prior Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Additional Limitations</B>. Subject to Section&nbsp;10 of the Plan, (i)&nbsp;no more than the number of shares of Common Stock
equal to the Plan&nbsp;Share Reserve may be issued in the aggregate pursuant to the exercise of Incentive Stock Options granted under the Plan; and (ii)&nbsp;during a single fiscal year, the number of Awards eligible to be made to each <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director, taken together with any cash fees paid to such <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director during such fiscal year, shall not exceed a total value of $1,000,000 (calculating
the value of any such Awards based on the grant date fair value of such Awards for financial reporting purposes). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>
<B>Substitute Awards.</B> Awards may, in the sole discretion of the Committee, be granted under the Plan in assumption of, or in substitution for, outstanding awards previously granted by an entity directly or indirectly acquired by the Company or
with which a member of the Company Group combines (&#147;<B><I>Substitute Awards</I></B>&#148;). Substitute Awards shall not be counted against the Plan&nbsp;Share Reserve;<I>&nbsp;provided</I>, that Substitute Awards issued in connection with the
assumption of, or in substitution for, outstanding options intended to qualify as &#147;incentive stock options&#148; within the meaning of Section&nbsp;422 of the Code shall be counted against the aggregate number of shares of Common Stock
available for Awards of Incentive Stock Options under the Plan. Subject to applicable stock exchange requirements, available shares under a stockholder-approved plan of an entity directly or indirectly acquired by the Company or with which a member
of the Company Group combines (as appropriately adjusted to reflect the acquisition or combination transaction) may be used for Awards under the Plan and shall not reduce the number of shares of Common Stock available for issuance under the Plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.</B> <B>PARTICIPATION</B>. The Committee may, from time to time, in its discretion grant Awards to Participants from among the
Eligible Individuals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.</B> <B>GRANTS OF OPTIONS</B>. The Committee is hereby authorized to grant Awards of
Options to Eligible Individuals. The terms and conditions of each Option shall be set forth in an Award Agreement between the Company and the Participant on such terms and conditions as may be deemed advisable by the Committee in its discretion, but
not inconsistent with the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Exercise Price</B>. The Exercise Price shall not be less than 100% of the Fair Market
Value of Common Stock on the date such Option is granted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Payment</B>. The Exercise Price multiplied by the number of
shares to be purchased by exercise of the Option shall be paid upon the exercise thereof. Upon exercise of the Option, the aggregate Exercise Price shall be payable in the manner provided by the applicable Award Agreement, which may include, without
limitation payment in the form of: (i)&nbsp;cash equal to such aggregate Exercise Price, (ii)&nbsp;shares of Common Stock owned by the Participant having a Fair Market Value at least equal to such aggregate Exercise Price on the day of exercise or
the trading day immediately preceding the date of exercise as determined by the Committee in its reasonable discretion, (iii)&nbsp;any cashless exercise mechanism, or (iv)&nbsp;a combination of any of the above methods which total to such aggregate
Exercise Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Stockholder Rights</B>. A holder of an Option shall have none of the rights of a stockholder until the
shares are issued to him or her;<I>&nbsp;provided</I>&nbsp;that if a Participant exercises an Option and the appropriate purchase price is received by the Company in accordance with this Section&nbsp;6(c) prior to any dividend record date, such
Participant shall be entitled to receive the dividends which would be paid on the shares subject to such exercise if such shares were outstanding on such record date. In no event shall dividends be paid with respect to Options prior to their
exercise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Term of Option; Exercise</B>.&nbsp;The Committee may designate the term of an Option in the Award
Agreement,<I>&nbsp;provided</I>&nbsp;that the term shall not exceed ten years. During such term, an Option shall be exercisable at such times and under such conditions as shall be permissible under the terms of this Plan and of the Award Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <B>Limitations Applicable to Incentive Stock Options</B>. It is intended that Incentive Stock Options shall conform to the
requirements of Sections 422 and 424 of the Code. To the extent that the aggregate Fair Market Value of the Common Stock, with respect to which Incentive Stock Options granted under this or any other Plan of the Company are exercisable for the first
time by a Participant during any calendar year exceeds $100,000, or such other amount as may be permitted under the Code, such excess shall be considered <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options. Notwithstanding anything
in the Plan to the contrary, any Incentive Stock Option awarded to any Participant who, at the time of the Award, is the owner, directly or indirectly, of stock possessing more than ten percent (10%) of the total combined voting power of all classes
of stock of the Company or any Subsidiary, shall (i)&nbsp;have a term not exceeding five years from the date of grant, and (ii)&nbsp;shall have an Exercise Price per share of not less than 110% of the Fair Market Value of the Common Stock on the
date the Incentive Stock Option is granted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B>Automatic Exercise at End of Term</B>. An Award Agreement may provide that, if
on the last day of the term of an Option the Fair Market Value of one share exceeds the Exercise Price, the Participant has not exercised the Option and the Option has not expired, the Option shall be deemed to have been exercised by the Participant
on such day with the payment made by withholding shares otherwise issuable in connection with the exercise of the Option. In such event, the Company shall deliver to the Participant the number of shares for which the Option was deemed exercised,
less the number of shares required to be withheld for the payment of the total purchase price and required withholding taxes; provided, however, any fractional share shall be settled in cash. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.</B> <B>GRANTS OF STOCK APPRECIATION RIGHTS</B>.&nbsp;The Committee is hereby authorized to grant Awards of Stock Appreciation Rights to
Eligible Individuals. The terms and conditions of each Stock Appreciation Right shall be set forth in an Award Agreement between the Company and the Participant on such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
terms and conditions as may be deemed advisable by the Committee in its discretion, but not inconsistent with the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Exercise Price</B>. The Exercise Price of a Stock Appreciation Right shall be not less than 100% of the Fair Market Value of the
Company&#146;s Common Stock on the date the Stock Appreciation Right is granted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Term; Exercise</B>. The Committee may
designate the term of a Stock Appreciation Right in the Award Agreement, provided that the term shall not exceed ten years. During such term, a Stock Appreciation Right shall be exercisable at such times and under such conditions as shall be
permissible under the terms of this Plan and of the Award Agreement. Upon the exercise of a Stock Appreciation Right, the Participant shall have the right to receive the excess of (i)&nbsp;the Fair Market Value of one share on the date of exercise
over (ii)&nbsp;the Exercise Price of the Stock Appreciation Right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Tandem Awards</B>. Stock Appreciation Rights may be
awarded on a stand-alone basis or in tandem with an Option. Notwithstanding any other provision of this Plan, any Stock Appreciation Right awarded in tandem with an Option: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shall entitle the Participant to exercise all or a portion of the Stock Appreciation Right in lieu of all or a
portion of the Option, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shall vest and expire on the same dates as the underlying Option and shall utilize the same Exercise Price as
the underlying Option, and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">may be exercised only to the extent that the related Option has not been exercised. The exercise of Stock
Appreciation Rights granted in tandem with an Option shall result in a pro rata surrender of the related Option to the extent that the Stock Appreciation Rights have been exercised. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Settlement of Stock Appreciation Right</B>. Stock Appreciation Rights will be settled in fully vested shares of Stock or in
cash, as specified in the Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <B>Automatic Exercise at End of Term</B>. An Award Agreement may provide that, if
on the last day of the term of a Stock Appreciation Right the Fair Market Value of one share exceeds the Exercise Price, the Participant has not exercised the Stock Appreciation Right and the Stock Appreciation Right has not expired, the Stock
Appreciation Right shall be deemed to have been exercised by the Participant on such day. In such event, the Company shall make payment to the Participant in accordance with this Section, reduced by the number of shares (or cash) required for
withholding taxes; provided, however, any fractional share shall be settled in cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.</B> <B>RESTRICTED STOCK AND RESTRICTED STOCK
UNITS</B>. The Committee is hereby authorized to grant Awards of Restricted Stock and Restricted Stock Units to Eligible Individuals. The terms and conditions of each Award of Restricted Stock or Restricted Stock Units shall be set forth in an Award
Agreement between the Company and the Participant on such terms and conditions as may be deemed advisable by the Committee in its discretion, but not inconsistent with the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Restriction Period</B>. The Committee shall determine the events or conditions necessary for the lapse of restrictions
applicable to the award of Restricted Stock or Restricted Stock Units, which may include, among other things, requirements of continuous service for a specified term or the attainment of specific performance standards or goals, which restrictions
may differ among Participants. Upon the lapse of the restriction period and the attainment of any other vesting criteria established by the Committee, with respect to any outstanding Restricted Stock Units, the Company shall deliver to the
Participant one share of Common Stock (or cash in lieu of delivering shares, as the case may be) for each such outstanding and vested Restricted Stock Unit; provided, however, that the Committee may elect to defer the delivery of Common Stock beyond
the expiration of the restricted period only (i)&nbsp;with written permission of the participant, and (ii)&nbsp;if such extension would not cause </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
adverse tax consequences under Section&nbsp;409A of the Code. Award Agreements for Restricted Stock and Restricted Stock Units shall provide for forfeiture of Common Stock covered thereby to the
extent the Restricted Stock or Restricted Stock Units do not vest during the restricted period specified in the Award Agreement, except as the Committee may otherwise determine in the Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Stockholder Rights</B>. Except to the extent restricted under the Award Agreement relating to the Restricted Stock, a
Participant receiving Restricted Stock shall have all the rights of a stockholder with respect to such Restricted Stock, including the right to receive dividends and vote shares of Restricted Stock upon the expiration of the applicable restriction
period. Until Common Stock is issued to the Participant in settlement of Restricted Stock Units, the Participant shall not have any rights of a stockholder with respect to the Restricted Stock Units or the shares issuable thereunder. The Committee
may determine in the applicable Award Agreement whether and to what extent the recipient of Restricted Stock Units has the rights of a stockholder of the Company including, but not limited to, whether the Participant receiving the Award has the
right to vote the shares or to receive dividends or dividend equivalents upon the expiration of the applicable restriction period. No dividends or dividend equivalents may be paid to a Participant with respect to an Award unless and until the date
the Participant vests in such Award, and dividends or dividend equivalents relating to unvested Awards may accrue and be paid to the Participant at the time of vesting of the underlying Award (or such later date of payment of the Award) and shall be
forfeited to the extent the underlying Award is forfeited. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.</B> <B>OTHER AWARDS</B>. The Committee may, in its sole discretion,
grant Awards of Common Stock, including fully vested Common Stock, and other Awards that are valued in whole or in part by reference to the Fair Market Value of Common Stock. These Awards shall collectively be referred to herein as Other Awards.
Other Awards shall be in such form, and dependent on such conditions, as the Committee shall determine, including, but not limited to, the right to receive fully vested shares. Subject to the other terms of the Plan, Other Awards may be granted to
such Eligible Individuals in such amounts and upon such terms, and at any time and from time to time, as shall be determined by the Committee and set forth in an Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.</B> <B>ADJUSTMENT IN THE EVENT OF CHANGE IN STOCK</B>. Subject to Section&nbsp;11, if there is any change in the number or kind of
shares of Company Stock outstanding (a)&nbsp;by reason of a stock dividend, spinoff, recapitalization, stock split, or combination or exchange of shares; (b)&nbsp;by reason of a merger, reorganization, or consolidation; (c)&nbsp;by reason of a
reclassification or change in par value; or (d)&nbsp;by reason of any other extraordinary or unusual event affecting the outstanding Company Stock as a class without the Company&#146;s receipt of consideration, or if the value of outstanding shares
of Company Stock is substantially reduced as a result of a spinoff or the Company&#146;s payment of an extraordinary dividend or distribution, the maximum number of shares of Company Stock available for Awards, the number of shares covered by
outstanding Awards, the kind of shares issued under the Plan, and the price per share of such Awards shall be adjusted by the Board to reflect any increase or decrease in the number of, or change in the kind or value of, issued shares of Company
Stock to preclude the enlargement or dilution of rights and benefits under such Awards; provided, however, that any fractional shares resulting from such adjustment shall be eliminated.&nbsp;Any adjustments determined by the Board shall be final,
binding, and conclusive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.</B> <B>EFFECT OF A CHANGE OF CONTROL</B>. Except to the extent reflected in a particular Award Agreement,
in the event of a Change of Control: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Assumption of Awards</B>. Upon a Change of Control where the Company is not the
surviving corporation (or survives only as a subsidiary of another corporation), unless the Committee determines otherwise, all outstanding Awards shall be assumed by, or replaced with comparable Awards by, the surviving corporation (or a parent or
subsidiary of the surviving corporation). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Termination of Awards</B>. Upon a Change of Control where the Company is not the
surviving corporation (or survives only as a subsidiary of another corporation), in the event the surviving corporation (or a parent or subsidiary of the surviving corporation) does not assume or replace the Awards with comparable
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Awards, (i)&nbsp;the Company shall provide each Participant with outstanding Awards written notice of such Change of Control, (ii)&nbsp;all Options and Stock Appreciation Rights shall become
immediately exercisable with respect to 100% of the shares or rights subject thereto, (iii)&nbsp;the Restricted Stock that is subject to time-based vesting and not subject to achievement of performance goals shall become fully vested and all
restrictions shall expire immediately, (iv)&nbsp;the Restricted Stock that is subject to achievement of performance goals and not subject to time-based vesting shall, unless the Award Agreement provides for vesting or earning in a greater amount
upon the occurrence of a Change of Control, become vested, free of restrictions, in such amounts as determined by the Committee as if the applicable performance goals for the unexpired performance period had been achieved at least at the target
level set forth in the applicable Award Agreement and the corresponding number of shares of Restricted Stock shall vest, (v)&nbsp;the Restricted Stock Units that are subject to time-based vesting and not subject to achievement of performance goals
shall become fully vested and the shares of Common Stock subject to such Restricted Stock Units shall be delivered as promptly as practicable, subject to any limitations imposed thereon by Section&nbsp;409A of the Code, and (vi)&nbsp;the Restricted
Stock Units that are subject to achievement of performance goals and not subject to time-based vesting shall, unless the Award Agreement provides for vesting or earning in a greater amount upon the occurrence of a Change of Control, become vested
and earned in such amounts as determined by the Committee as if the applicable performance goals for the unexpired performance period had been achieved at least at the target level set forth in the applicable Award Agreement and the corresponding
number of shares of Common Stock subject to such Restricted Stock Units shall be delivered as promptly as practicable, subject to any limitations imposed thereon by Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Other Alternatives</B>. Notwithstanding the foregoing, in the event of a Change of Control, the Committee may, in its
discretion, cancel any outstanding Options, Stock Appreciation Rights or Restricted Stock Awards and pay to the holders thereof, in cash, the value of such Awards based upon the highest price per share of Common Stock received or to be received by
other stockholders of the Company in connection with the Change of Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Terminations in Connection with a Change in
Control</B>. Notwithstanding any provision in this Plan or an Award Agreement to the contrary, in the event of a Termination without Cause that occurs in the twenty-four (24)-month period following a Change in Control, such terminated
Participant&#146;s unvested Awards shall become fully vested immediately upon such Termination without Cause. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12. RESTRICTIONS ON
TRANSFER.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Each Award shall be exercisable only by such Participant to whom such Award was granted during the
Participant&#146;s lifetime, or, if permissible under applicable law, by the Participant&#146;s legal guardian or representative. No Award may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by a Participant
(unless such transfer is specifically required pursuant to a domestic relations order or by applicable law) other than by will or by the laws of descent and distribution and any such purported assignment, alienation, pledge, attachment, sale,
transfer or encumbrance shall be void and unenforceable against the Company;<I>&nbsp;provided</I>, that the designation of a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Notwithstanding the foregoing, the Committee may, in its sole discretion, permit Awards (other than Incentive Stock Options) to be
transferred by a Participant, without consideration, subject to such rules as the Committee may adopt consistent with any applicable Award Agreement to preserve the purposes of the Plan, to (i)&nbsp;any person who is a &#147;family member&#148; of
the Participant, as such term is used in the instructions to <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> under the Securities Act or any successor form of registration statement promulgated by the Securities and Exchange Commission
(collectively, the &#147;<B><I>Immediate Family Members</I></B>&#148;); (ii)&nbsp;a trust solely for the benefit of the Participant and the Participant&#146;s Immediate Family Members; (iii)&nbsp;a partnership or limited liability company whose only
partners or stockholders are the Participant and the Participant&#146;s Immediate Family Members; or (iv)&nbsp;a beneficiary to whom donations are eligible to be treated as &#147;charitable contributions&#148; for federal income tax purposes (each
transferee described in clauses (i), (ii), (iii)&nbsp;and (iv)&nbsp;above is hereinafter referred to as a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;<B><I>Permitted Transferee</I></B>&#148;);<I>&nbsp;provided</I>, that the Participant gives the Committee advance written notice describing the terms and conditions of the proposed transfer
and the Committee notifies the Participant in writing that such a transfer would comply with the requirements of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> The
terms of any Award transferred in accordance with clause (b)&nbsp;above shall apply to the Permitted Transferee and any reference in the Plan, or in any applicable Award Agreement, to a Participant shall be deemed to refer to the Permitted
Transferee, except that (i)&nbsp;Permitted Transferees shall not be entitled to transfer any Award, other than by will or the laws of descent and distribution; (ii)&nbsp;Permitted Transferees shall not be entitled to exercise any transferred Option
unless there shall be in effect a registration statement on an appropriate form covering the shares of Common Stock to be acquired pursuant to the exercise of such Option if the Committee determines, consistent with any applicable Award Agreement,
that such a registration statement is necessary or appropriate; (iii)&nbsp;neither the Committee nor the Company shall be required to provide any notice to a Permitted Transferee, whether or not such notice is or would otherwise have been required
to be given to the Participant under the Plan or otherwise; and (iv)&nbsp;the consequences of a Participant&#146;s Termination under the terms of the Plan and the applicable Award Agreement shall continue to be applied with respect to the
Participant, including, without limitation, that an Option shall be exercisable by the Permitted Transferee only to the extent, and for the periods, specified in the Plan and the applicable Award Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13. AMENDMENT AND DISCONTINUANCE.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> The Board may from time to time amend or revise the terms of the Plan, or may discontinue the Plan at any time as permitted by law,
provided, however, that such amendment shall not (except as provided in Section&nbsp;10), without further approval of the stockholders, (i)&nbsp;increase the aggregate number of shares with respect to which awards may be made under the Plan,
(ii)&nbsp;change the manner of determining the Exercise Price (other than determining the Fair Market Value of the Common Stock to conform with applicable provisions of the Code or regulations and interpretations thereunder), (iii) extend the term
of the Plan or the maximum period during which any Option may be exercised, or (iv)&nbsp;make any other change which, in the absence of stockholder approval, would cause awards granted under the Plan which are then outstanding, or which may be
granted in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> No amendments, revision or discontinuance of the Plan shall, without the consent of a Participant, in
any manner adversely affect his or her rights under any Award theretofore granted under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Notwithstanding anything
herein to the contrary, the Company shall not, without stockholder approval, reduce the Exercise Price of any Option or Stock Appreciation Right and shall not exchange any Option or Stock Appreciation Right for a new Award with a lower (or no)
Exercise Price or for cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.</B> <B>EFFECTIVE DATE AND DURATION</B>. The Plan was adopted by the Board and became effective on
March&nbsp;21, 2024, and remains subject to approval by stockholders. No Award may be granted under the Plan after March&nbsp;21, 2034. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.</B> <B>TAX WITHHOLDING</B>. Notwithstanding any other provision of the Plan, the Company or its Subsidiaries, as appropriate, shall
have the right to deduct from all Awards under the Plan cash and/or stock, with a Fair Market Value in the amount of all federal, state or local withholding taxes (up to the maximum permissible statutory tax rate for the applicable tax jurisdiction,
to the extent consistent with applicable law) with respect to such Awards. In the case of Awards paid in Common Stock, the Participant or Permitted Transferee may be required to pay to the Company or a Subsidiary thereof, as appropriate, the amount
of any such taxes which the Company or Subsidiary is required to withhold, if any, with respect to such stock. Subject in particular cases to the disapproval of the Committee, the Company may accept shares of the Company&#146;s Common Stock of
equivalent Fair Market Value in payment of such withholding tax obligations if the Participant elects to make payment in such manner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>16.</B> <B>GOVERNING LAW</B>. The Plan shall be governed by and construed in accordance
with the internal laws of the State of Delaware applicable to contracts made and performed wholly within the State of Delaware, without giving effect to the conflict of laws provisions thereof. EACH PARTICIPANT WHO ACCEPTS AN AWARD IRREVOCABLY
WAIVES ALL RIGHT TO A TRIAL BY JURY IN ANY SUIT, ACTION, OR OTHER PROCEEDING INSTITUTED BY OR AGAINST SUCH PARTICIPANT IN RESPECT OF THE PARTICIPANT&#146;S RIGHTS OR OBLIGATIONS HEREUNDER. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17. GOVERNMENT AND OTHER REGULATIONS.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> The obligation of the Company to settle Awards in shares of Common Stock or other consideration shall be subject to all applicable
law. Notwithstanding any terms or conditions of any Award to the contrary, the Company shall be under no obligation to offer to sell or to sell, and shall be prohibited from offering to sell or selling, any shares of Common Stock pursuant to an
Award unless such shares have been properly registered for sale pursuant to the Securities Act with the Securities and Exchange Commission or unless the Company has received an opinion of counsel (if the Company has requested such an opinion),
satisfactory to the Company, that such shares may be offered or sold without such registration pursuant to an available exemption therefrom and the terms and conditions of such exemption have been fully complied with. The Company shall be under no
obligation to register for sale under the Securities Act any of the shares of Common Stock to be offered or sold under the Plan. The Committee shall have the authority to provide that all shares of Common Stock or other securities of the Company
issued under the Plan shall be subject to such stop-transfer orders and other restrictions as the Committee may deem advisable under the Plan, the applicable Award Agreement and applicable law, and, without limiting the generality of Section&nbsp;8
of the Plan, the Committee may cause a legend or legends to be put on certificates representing shares of Common Stock or other securities of the Company issued under the Plan to make appropriate reference to such restrictions or may cause such
Common Stock or other securities of the Company issued under the Plan in book-entry form to be held subject to the Company&#146;s instructions or subject to appropriate stop-transfer orders. Notwithstanding any provision in the Plan to the contrary,
the Committee reserves the right to add, at any time, any additional terms or provisions to any Award granted under the Plan that the Committee, in its sole discretion, deems necessary or advisable in order that such Award complies with the legal
requirements of any governmental entity to whose jurisdiction the Award is subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> The Committee may cancel an Award or any
portion thereof if it determines, in its sole discretion, that legal or contractual restrictions and/or blockage and/or other market considerations would make the Company&#146;s acquisition of shares of Common Stock from the public markets, the
Company&#146;s issuance of Common Stock to the Participant, the Participant&#146;s acquisition of Common Stock from the Company and/or the Participant&#146;s sale of Common Stock to the public markets, illegal, impracticable or inadvisable. If the
Committee determines to cancel all or any portion of an Award in accordance with the foregoing, the Company shall, subject to any limitations or reductions as may be necessary to comply with Section&nbsp;409A of the Code, (i)&nbsp;pay to the
Participant an amount equal to the excess of (A)&nbsp;the aggregate Fair Market Value of the shares of Common Stock subject to such Award or portion thereof canceled (determined as of the applicable exercise date, or the date that the shares would
have been vested or issued, as applicable); over (B)&nbsp;the aggregate Exercise Price or any amount payable as a condition of issuance of shares of Common Stock (in the case of any other Award). Such amount shall be delivered to the Participant as
soon as practicable following the cancellation of such Award or portion thereof, or (ii)&nbsp;in the case of Restricted Stock, Restricted Stock Units or Other Awards, provide the Participant with a cash payment or equity subject to deferred vesting
and delivery consistent with the vesting restrictions applicable to such Restricted Stock, Restricted Stock Units or Other Awards, or the underlying shares in respect thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.</B> <B>NO CLAIM TO AWARDS; NO RIGHTS TO CONTINUED EMPLOYMENT; WAIVER</B>. No employee of the Company or its Subsidiaries, or other
Person, shall have any claim or right to be granted an Award under the Plan or, having been selected for the grant of an Award, to be selected for a grant of any other Award. There is no obligation for uniformity of treatment of Participants or
holders or beneficiaries of Awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The terms and conditions of Awards and the Committee&#146;s determinations and interpretations with respect thereto need not be the same with respect to each Participant and may be made
selectively among Participants, whether or not such Participants are similarly situated. Neither the Plan nor any action taken hereunder shall be construed as giving any Participant any right to be retained in the employ or service of any member of
the Company Group, nor shall it be construed as giving any Participant any rights to continued service on the Board. The applicable member of the Company Group may at any time dismiss a Participant from employment or discontinue any consulting
relationship, free from any liability or any claim under the Plan, unless otherwise expressly provided in the Plan or any Award Agreement. By accepting an Award under the Plan, a Participant shall thereby be deemed to have waived any claim to
continued exercise or vesting of an Award or to damages or severance entitlement related to <FONT STYLE="white-space:nowrap">non-continuation</FONT> of the Award beyond the period provided under the Plan or any Award Agreement, except to the extent
of any provision to the contrary in any written employment contract or other agreement between any member of the Company Group and the Participant, whether any such agreement is executed before, on or after the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>19.</B> <B>INTERNATIONAL PARTICIPANTS</B>. With respect to Participants who reside or work outside of the United States of America, the
Committee may, in its sole discretion, amend the terms of the Plan and create or amend <FONT STYLE="white-space:nowrap">Sub-Plans</FONT> or amend outstanding Awards with respect to such Participants in order to permit or facilitate participation in
the Plan by such Participants, conform such terms with the requirements of applicable law or to obtain more favorable tax or other treatment for a Participant or the applicable member of the Company Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>20.</B> <B>TERMINATION</B>. Except as otherwise provided in an Award Agreement, unless determined otherwise by the Committee at any point
following such event: (a)&nbsp;neither a temporary absence from employment or service due to illness, vacation or leave of absence (including, without limitation, a call to active duty for military service through a Reserve or National Guard unit)
nor a transfer from employment or service with one member of the Company Group to employment or service with another member of the Company Group (or vice-versa) shall be considered a Termination; and (b)&nbsp;if a Participant undergoes a
Termination, but such Participant continues to provide services to any member of the Company Group in a <FONT STYLE="white-space:nowrap">non-employee</FONT> capacity, such change in status shall not be considered a Termination for purposes of the
Plan. Further, unless otherwise determined by the Committee, in the event that any member of the Company Group ceases to be a member of the Company Group (by reason of sale, divestiture, <FONT STYLE="white-space:nowrap">spin-off</FONT> or other
similar transaction), unless a Participant&#146;s employment or service is transferred to another entity that would constitute a member of the Company Group immediately following such transaction, such Participant shall be deemed to have suffered a
Termination hereunder as of the date of the consummation of such transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>21.</B> <B>SEVERABILITY</B>. If any provision of the
Plan or any Award or Award Agreement is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction or as to any Person or Award, or would disqualify the Plan or any Award under any law deemed applicable by the Committee,
such provision shall be construed or deemed amended to conform to the applicable laws, or if it cannot be construed or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award, such
provision shall be construed or deemed stricken as to such jurisdiction, Person or Award and the remainder of the Plan and any such Award shall remain in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>22.</B> <B>SUCCESSORS</B>. The obligations of the Company under the Plan shall be binding upon any successor corporation or organization
resulting from the merger, consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets and business of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>23.</B> <B>CLAWBACK/REPAYMENT</B>. All Awards shall be subject to reduction, cancellation, forfeiture or recoupment to the extent necessary
to comply with (a)&nbsp;any clawback, forfeiture or other similar policy adopted by the Board or the Committee and as in effect from time to time; and (b)&nbsp;applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>24. SECTION 409A OF THE CODE.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Notwithstanding any provision of the Plan to the contrary, it is intended that the provisions of the Plan comply with
Section&nbsp;409A of the Code, and all provisions of the Plan shall be construed and interpreted in a manner consistent with the requirements for avoiding taxes or penalties under Section&nbsp;409A of the Code. Each Participant is solely responsible
and liable for the satisfaction of all taxes and penalties that may be imposed on or in respect of such Participant in connection with the Plan (including any taxes and penalties under Section&nbsp;409A of the Code), and neither the Company nor any
member of the Company Group shall have any obligation to indemnify or otherwise hold such Participant (or any beneficiary) harmless from any or all of such taxes or penalties. With respect to any Award that is considered &#147;deferred
compensation&#148; subject to Section&nbsp;409A of the Code, references in the Plan to &#147;termination of employment&#148; (and substantially similar phrases) shall mean &#147;separation from service&#148; within the meaning of Section&nbsp;409A
of the Code. For purposes of Section&nbsp;409A of the Code, each of the payments that may be made in respect of any Award granted under the Plan is designated as separate payments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Notwithstanding anything in the Plan to the contrary, if a Participant is a &#147;specified employee&#148; within the meaning of
Section&nbsp;409A(a)(2)(B)(i) of the Code, no payments in respect of any Awards that are &#147;deferred compensation&#148; subject to Section&nbsp;409A of the Code and which would otherwise be payable upon the Participant&#146;s &#147;separation
from service&#148; (as defined in Section&nbsp;409A of the Code) shall be made to such Participant prior to the date that is six&nbsp;months after the date of such Participant&#146;s &#147;separation from service&#148; or, if earlier, the date of
the Participant&#146;s death. Following any applicable six month delay, all such delayed payments will be paid in a single lump sum on the earliest date permitted under Section&nbsp;409A of the Code that is also a business day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Unless otherwise provided by the Committee in an Award Agreement or otherwise, in the event that the timing of payments in respect
of any Award (that would otherwise be considered &#147;deferred compensation&#148; subject to Section&nbsp;409A of the Code) would be accelerated upon the occurrence of (i)&nbsp;a Change in Control, no such acceleration shall be permitted unless the
event giving rise to the Change in Control satisfies the definition of a change in the ownership or effective control of a corporation, or a change in the ownership of a substantial portion of the assets of a corporation pursuant to
Section&nbsp;409A of the Code; or (ii)&nbsp;a disability, no such acceleration shall be permitted unless the disability also satisfies the definition of &#147;disability&#148; pursuant to Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Approved by the Board of Directors on the 21st day of March, 2024. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="toc785934_25"></A>Appendix B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SAVARA INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE
OF AMENDMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Savara Inc., a corporation organized and existing under the laws of the State of Delaware (the &#147;<B><I>Corporation</I></B>&#148;), does
hereby certify that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&#8195;The name of the Corporation is Savara Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&#8195;The original Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on
December&nbsp;1, 1995 under the name Victoria Enterprises. The Corporation&#146;s current Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware under the name Mast Therapeutics, Inc. on
April&nbsp;27, 2017 and amended on June&nbsp;4, 2018 and June&nbsp;10, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&#8195;Pursuant to Section&nbsp;242 of the General
Corporation Law of the State of Delaware (the &#147;<B><I>DGCL</I></B>&#148;), this Certificate of Amendment of the Amended and Restated Certificate of Incorporation amends Section (A)&nbsp;of Article VII of the Amended and Restated Certificate of
Incorporation of the Corporation to read in its entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(A) To the fullest extent permitted by the DGCL, as the same
exists or as may hereafter be amended, no director or officer shall be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, as applicable.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&#8195;This Certificate of Amendment of the Amended and Restated Certificate of Incorporation has been duly adopted by the board of
directors and stockholders of this corporation in accordance with the provisions of Section&nbsp;242 of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the
Corporation has caused this Certificate of Amendment to be executed by its duly authorized officer as of the &#8195; day of June, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SAVARA INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name: &#8194;Matthew Pauls</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: &#8195;Chief Executive Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g785934g07g07.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">SAVARA SAVARA INC. ATTN: CORPORATE SECRETARY ONE SUMMIT SQUARE 1717 LANGHORNE NEWTOWN RD., SUITE 300 LANGHORNE, PA 19047 SCAN TO VIEW
MATERIALS&nbsp;&amp; VOTE VOTE BY INTERNET&#151;www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 P.M. ET on 06/05/2024. Have your proxy
card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. VOTE BY <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">PHONE&#151;1-800-690-6903</FONT></FONT></FONT> Use any touch-tone telephone to transmit your voting instructions. Vote by 11:59 P.M. ET on 06/05/2024. Have your proxy card in hand when you call and then follow the
instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR
BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. The Board of Directors recommends you vote FOR the following: 1. To elect six directors to hold office
until the next Annual Meeting of Stockholders. Nominees For Against Abstain 1a. Matthew Pauls [&#8195;] [&#8195;] [&#8195;] 1b. Nevan Elam [&#8195;] [&#8195;] [&#8195;] 1c. Richard J. Hawkins [&#8195;] [&#8195;] [&#8195;] 1d. Joseph S. McCracken
[&#8195;] [&#8195;] [&#8195;] 1e. David A. Ramsay [&#8195;] [&#8195;] [&#8195;] 1f. An van <FONT STYLE="white-space:nowrap">Es-Johansson</FONT> [&#8195;] [&#8195;] [&#8195;] The Board of Directors recommends you vote FOR proposals 2, 3, 4 and 5. For
Against Abstain 2. To approve the Savara Inc. 2024 Omnibus Incentive Plan. [&#8195;] [&#8195;] [&#8195;] 3. To approve an amendment to our Amended and Restated Certificate of Incorporation to allow for exculpation of officers as permitted by
Delaware law. [&#8195;] [&#8195;] [&#8195;] For Against Abstain 4. To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2024. [&#8195;] [&#8195;] [&#8195;] 5. To
approve, on an advisory basis, the compensation of our named executives. [&#8195;] [&#8195;] [&#8195;] NOTE: Such other business as may properly come before the meeting or any adjournment thereof. Please sign exactly as your name(s) appear(s)
hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or
partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date 0000643139_1 R1.0.0.6 </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g785934g08g08.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Form
<FONT STYLE="white-space:nowrap">10-K</FONT> and Notice&nbsp;&amp; Proxy Statement are available at www.proxyvote.com SAVARA INC. This proxy is solicited by the Board of Directors for use at the Annual Meeting of Stockholders to be held on
June&nbsp;6, 2024 at 3:00 PM The stockholder(s) hereby appoint(s) Matthew Pauls and David Lowrance, or either of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them to represent and to vote, as designated on
the reverse side of this ballot, all of the shares of common stock of SAVARA INC. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held at 3:00 PM, EDT on June&nbsp;6, 2024, and any adjournment or
postponement thereof. This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors&#146; recommendations. Continued and to be signed
on reverse side 0000643139_2 R1.0.0.6 </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g785934g07g07.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g785934g07g07.jpg
M_]C_X1(817AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    ?    <@$R  (    4
M    D8=I  0    !    J    -0 +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P(#(R+C @*%=I;F1O=W,I #(P,C0Z,#0Z,C @,#DZ,S,Z,#$
M  .@ 0 #     ?__  "@ @ $     0   N:@ P $     0   \
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   0W@        !(     0   $@
M   !_]C_[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@     '_VP"$  P(" @)
M" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,
M# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( *  ? ,!
M(@ "$0$#$0'_W0 $  C_Q $_   !!0$! 0$! 0         #  $"! 4&!P@)
M"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q   00! P($ @4'!@@%
M PPS 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A
M\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%
MU>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"! 0#! 4&!P<&!34!
M  (1 R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:B
MLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F
M=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$  A$#$0 _ /54DDSG-8TN<0UK
M1+G'0 #N4E+I+CW?6VW*PNIUX]S,;(P[,>T7/?2P_9<HL>PT?:]F*W*8SU,>
MMF6_T[+_ $M]GZPQ-9];\AM[[FN<<*FJF\O-#FA]=0ILZLYKG#^>91G;_LM-
MMM^-9TK)KN24]BDN+L^LO66MNQ'ES<OTL>MKZJVN'VD68S.I5XEMP;A9-W^4
M/LM&/Z_Z&[IUWVE6>D_6C+OS.FT91W5Y%1;=:*RT>K:;;,+[38S?CXF8S'P_
M3RL'UOZ7U"OT?YI)3U:2222E)+G;Z\?]HVY1S;VY;<ZBMF.,JP5[3]G9Z7V$
M6^A[Z7V6_P S[_YY6<SK&:,FLX=1?B-D97J8^2+0=S=OV?\ 1"NS>SU-W^B_
MG?TG\S8E.RDN=IZOU]S+&W5XU=P:PL+:<QS2X%OVEKO4QZ?;Z>]U&UV__@OT
M2N5=6R/L,Y$59K=;'&FX4M:;&U[MUPJ:]WI6L_1LO^G_ #?J5I*=9)!Q+[;Z
M19;4ZATD;7=QV>WZ+]KO^%KJM_X-&24I))))3__0]55;J-EM6#?93'J,K<63
M$2!_++6?YRLIG-#@6N (/(.H24\L_K-['$$T9+64FW( :"'M(;%?Z 7.IKK]
MOOR/\)_P/O5VOK61=8ZAF/6+:]'UD6O(<6[W%WV:F]E3';MGZ1WJ?VUM"JH<
M,:)$& ."I!K020 ">2.Z2FLS*IBIKV/WV-;8-M-A:"Z3J[T_T3MW^EV6?Z1%
MI=5;4+&-+6/]\.86.G]YU=C6/:[^NU%224I1>88XS&AU4E&SZ#O@4E/+,P<9
MV1]J=6UV:6LL.2:ZS<7M&T'[1Z+;_4]#V5V._F*O7K_XNVV_(8PL9EV.<^-S
MGN!(@P/2<*]FRRS]]OT%59Z&S0N;3#=SG-O)C]&'?1=N]]GI[;*__2RTJ^DN
M?55LMFAKC95#G@PZ7[S^?O=N_P"+24A]3J+FBRJZ^P;I( 'T08VR,;^=_?;M
M4FV=4#-SW7^TF0UDDP9;/Z)NYCMVW8SW_P#"(^-TG)QWA]5WIN+-CCN<_0'V
M[6W;V_\ ?T?T.J$R<EHF9:&M@0/9M)9^]_.)*:!;U)I#FVY4B&ZM!&@:WM5_
M*W^I_A5.NSJ-5F_=?:T0QK7LD'39ZC@RJMWM?[_\$KGH=4]L9+=.26@SH/I>
MQO\ A/W?\%_PB?T>IR3]H;!VD"!S+?4;_-_N[]B2FZDDDDI__]'U5))))2DD
MDDE*22224I,YNYI;,2(GXITDE.?3T>BLC=8]X# P"=L1!W,V;=GO]ZF>D=//
M-6G<28/C.OYT[GJZDDII#H^!K+"Z9D.<3S'[W]5+]CX$B6.< " USG$01MX<
M5=224T1T7IH)VU$ SH'.CW'?I[O;[D_['P ?H&)!V@D-D:SL'M]_^$5U))2D
MDDDE/__2]522224I))))2DDDDE*22224I))))2DDDDE*22224I))))3_ /_3
M]520;\CT8_1/MD$^R#Q&GN<SZ6Y"=GP0/L]QE@>2&M('C6[W_P XU)3;25/]
MHG2<6\3/YK=(V\^_^4G.>07#[->2T$Z-;K'8>])3;257[?J1]GNT('T1W.TN
M^G]%GYZB[J.T3]FO/&@:TG69_/\ S/S]R2FXDH^I6/SAIY^"7J5_O#[QV24R
M24?4K_>&GGX)>I7^\/O'9)3))1]2O]X?>.RA;DT4UNMM>&L9])Q/&H'_ 'Y)
M25)5'=6Z>T$NN #6BPR#]%T%K^/Y20ZKT\DCUA(+@1!Y8WU']OS6)*;:2I.Z
MUTMHW.R&@$3)G@SKQ_)5U)3_ /_4]/N;6XG>UA#6F7/$Z'Z7]G11-51F6U'F
M9:.\;I4KV->VQCVE[75EKFMT)!D$#5JS+<?HU5SF>FYEC2VMUC'P1#6-J<YP
ML]OT?^W*=Z2G1]*IWYM3MT_F@S/TO\Y(TU'EM1W3^:-=WTO\Z%1;D=&8YI;0
MPO !:_97NUT8_?/Y_P"^EOZ'4]I&)4UY+8(KK!$[MCNWT4E-B[#QS;]HLL]/
M:/<P/VU$3S;5]!V^=K_WU%G2*V!X]:YWJ ME]KGEL\^F7SM=_*4:QTR^MWIX
M+;&;15 KK(+)_F^?H?X3TW*]787N<TUN9MC5T09$^W:7?124U6=+8QK&^K:_
M9O$O>7%WJ?2]5Q_G-G^"_P!&H_LAGI.K-]QW!H]0V'>-IGVOV_X3Z%_^F9_.
M+0224T7]+8^QCS98-D2T/(:^#)]9G^%]3Z-G_!_HTS.DL9<+?6N?!)-;["YA
MW#;[Z_SE?224YPZ.STVUG(R'!NZ7&T[W;@&GU'Q[]NWV(SNG4OJ958T6!D'<
MZ=Y(&W=98TL=9N_PG^D5M))30_8^)W8#I&KK#WWF9L_.</?^_P#047],P*JC
M9:&MKK:\O>][X#72^XV.?9]'^NM%))3CX]/0\EYJQ;Z;[ -Y97>YYAH]-SG-
M;<[V_I-MO[_^$6KN'I;HTVS'RX0;L>Q^=1D C957:QP/,O-)9MT_X)R+_P!I
M_P"Q_!)3_]7U%SFL>YSB&M:V7..@ '<JI9]E.0[_ "@YCRX$U"QD P#L#'-+
MO<WW*U82"\M(#MFA=]&=?I?R4$G(WN#74  C:#,@^SVNU\W_ /@:2FQ5=3<W
M?2]MC?WF$.'C^:IH=3VAK6O+!; WM:=-T>[;^<B)*4HO):QSA!(!(DP/F[\U
M23.G:8B8[\?-)31LZA>VG'MJIKL&0WGUFAH>0"RIC]OZ;U/=L]-$9F7G+LHL
MJ8RNL%SK/5!<&1[+'T[=S-\.4&[OLF'IC3NKF/YOC_M'_+_T",TD9EQ/I!HK
M9J/YWFS^=_X+_1?]=24S.3CCFU@X_.'YPEG^?'M2.5BB9N8(@&7#\X;V]_SF
M^Y NP\:^PV.M<" P -<  !+O_!/Y7_6U!W2\9S0SU7PWZ&K3M$_FRWW?U[/4
MV?X-)3:&7BNG;=68YAPTGYIF9F(]H<R^MS706D/:0=T[8U_.VJM^S\??ZC,A
M[8,M@L(:2X/]LL_L?I-_L3LZ=C@@>M8]XES27"8.GMV-;[6_Z_HTE-MEM5D^
MF]KXB=I!B1+>%3?U"YN+7D"JIP>XLL/KM#&D$UM_3%NU^YXV?UU9Q<5N-7Z;
M7.?)DN=MD]O\&VMGT1^XFC"]"(J^S[N/;LW;_P#,W^O_ ."I*0C+RCE-QWT,
M:'-#R?6!>!'O=Z.W<YK+?T>Y6?\ M/\ V/X)$4^K/M]?88XW[)U_E;-R7_:?
M^Q_!)3__UO4+ 27@ .)9 :[Z)Y]KM'>U =18;=PQ<<Z?SA<=T[1V]']\;?I_
M01[6[M[=HLEA&QWT73/M=H[VN_JH#L<-L=8S#J<^9#Y )VM::W%WI_Z1OI_R
M-F])2WH6BTV#%QB=_P#.;B';6G]&[^8=^D:S^4KJHTT.Q["<?!JJ!,%S'!I+
M9F2UM:O)*4F<):1 ,C@\'XIU%XEI$;I!]I[^22FFVI_V3#;Z%(+'5EU8/L9
M^E08]SV?X-%V.^U7O]&L@U, ?/O<9L_1V"/YO]U!;01AX;/L@!J?633ZG\S
M^GO_ ,-Z7_@B.RN,ZVST0T.K8/7W2707_H_3_-].?I?G[TE- 46WBI^3A0\%
MH<UEK@U@ _1.K8-K?T?O;]%B>J@EH;]A+#!YM>(&FW:YN[;[O\S_  ?\]:M9
M))3D''9_Y7NBQH+VBQP &I])C?:SVN:S]'[*T2D74?I68+@\M(8/5+HU^@?4
M_F_4^G[%II)*8M+BT%X = W &0#WAT-W?YJ']DQO1]#TF^ENW;(TG=ZDQ_7]
MR,DDI&::O4];:/5#2P/C7:?=ME+_ +3_ -C^"F>"H?\ :?\ L?P24__7],R
MV]F12 7GTRQS6Q/N!]H]4>E[OY2SSBTX^006Y5Q!U(#2R&BNQI,,KW;MGH?O
M_P"D6@UM3K\ENZ=P:+(.TM]O[[(>WV^Y5,BG.=DN+/6V>I[=KPUNTL:UWT7;
MOI?0_MI*1LQ&;P::LIIJ(! +&S+?I?IH:[;8W_!_G_\  HOV*FN;*\*PO:6E
MH]7G3Z39NVM]/=M468>=:W])99402/YUTQ]#=[/I?HV,]/=_+L]/U$08?4(
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M       0Z/%<\R_!&*&B>V>MQ635NCA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 2P    !  $!
M+     $  3A"24T$)@      #@             _@   .$))300-       $
M    6CA"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #00    8              \    +F    !@!G #  -P!G
M #  -P    $                          0             "Y@   \
M                     0                         0     0
M &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   \
M    4F=H=&QO;F<   +F    !G-L:6-E<U9L3',    !3V)J8P    $
M  5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N
M97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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M=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*
M    #     (_\        #A"24T$$0       0$ .$))3004       $
M CA"24T$#      0^@    $   !\    H    70  .B    0W@ 8  '_V/_M
M  Q!9&]B95]#30 !_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+
M"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@ H !\ P$B  (1 0,1
M ?_=  0 "/_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04!
M 0$! 0$          0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1
M P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R
M@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&
MEJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#(3$2
M!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R@P<F-<+2
M1)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6
MYO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\ ]5223.<UC2YQ#6M$N<=  .Y2
M4NDN/=];;<K"ZG7CW,QLC#LQ[1<]]+#]ERBQ[#1]KV8K<IC/4QZV9;_3LO\
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M02ZX -:+#(/T706OX_E)#JO3R2/6$@N!$'EC?4?V_-8DIMI*D[K72VC<[(:
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MM(W9UKP(TF"0/%P/YR7[,RX@9]H,\^7N]NWYM_S$E,W]-QK)#V/<T@#82W:
M-VUK6_NL]1VQ$.)B[B;,<6/L.KGAKB8'&Y19@.#8?=;8[7W>J]O?3VM4;>GV
M/9%61;2^019ZCG_$;'^WW)*;@=K!:1/C'\"I*M3C/I(=O<]T02^QS@?Y6QTM
M:C?I?!OWG^Y)3(\%0_[3_P!C^"<^K'#?O/\ <GV?H]D]HGY)*?_9.$))300A
M      !7     0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P
M    % !! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ #( ,  R #$
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M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P  1" /  N8# 1$
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M0G'EU"[:_E =&?(B6LS'R,[6[G[HWID?A?N_X75N^,\G4.V<Q'A-R=N8/NO
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M[(Q%/MW9FQ]MX79^TL!2/42T>"VSMW&T^(P>&HVJYJBH^SQ>+I(H(@[L5CC
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MD<J>Z]T-G\QC_A-+_-$_FD?(R;Y2?)/Y8_!C:G84^Q]J]?4^U^G>O.[<-L/
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MDU7YK;,^)QM!D8L9MJ1ZB2I<U*4GNO=&)[-^>?S&3XF_#'N4)U7TWO\ S/\
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M1.\MZ4NTNGDVSA-VONW<V,SN!D3$[E?'T^W:=]M93%TN[4W'GLCEZ2AHL,:
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M^J]R]G[1[3VQV#M4=K[FP_:>:VC6]3F?;>WZ3MOIG,4?5LX&[&DQ&F>I\/\
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MKW1C:?XX=!_S0JCY>=7[=[5^0=3MW=O>W=G<NX>WLCTYC-N;2P?<N0Z(V_\
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M82K"%4")9 /4%L#^??NO=<HJ>"#5X((8=94OXHTCUE(TB4MH4:BL4:J+_15
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MAI]ER[AJM]566IL[6TSIA*B.94]^Z]TG>M?Y_&V?DWFL5L7X8?'>/O[L;?\
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M[3Q]'FMP[[[EW;M?<6]Z#*T\D>(ZUK]V]S8/+XK;.1KJO$8W/92E,6'%;+#
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MVIG=@;;S^&Z*G>/;$2U\^U)H<UO+JROJLC#)2PD)6PRQ2F43J_NO=%@^'O\
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M[9BU>7<29O&M@H]%0*-_)EQ4G'IHJSXC>06D]/ZN/?NO=,7^E?JW_GY6P/\
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M$>Z-NOMF'7Y=Q)F\:V"B\=0*1_)EUJ3CTT51\1O(+2>GZ\>_=>Z8O]*_5O\
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M'NC;LFV8=?FW$F;QK8*+QU I)/)EUJ3CTT51\9O(+2>D\\>_=>Z8O]*_5O\
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MYO&/@H3%.*642Y=:DX^,QU1\;7D%I/2>>/?NO=,7^E?JW_GY6P/_ $,MN_\
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MFM19O\X WOW7NBY_\,Z_RG_^];OPB_\ 29NH?_L3]^Z]T8R@^&OQ+Q?0-?\
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M'L/8M-UUE,3/NNGW#69JHZJBQZ8:JQTF]8HJMZDT9B_B*HY;R@'W[KW0$?\
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M\XW86QH>JL_0UN>@W=4Y(=<4V/&W<E25&Y(HLBTPI71JM5FOK ;W[KW0#?\
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M]DT=!_=*JB;=M"M7+(T!'W\(D)\BW'NO= 5_PSK_ "G_ /O6[\(O_29NH?\
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M=%DHOY17\HS(K5/C_P"7=\$Z]**HEI*UZ+XY=,U2TE7"JM-2U30;8<4]1$K
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M??NO=>_V8OJ3_GI)O_/-F?\ ZA]^Z]U[_9B^I/\ GI)O_/-F?_J'W[KW7O\
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M_/-F?_J'W[KW7O\ 9B^I/^>DF_\ /-F?_J'W[KW7O]F+ZD_YZ2;_ ,\V9_\
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M_GI)O_/-F?\ ZA]^Z]U[_9B^I/\ GI)O_/-F?_J'W[KW7O\ 9B^I/^>DF_\
M/-F?_J'W[KW7O]F+ZD_YZ2;_ ,\V9_\ J'W[KW7O]F+ZD_YZ2;_SS9G_ .H?
M?NO=>_V8OJ3_ )Z2;_SS9G_ZA]^Z]U[_ &8OJ3_GI)O_ #S9G_ZA]^Z]U[_9
MB^I/^>DF_P#/-F?_ *A]^Z]U[_9B^I/^>DF_\\V9_P#J'W[KW7O]F+ZD_P">
MDF_\\V9_^H??NO=>_P!F+ZD_YZ2;_P \V9_^H??NO=>_V8OJ3_GI)O\ SS9G
M_P"H??NO=/6W^[>LMSY2GPN*W- <E6.(Z.FK*6NQYJY6_3!3RUM-!#+.QX5
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M6T'_ )QT_P#U[]^Z]U[^%8O_ )UM!_YQT_\ U[]^Z]U[^%8O_G6T'_G'3_\
M7OW[KW7OX5B_^=;0?^<=/_U[]^Z]U[^%8O\ YUM!_P"<=/\ ]>_?NO=>_A6+
M_P"=;0?^<=/_ ->_?NO=>_A6+_YUM!_YQT__ %[]^Z]U[^%8O_G6T'_G'3_]
M>_?NO=>_A6+_ .=;0?\ G'3_ /7OW[KW7OX5B_\ G6T'_G'3_P#7OW[KW7OX
M5B_^=;0?^<=/_P!>_?NO=>_A6+_YUM!_YQT__7OW[KW7OX5B_P#G6T'_ )QT
M_P#U[]^Z]U[^%8O_ )UM!_YQT_\ U[]^Z]U[^%8O_G6T'_G'3_\ 7OW[KW7O
MX5B_^=;0?^<=/_U[]^Z]U[^%8O\ YUM!_P"<=/\ ]>_?NO=>_A6+_P"=;0?^
M<=/_ ->_?NO=>_A6+_YUM!_YQT__ %[]^Z]U[^%8O_G6T'_G'3_]>_?NO=>_
MA6+_ .=;0?\ G'3_ /7OW[KW7OX5B_\ G6T'_G'3_P#7OW[KW7OX5B_^=;0?
M^<=/_P!>_?NO=>_A6+_YUM!_YQT__7OW[KW7OX5B_P#G6T'_ )QT_P#U[]^Z
M]U[^%8O_ )UM!_YQT_\ U[]^Z]U[^%8O_G6T'_G'3_\ 7OW[KW7OX5B_^=;0
M?^<=/_U[]^Z]U[^%8O\ YUM!_P"<=/\ ]>_?NO=>_A6+_P"=;0?^<=/_ ->_
M?NO=>_A6+_YUM!_YQT__ %[]^Z]U[^%8O_G6T'_G'3_]>_?NO=>_A6+_ .=;
M0?\ G'3_ /7OW[KW7OX5B_\ G6T'_G'3_P#7OW[KW7OX5B_^=;0?^<=/_P!>
M_?NO=>_A6+_YUM!_YQT__7OW[KW7OX5B_P#G6T'_ )QT_P#U[]^Z]U[^%8O_
M )UM!_YQT_\ U[]^Z]U[^%8O_G6T'_G'3_\ 7OW[KW7OX5B_^=;0?^<=/_U[
M]^Z]U[^%8O\ YUM!_P"<=/\ ]>_?NO=>_A6+_P"=;0?^<=/_ ->_?NO=>_A6
M+_YUM!_YQT__ %[]^Z]U[^%8O_G6T'_G'3_]>_?NO=>_A6+_ .=;0?\ G'3_
M /7OW[KW7OX5B_\ G6T'_G'3_P#7OW[KW7OX5B_^=;0?^<=/_P!>_?NO=>_A
M6+_YUM!_YQT__7OW[KW7OX5B_P#G6T'_ )QT_P#U[]^Z]U[^%8O_ )UM!_YQ
MT_\ U[]^Z]U[^%8O_G6T'_G'3_\ 7OW[KW7OX5B_^=;0?^<=/_U[]^Z]U[^%
M8O\ YUM!_P"<=/\ ]>_?NO=>_A6+_P"=;0?^<=/_ ->_?NO=>_A6+_YUM!_Y
MQT__ %[]^Z]U[^%8O_G6T'_G'3_]>_?NO=>_A6+_ .=;0?\ G'3_ /7OW[KW
M7OX5B_\ G6T'_G'3_P#7OW[KW7OX5B_^=;0?^<=/_P!>_?NO=>_A6+_YUM!_
MYQT__7OW[KW7OX5B_P#G6T'_ )QT_P#U[]^Z]U[^%8O_ )UM!_YQT_\ U[]^
MZ]U[^%8O_G6T'_G'3_\ 7OW[KW7OX5B_^=;0?^<=/_U[]^Z]U[^%8O\ YUM!
M_P"<=/\ ]>_?NO=>_A6+_P"=;0?^<=/_ ->_?NO=>_A6+_YUM!_YQT__ %[]
M^Z]U[^%8O_G6T'_G'3_]>_?NO=>_A6+_ .=;0?\ G'3_ /7OW[KW7OX5B_\
MG6T'_G'3_P#7OW[KW7OX5B_^=;0?^<=/_P!>_?NO=>_A6+_YUM!_YQT__7OW
M[KW7OX5B_P#G6T'_ )QT_P#U[]^Z]U[^%8O_ )UM!_YQT_\ U[]^Z]U[^%8O
M_G6T'_G'3_\ 7OW[KW7OX5B_^=;0?^<=/_U[]^Z]U[^%8O\ YUM!_P"<=/\
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MQR;IW1CL-6UF VX^0G9(:!,WE88J8S.0L0EU$@#W[KW6LK%_,Y_X4:F.,O\
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M'YG?$;;'S,V/U7USO>;;<^R]C?(OI;O#=FU=W[,HM^;9[%P/4VYQN.MZ[S>
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M'S2+1SY*:O :!I<;+[KW00;8_D+Y[:V%V?!AN_>J=I[DVEW/UCV'B-Q=<?'
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M\@/^9.[[_P"U73_^[.A]^Z]T(VV/^/:V]_VH\3_[@4_OW7NGSW[KW5+W:O\
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ME9I9&\84NP4>_=>Z$#W[KW7O?NO=>]^Z]U4+NWXJ_P PWI?Y!_)CM/X*]O\
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M':^Q^W^M:)3B8*^+&3X_(;%[WW1C,C2R1-3Y&FR"BH20T].8O=>Z2NQ_@?\
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MXZORV*&;V9V!M#)XN>6BJZN@J7I#-2SST\D4K^Z]T8KW[KW7O?NO=5I]T?S
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M[XR5!LO(9^B[6[KV54[/Q>S^I\\]919';^[J_!;<KI,/D$JI**I*3PY.@RM
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M<RUC;%P7>$6/FZLS>Y(Z""JEQN&W9%EJ0QU3KX*;[N#[EX3-'J]U[I4]6_S
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M-69*LH]K;&VMD<G5""*21:2CD8*=-O?NO=%B^3OSB^'_ ,W^_P#^5_U5\/\
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M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJI_YW.]]Y=?\
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MCV,&X9YTDES4)T5C3+Q[]U[H9H((::&&FIXHX*>GBC@@@A18X888D$<444:
M)''&B@*H   L/?NO=9??NO=>]^Z]U[W[KW7O?NO=5I_S#OEIW7\:=S?";9'1
M^V\)G,U\H?E)3=+[KR&1Z>[$[ZRFU-C4/5W8?9.X=R8+K+K+L/K+<-:U%%LE
M5K\K)D9:+ 8UY\A/25:0>%O=>Z GK?\ G,;1[3W7U=L3:7Q;[QK]X_(#LW8>
M.^/V*AW#T]44G8WQO[$Q_=N6P?RVR>7I]_R46P.OJ'&_'+>$U?M[*:-Y0"DH
MUCQDS5RK%[KW5T7OW7NBA_/;Y14/PP^'_?'R5JCM_P"_ZVV86VE%NV:JI]I5
M78NZ\MC=D=9T6[JF@GILA2[2K.P-RXV/*S4SBH@Q[321 NJ@^Z]U6=TO_/.V
M!O'9?Q(RN\NJ\AE$[<VCU)0_([N7KS=_7F/Z*^/O;?:6]^Y>H\'0RQ[]WYC=
M^9KKO/=C_'#>U2,G3TU4,#MRDH*S)NHK 5]U[J#M?^=K2[UDPFX=I=&=@[IR
M^<AJ.J\/\<-NOUY)N3<'?N3^2&RNE-G56*[UW-V%M38\77N;Q.]*+*?<5.,A
MB7&U+51GUPK33>Z]TXI_.^@WSG>F,9TQ\6-]9VD[7[C^#6RXF[(WMM+K/<=9
MU5\R<3F<C)WGL;:F7EEJM[]:[&R^'J-NTN;I)VP^=W1C,ICH:B-Z%6J/=>ZO
MFFFAIX9:BHEC@@@C>:>>9UBAAAB4O)++(Y5(XXT4EF)  %S[]U[K5TZP_GY=
ME]S;)R6^>K.J]A=P97 _/7)]=T/4W4V;Q..W3N[X6;H^,GR3[WZKSV7W5VMO
MO;.S]G=^TE/T'7U.XH'J/X2$HUI*13/6QF/W7NCDX_\ G28/??8/7.$ZKZ"S
M%1UUNCOS8_7^YM[=J]E[$ZAW-A.B=Z_$K>_ROQORFHNM]W5M)E9.F,WMS8V3
MI<'G:JJI\-F/X!F2M7%-1"GD]U[H/MK_ ,\"FWM6PYG970W8V]LUD8:'JW ?
M&_:[==#<FX.]LUWQ5=:;<R>,[VW3V)M79*]=9W:OVV62:IQ5.B4,_P!QYG<+
M3O[KW5U7Q_[GVM\C>BNF_D!L>GRE)L[NWJ_8G:VV*+.014N:H<%O_;.,W1C*
M',4U//54T.5HJ3)K%4+%++$)D;0[K9C[KW0N^_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@7^0O\ S)[>G_4'1?\ NUH??NO=
M"E@/^+%A?^U3CO\ W#A]^Z]T[>_=>Z][]U[K_]'?X]^Z]U[W[KW0._(#_F3N
M^_\ M5T__NSH??NO="-MC_CVMO?]J/$_^X%/[]U[I\]^Z]T239'\N_XD[,W3
M\BM[U?4>T]_;P^4O8.9W]V_N?L7;.T=RY[.1Y;(;/R]-L-<L-NT-?+USM[,[
M$QE;CL75R5?V]73)*9'9(RGNO=.WR0^!OQC^4=)V94=C=<X:AWYVSTY6?'[=
M_<6U<3MW'=N5'363SU%N++=>0[PR>#S+MM?,5U"$JJ.H@G@F@DDC*Z7/OW7N
ME)A?A)\/]MY[K7=& ^,G1V&W!TYL_>O7_5F5QO6NU*2KV'LCL>7+3[\VKMIH
M<8BX[!;LEW#D6KJ=!XYSDZS4/\KJ?+[KW4>A^#GP]QN/ZYQ=%\;.GH:#J/+Y
M3<'6D']R<-+_ ',SF9S^WMU9'+826:GDFI\A-N;:&(R"REF>*MQ%#-&5DHZ=
MH_=>Z4&ZOB-\7]\1XV+=W0?5.X8\1V'N?M>@3*;+PE2L78F]\@N6WMNF4-26
MJLAO3*1I49=9O)#E)XHWJ4E:.,K[KW3Q\@/C3T#\JMD4W6WR.ZCV-W-L2ASU
M'NJ@VOO[!TV=Q>.W/CJ')8W'[CQT-2-6/SM!09FKA@JX62HACJ9 C@.U_=>Z
M=.O>C.MNK=V[_P!Z;'P<F%S'95'U[CMRQQU]9+BEQW5NTX]E;)H,1B99FH</
M2XG;T0A(@13,?4Y8A;>Z]TFLU\5?COF][=N=H2=0[$QO:_>W63=.]L=L8/;>
M*P_9>]NNACFQ--MO.;TH:6+.5])04'BC@\LKM&E+3*#IIH%C]U[H6MD[/P/7
MVS-H[ VQ32TFV=C[8P&T-NTE355%?/2X+;.*I,-B*>>MK))JNLF@H*&-6EE=
MI)&&IB6)/OW7NFS;'5_6^RMEU'7&TMA[1VYU_5R[JFJ]DX?;V+H=JU4F^<SE
M]Q;S:IP,%*F,J!NK.[@KJO(!XB*N>KF>0,9&O[KW0,[7^$WQ$V5MYMI[4^-W
M3>"VV^,JL-+AL?L+ 144V*K<IL;-55!/$:-O/33Y3K';<S*Y8%L!CQ]*.G$?
MNO=+KJ/XY]"]!5.^ZSI+I[KGJFK[/W-/O+L2IV%M/#;8GWINBHFK*A\WN.3%
M4E,^4K4DR$_B,I80K*RQA5-O?NO=)NB^(?Q=QB=U1XOH+JG$K\C]V4&_.^3B
M=F87%OVYO/%U4%?0;GW[)04M/)N+-4^1@^Z$]07=JN26=B99I7?W7NC%^_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[I(;@V!LC=>X-C;LW-M/ 9[<W669RN
MXNO,]E<725V5V5GLYMG,[+S&8VS6U$3SX?(Y/:6XJ_&SS0,CR459-$24D8'W
M7N@4ZR^%_P 3.F,[E-S]4?'7J'KW<.:[5S?>&1S6U-CX/$9*7MG<6U\_LG,[
MZBJJ6D26CSE=M/=>5QY:$QHE-E*Q$5153^3W7NC->_=>Z1>]NN=A]DP;;I=_
M[0V_O&EV?O3:_8VUZ;<6,ILI3X'?FR,DF9V?N_&0U221TVX-L9>)*N@J5'EI
M:E%EC*NJL/=>Z(/V]_*G^*7<OR'Z6^0&?VKCL,>G-\;_ .TY.NMM;%ZJQVV>
MRNS^Q:K+9#<F[>Q=SR;#J>T,M2YO*YZJK<OAH,]38//UOBER5)4E9!-[KW1@
M]@_!SX>]74.UL=U]\;.G=JTVRLE09G:K8S8^%6LPN9QFY<=O''9BDR,U--D#
MEJ/=6(I,A'4O*TZU5+%(&U1I;W7NF:B_E^_"G'46X<=C_C+U'0T.Z'ZG;*TM
M'M:DIHHTZ*SM)NCIZEPJPE/[LT'7.YZ-,EBJ;&_:4]-D&DJ0GFEE=_=>Z-5N
M+;V$W;M_.[4W-BZ+.;;W-A\GM[<&%R4*U./S&$S5%/C<KBZ^G>Z5%%D*"IDB
ME0\.CD'Z^_=>Z*QV?_+^^$?=&W<1M+M7XK=&[[VWM_8.RNK,!A]P]>[?K*/!
M=<];S96;8&R\*GVB-BMN[-;/5ZXVFIS''1Q5]5'&%CJ9E?W7NI&6^!?PRS[[
MSDS_ ,:.H,\_86^MB=D[S;-[/QV7_CV\NL,+4;;Z[R54,C'4B*DV7MVNJZ#'
M4$7CQ]+15]9 D BK*I9O=>ZG[#^#OP^ZOAV]#U_\:^F]J_W4R&/R^WZC%;%P
M<5?C,OB<S+N'&9>+)24LF0DRM#FYFJHZF25YUFLP;@6]U[HP.R=E;1ZWV?M?
MK[8&VL+LW8VR<!B=J[0VEMO'TV)V_MG;6!H8<;A<%A,71QQ4F.Q6*Q]-'#!!
M$JQQ1(%4  >_=>Z4_OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[H%_D+_S)[>G_4'1?^[6A]^Z]T*6 _XL6%_[5.._]PX??NO=
M.WOW7NO>_=>Z_]+?X]^Z]U[W[KW0._(#_F3N^_\ M5T__NSH??NO="-MC_CV
MMO?]J/$_^X%/[]U[I\]^Z]T1G;7RN[#R/SOWE\0]Q].8/#[2H>HZKMC978&&
M[0HMU[XJ=OXK([+P+;J[1ZSQVW(\9U5L;L7=VYLQAMDRS[@KLYGJS9&=FEQ=
M'20QSGW7NCS>_=>Z)%W)\ANX.J?DGU]L:HVQTO3_ !VSO4_:O;^_.S]Q[ZWU
M0]A[-VWTC%MI^P32;&Q/7.8V[F%=-^XF:BD;-4Y\%/7>2/6M.LONO=#GT/WS
MLOY#[+JMZ;+Q^\\$F+SU7MC<&U^P]H9C8N]MLYRFH,7FX:#/[:S<,-91/E-M
M9['92D<%XY\?D*>0-=RJ^Z]T6NF_F3_'*IGJJ5:3M=:K&=C93K_<%,O66?JI
MMJ4.(VKB-]5W9>[%H!5C;?6,&S<[39&3(59BJ:>)GCGI8JB.2%/=>ZR9/^9!
M\>,?C-TUU/C.X\]D,%O_ !W6^WMK[9ZBW?GMU=HYW,;G[$V5A\AU;B,?22MN
MG:>3W;U-N*@BS!>GQWEQI=IEAGI99_=>Z5DOSS^/U)OC<6Q\I6[SPC[<W91;
M+FW=F]DYK%]?9/-)F\?M7>9PV\ZN*/#UN-ZFWCFJ##[MJRZ4^"R5?!%.UB[)
M[KW4OK;YT_'SM7MW!]([5S>>&^]Q[ Q/8&)H\OMRMQ--+3Y796T^RCMBI:J(
MK,=O'%]=[]P>9JZ.H@B6*CRD*B5IUGAA]U[I#_(;YV4/1/9'<O5R=0;ZW)E>
MH_ACNSYC2;S?PXSK7-XO:^X<QM[_ $9Q9^G@R^5@WOE)L,\E/%'05!E$B(B.
M[6]^Z]U*V_\ S'?C/GMV]1[!ER>\]N[X[>S^;VG2;0W5L[(8/<VPMV8?>.7Z
M]@VUV=@ZB1LEM/+9_>V!J\?CU\51%,T0G=XZ62.=_=>ZE?+OY:;O^-.\^@L)
MC.N,#EMG=I[Q3;V[>S=_;JSNQ]@[8FGS^T]NXC9=+N_$;)WGMO!=E[O;=,U7
M@DW=4[8V]E6Q,N.ARAR-530>_=>ZQ?\ #BWQM@;L=,Q6[ZVV_5NY]T;4W6FX
MMBYC&209/;VQLKV)BTBBD#R0U._]N8#(#;U#4BFRN1KJ*6C-+'5:(G]U[KEO
M/^8=T'L7-=I;8R^,[9KMV=7;AZ]VJVTMN=99[<FY]_9WM#<V>V/LZBZZPF'%
M779K[_?6UZ_$O)5)010ST_W#L*"6"KE]U[H6-C?*CK'?W>&YOCUC*;>6)[(V
MOL>E[ J*+<NUJS"X_(8$R;:ILVF-K)W>3^);4KMY8JGKX:F*G_>K0*8U"Q5#
M0^Z]T#G;OS)KNB_D-V%LWL?;>W*'H#KKXITGR*R_8>%R&[=P]H2YRJ[.FZYC
MV30]8XK:-119&BJ&B$\%93Y66LFJ)4IQ1 ?O^_=>Z7'7?S7ZE[1WSM;KO:.W
MNW:S<>;I,R=U+)U;N<8WIO.X?-[MVXNS>[<G3T]32=;;KR^8V%F(J&"M;PU"
MT2R^415E ]7[KW1NI&9(Y'6-YF1&98HS&))6521'&99(H@[D6&IE6YY('/OW
M7NJA?^')NS\:N^*/<G1VQ:?,]-[IW1E^Z)-M=L5N[-H[?ZJV/'U*G8VWME;Q
MHMD08W?WR(ZES'<F/Q6YL# L&$H<E15$(RAED2)/=>ZS=R_S/<YT!M?Y793L
M+IO:U;NGH[=.T-L=9[0VUW%B?M]];AWW'O3/X?KG?N]<QM^BVIU_V?M[I_9)
M[&W%0TD^:@PNSLK1R32FJ9(9_=>Z/#\D^YM]=7[3Z_3I[96V.R>S.WNQ<1UM
MUWB-W[OJME;%.2K-I[OW_79?<^Z<5@-V96AQ$&T]BU_A-)CJR6:MDIT*K&[R
MI[KW17-F?S9?BSNU)\88NT*/>V.VEM7.Y/9]%UGN[.//NC<N/ZPJ).M]I9^@
MQ2X+>N\L3D^V<712Q44IB=UGE5_!"\@]U[J?V!_,AV9@]F;HWQL38.\-V8W
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M5JH/A#A:_:?2>.HX\32]2X_#YB#?E7EM\X^EH(,E'F*SRRZ)93B?=>Z'BOZ
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M=)GYC[#^2^\^^OBHW3'<.>V%LNBS>2FW;M?:>Z=G;>R>1RF,WWU7N&LW?N?
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M>EMNOU%V1!V1V?MN@[4WAA=@=G;VWCUYG]Q;>Z<QVPML9G:E;O:OQ]5A<UN
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M)8::67%Y*C]U[HQ/SFQ'RGR)^/\ 7_&*3>M54;>[=Q^;W_MG;6X-H[3VYNW
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M=+DVJ:>GC6)8UE(\:?I'NO=5S;BWW_,GCZDW)608[Y-4_95-VYN#';]IMO\
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M;_\ *MO#_P!&EVE_]F?OW7NO?Z!NM_\ E6WA_P"C2[2_^S/W[KW7O] W6_\
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M#_T:7:7_ -F?OW7NO?Z!NM_^5;>'_HTNTO\ [,_?NO=>_P! W6__ "K;P_\
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M73_^[.A]^Z]T(VV/^/:V]_VH\3_[@4_OW7NGSW[KW0&)_P!E+5/_ (@RB_\
M>^K_ '[KW0Y^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7N@+[R^G4'_B=.O?^A\K[]U[H=/?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MT#_1/_,N8/\ P\NT_P#WZ>\_?NO=#![]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H#>]/^ ?5G_B<NK?\
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M-)'A*.KJ5CI)0DB4\/NO=64_Q7%_\[*@_P#.RG_Z^>_=>Z]_%<7_ ,[*@_\
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MC2O%19#)T=*'8DL8J6GK(X(%)/Z455'X ]^Z]U'_ -ETZD_YYN;_ ,_.9_\
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M_GFYO_/SF?\ ZN]^Z]U[_9=.I/\ GFYO_/SF?_J[W[KW7O\ 9=.I/^>;F_\
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MV73J3_GFYO\ S\YG_P"KO?NO=>_V73J3_GFYO_/SF?\ ZN]^Z]U[_9=.I/\
MGFYO_/SF?_J[W[KW7O\ 9=.I/^>;F_\ /SF?_J[W[KW7O]ETZD_YYN;_ ,_.
M9_\ J[W[KW7O]ETZD_YYN;_S\YG_ .KO?NO=>_V73J3_ )YN;_S\YG_ZN]^Z
M]U[_ &73J3_GFYO_ #\YG_ZN]^Z]U[_9=.I/^>;F_P#/SF?_ *N]^Z]U[_9=
M.I/^>;F_\_.9_P#J[W[KW7O]ETZD_P">;F_\_.9_^KO?NO=>_P!ETZD_YYN;
M_P _.9_^KO?NO=>_V73J3_GFYO\ S\YG_P"KO?NO=>_V73J3_GFYO_/SF?\
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M_P">;F_\_.9_^KO?NO=>_P!ETZD_YYN;_P _.9_^KO?NO=>_V73J3_GFYO\
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$]U__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g785934g08g08.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g785934g08g08.jpg
M_]C_X0\217AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    ?    <@$R  (    4
M    D8=I  0    !    J    -0 +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P(#(R+C @*%=I;F1O=W,I #(P,C0Z,#0Z,C @,#DZ,S,Z,3(
M  .@ 0 #     ?__  "@ @ $     0   N:@ P $     0   \
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   -V         !(     0   $@
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MM;_3OHO<?5_TE2B;^NEX_2/8)<UWZ"C:!#-MG]/+OT7O=_Z)3_;E_5_QH?\
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MVIP)%V X:@G83R/=_AOW4+'P/2+Q9TUMY#G>G8\8P(;!VL9Z-5.VKV,:S?\
MI?TGZ12LQI87MZ)2YY(]KC2"1[OSMK_H[*?\_P#X-)2?[+U,\_8S,S^B?W$.
M_P *D<7J9F?L9F9_1/[Z._PJF[)ZDT15@ @!T;KFM$MD5M]K7_SD*W4ZQU3'
M6,].QS07LG=M<1[F;Q]+:DIHG%ZF9G[&9F?T3^^CO\*D<7J9F?L9F9_1/[_2
M_P *M%))3FV8_4PQSC]C,!QUJ?K(UG]+^="/]N'[*_:'IZ?9_7]*?Y'J^GOC
M^S]!6+OYI_\ 5/Y%F_\ K+?^@'_HE)3_ /_5]('_ "R[_P +-_\ /CT#J64:
M<_':RUS#M+[&"ZEC36W<][GTY(?8[Z'\Y3L]G^%1Q_RR[_PLW_SX] ZK5G69
M%?V=N1LCW.H., -7?]S*[+=W]7]&DIS1U"_TY^V7O>VHN>!D8&D'W:^FW^0_
MU?\ A$2WJ-E3-,RVQKC+;Q?@@0'/8R-[&-V9&VS_  7^!_TB.W'ZB6[#5D-E
MH'JSAEPB2[3T-F^W]&QWL]+]#7]#_"(U=2#VM%&2ZL%A<-V&&N :W?6]OI_S
M=EGJ.L_PGJ76^CZ=?I^FE(/VA>":?MEGJU!UCPV[!+]#MLIL:^MK6-J:RS(W
M_P#&,2HS[K'MI?E7#UX:QXR,(D2&VL?6UC&[W6>QFW:_]%?ZB*S'ZI,FO))V
MO!+W8?N)8]@WN91OW;]K_P#S][/4J4\7%ZDZ\-N?DUUB27V?9'"0-E>UM%&_
M>UVVQK_^!KWI*:5?4K32XC,MNWL<7#[3@@M 'J.MWU5LV[=WYCO31']2NJ(J
M=EVS.ZQS[\!KA[=AIV^G_I&[_HL_XS_ K3/2G;B6YES!I[0S'C1H8[Z6,YWZ
M3;[T[>EO&[=F76;OWF8^AEKB[VXK?I[=ON_TG_%I*<P=1N8^R<BW<W<[T7Y&
M'[1'J61[/4_04[KV>L_^;_G$SNJ/I&Y^<\N86;JS?@CES]U;YJ9M]K&[O=_Q
M7Z1:IZ8XN#CEV_3<YPV4>YKO\"\_9MWIM;[/]+_I+'J7[/?N:XY=Q+22[2GW
MSO\ YR*/Y;/H?Z"G^VE.2[J-]SG;,JVLU,=>0R_!/Z-Q]1MA#J[/T%=+_P!'
M99_@?I^I:E?U*QS'V5Y5C7PZT5UY&''I\6?SS'-;7C/ILJW_ +_J_I5I_LM^
MU@.;D'9NEWZ,.<';8:]S:1_-[?8GLZ8YS2UF596)>1M91HU_^"&_&?\ HZOS
M/S_],^U)3F9/5XLL]/,=M]73;?A !NQH;L]5KG>G99[_ -+^F]3_ (']&H'J
M>1Z0:_)NK;+GBXWX <=!^K?S?I^Q[F-_KV_SW\VM6SI9> &95M4%YEC:==[M
M[0[U*+&_H?YNGV_S?\YZB=W3"XV$9-C ]P<UK640S5KG>GOQGN]^S;^E]5)2
M:MV_ :[<7[J@=Q+7$RWZ6^K]&[_K?L5+_P!9;_T _P#1*T"PUXOIEVXLKVET
M 3 C=M8&L;_96?\ ^LM_Z ?^B4E/_];T@?\ ++O_  LW_P ^/0.JX&;D9-5^
M(RK?4V&OLMOJ(,[@'-Q2UMU7_!V(X_Y9=_X6;_Y\>KJ2G#'2>HLLL=61M<W:
MP.S,LD;PUE_J2]S7[=U[J+*V4V?S'\THU]&Z@VMM8VM'J O/VS,=[ (]FZQK
MO\+D?H]_I?S%O_%[R22G _8_5&U@5[/4>W;:79F:>'&QGIO]3U&_F?\ @U/\
MVI_LC.9:RRL-<ZOZ/J9>602USG5;ZG/LK?[=F_U-_O6XDDIP:.C]2J,Q7+?4
MVN^UYA)WL]-OJE[W[W>VKZ>_T?Z13^F2KZ/U2O5IJW$O)+LG,< 0'_9OIW.]
MFZUWVFK_  W_ %NM;R22G 9T3J.QE3BUC*@&LVYF:3!=7ZF[],QSO9ZWI5O=
M_H4OV/U4BO=Z9=5(#AEY@T<[U'S^EW._,_G'/_T/\VM]))3@/Z)G ;:PV  0
MXYF8'2YK6W-<6V[G5M<S]"W?_+_G$CTKJ\,#6T MAN[[3E[MH?ZWT]^]WZ1[
M_I.^ALK_ )K]&M]))3DXW1S8VW]H!VZS0&G*R7#:2VTC])8STOTK/\%^8K#>
MC837;@[()@@SDY!D$.;KNO\ =]/V_N*\DDI$YC:\8UMDM8S:"XEQ@"/<]Y<]
M[OY;UG_^LM_Z ?\ HE:5W\T_^J?R+-_]9;_T _\ 1*2G_]?T=KFGK=@!U;C,
MGYO>KRSJMG[=OVF7?9Z]PTT]S]HT_P"_+124I))))2DDDDE*22224I))))2D
MDDDE*22224PN_FG_ -4_D6;_ .LM_P"@'_HE:5W\T_\ JG\BS?\ UEO_ $ _
M]$I*?__0]#I#_P!OY.X$-./7L)[C<_=']I:2I9&/FMS1E8OI/W5>DYEI<V(=
MO:YKF-LW?2<ENZU_H\;_ +<L_P#2*2FZDJ6[K7^CQO\ MRS_ -(I;NM?Z/&_
M[<L_](I*;J%]IQICU63);&X?2'TF_P!9JK[NM?Z/&_[<L_\ 2*J6=,NM>;+>
MG]/>\G<7.!)).N[<<?S24ZAR<<3-K!!@^X:'33_I)#(H/%C#Q^<.^K?\Y93>
ME6-V[>F].;Z9W,@$;22T[F_J_M_FZ_\ ,2=TE[F.K=TWIQ8]H8YL&"UL[6?T
M?Z+=[MJ2G5&103 L83X!P[_^<I#(H/%C#(D>X<<K+9TNUD;.G=.;!W" 1!C;
MN_H_[J9O2K&D%O3>G-(X@1V+/^X_[CMB2G7KMKL!-;VO ,$M((D=M%)9F/C]
M0Q6N9BXN%0QSB]S:W.8"XZ%[@RAON]J-NZU_H\;_ +<L_P#2*2FZDJ6[K7^C
MQO\ MRS_ -(I;NM?Z/&_[<L_](I*;5W\T_\ JG\BS?\ UEO_ $ _]$HSSUIS
M'-]/%]P(_G+.X_XI$^P_Y*_9V_\ P'V?U(_D>EOV3_T=R2G_V?_M%NY0:&]T
M;W-H;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (    X0DE-!"4
M     !#-S_I]J,>^"05P=JZO!<-..$))300Z      #E    $     $
M  MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN
M=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P
M4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L
M     BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O
M;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M         $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M        0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M           *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',
M    4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B-2
M;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5VAE
M;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG          QC
M<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M   +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !+     $  0$L
M     0 !.$))300F       .             #^    X0DE-! T       0
M  !:.$))3009       $    'CA"24T#\P      "0           0 X0DE-
M)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M   ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    !
M "T    &       !.$))30/X      !P  #_________________________
M____ ^@     _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M #A"24T$"       $     $   )    "0      X0DE-!!X       0
M.$))300:      -!    !@             #P    N8    & &< ,  X &<
M,  X     0                         !              +F   #P
M                   !                         !     !
M;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   #P
M  !29VAT;&]N9P   N8    &<VQI8V5S5FQ,<P    %/8FIC     0
M!7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M        !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE
M<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
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M='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M   ,     C_P        .$))3001       ! 0 X0DE-!!0       0    "
M.$))300,      WT     0   'P   "@   !=   Z(    W8 !@  ?_8_^T
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MDDDDE/\ _]+U5))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE/\
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MZ2FE7U*TTN(S+;M['%P^TX(+0!ZCK=]5;-NW=^8[TT1_4KJB*G9=LSNL<^_
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M %W_Q &B    !@(# 0             '" 8%! D#"@(!  L!   & P$! 0
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M]W[#Q.Y/B1L7$=G?)'!5>49,MU#U_G=JU>]\3N[== (&J8L)6[5H9:Q9H%F
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M:EJZF#[.+.5V:AI%CD]U[HN=%_(M3[_I"IW'\NMQ;V3I3;/Q2VYA,CO'X_\
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MP=4E9ON+,MM:E:FS;BCD#U2E*HB(VD.GW[KW0:_[/%\*O^\P/BY_Z4!U/_\
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MU?&M0;RJ''NO= 7_ ,-5?ROO^];WP)_](^^/7_VN_?NO=#I0_$OXJXSI*O\
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MKW[KW7O^@K;^2)_WD[O3_P!)T[__ /M=>_=>Z]_T%;?R1/\ O)W>G_I.G?\
M_P#:Z]^Z]U[_ *"MOY(G_>3N]/\ TG3O_P#^UU[]U[KW_05M_)$_[R=WI_Z3
MIW__ /:Z]^Z]U[_H*V_DB?\ >3N]/_2=._\ _P"UU[]U[KW_ $%;?R1/^\G=
MZ?\ I.G?_P#]KKW[KW7O^@K;^2)_WD[O3_TG3O\ _P#M=>_=>Z]_T%;?R1/^
M\G=Z?^DZ=_\ _P!KKW[KW7O^@K;^2)_WD[O3_P!)T[__ /M=>_=>Z]_T%;?R
M1/\ O)W>G_I.G?\ _P#:Z]^Z]U[_ *"MOY(G_>3N]/\ TG3O_P#^UU[]U[KW
M_05M_)$_[R=WI_Z3IW__ /:Z]^Z]U[_H*V_DB?\ >3N]/_2=._\ _P"UU[]U
M[KW_ $%;?R1/^\G=Z?\ I.G?_P#]KKW[KW7O^@K;^2)_WD[O3_TG3O\ _P#M
M=>_=>Z]_T%;?R1/^\G=Z?^DZ=_\ _P!KKW[KW7O^@K;^2)_WD[O3_P!)T[__
M /M=>_=>Z]_T%;?R1/\ O)W>G_I.G?\ _P#:Z]^Z]U[_ *"MOY(G_>3N]/\
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MKKW[KW7O^@K;^2)_WD[O3_TG3O\ _P#M=>_=>Z]_T%;?R1/^\G=Z?^DZ=_\
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MU[]U[KW_ $%;?R1/^\G=Z?\ I.G?_P#]KKW[KW7O^@K;^2)_WD[O3_TG3O\
M_P#M=>_=>Z]_T%;?R1/^\G=Z?^DZ=_\ _P!KKW[KW7O^@K;^2)_WD[O3_P!)
MT[__ /M=>_=>Z]_T%;?R1/\ O)W>G_I.G?\ _P#:Z]^Z]U[_ *"MOY(G_>3N
M]/\ TG3O_P#^UU[]U[KW_05M_)$_[R=WI_Z3IW__ /:Z]^Z]U[_H*V_DB?\
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M/_UD]^Z]U[_9=OC]_P ^+Z<_]%CLG_ZR>_=>Z]_LNWQ^_P"?%].?^BQV3_\
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M3_\ 63W[KW7O]EV^/W_/B^G/_18[)_\ K)[]U[KW^R[?'[_GQ?3G_HL=D_\
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MG_ZR>_=>Z]_LNWQ^_P"?%].?^BQV3_\ 63W[KW7O]EV^/W_/B^G/_18[)_\
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M]U[W[KW5$W_"F+_MQY\\/_#:Z9_^"3Z:]^Z]U9?\$_\ LB'X;_\ BJOQY_\
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M]T5;KC^?!\C*CO'Y-]S9+ U/8OQ9Q?QE^/M!\=.CX=H4VTLQE/D_G/D]U/\
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M7]+]5/U'FJ[X-T74^=RFZL3WGB>S$^0&TNSQLG<60W+N5MZ;:78%?BLE1TF
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M11^Z]T=GM/\ F%?+C!_R"NP?E]@^Q(:GY3]?]IU70='W1L+JS9>;J.R3L?\
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MC\U\<\#T_P!4;B[*H_XSBLONVGS\N'I,CE&-$8*7'5WNO=-/4'\POY,?,(_
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M[,[D['R&U=CU_P ?-EX/=M;LN:EFV#D-S4N^,11U4%9.CU/EQ47NO=!;MO\
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M^67.5/3G9,'Q\W-O_ 8RHS&9PF(@K\QL/.)3QU,DU#% :NE?T&.U_=>ZI/\
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M178NQ=T]F093K7/=?[1/>>"^/.<J,1+AOX])L6NFQ@R4>4$U7]E[KW3QM?\
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M-G_O:_:&Y:6DR6'KYEAK)*N&.&:;W7NF[XG?S3/D%%OC<LN^\$G8/16YJ?\
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M9O<.$Q.(RV[>M\GO7:>^7."? ;@D&+84]/&V3QTY:=*"+W7NCY_S(OF[V/\
M$%.D\)UM!\<<?F.X<GOBD3=GR,[#WOC<;2UFS*+;M5B]G;(Z9Z7V9V'WUV[N
M??%5N#Q25>#Q+XO:M)3/69&21YJ&AK?=>Z)-G_YR7R WOU/C.W/CQ\6NM:G
M[._EE=:?S1^Z:?N/N;<. JTV!G\SW#CMZ?'SK:+:O6N8J*GL:"BZ7RM1A]R9
M>.DQ<C>&*MQU,\K>#W7NIW?7S_\ ECVANO;NX/CKL_9VR_B=L/\ F8_"CXB=
M@=BU&_J^A^0FY)-U=J='U/<>7CZ[K-E5^QHNH*R/L^#9<M ,T-QUEJW*0M#
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M>O,9B\74T#T\%+0TN$QJ8]*-*.%5]U[IJKOY1_PWJL#F]L46'[/V]@\YT?\
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MH?Y0[#^!'6U55[Y[)SG8':_RL[?Q'Q_W/L?<F9VKL3J3<F0V?TAM3 =S5?\
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MUOM?J?,[/W =D;-^'.[_ (';?QE'O3<='+1?&_?#]5/G]KFMAKEJILU*>F,
M(LJ[&N@%/($D'FDU>Z]TZ]Z?R^?CA\A<IVCN3?6,WMCMZ=IT'QX2JW]LC?\
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M^](]D;YPU3EMS?'S=&]=W];,,E64^+I,QV%U9O3IG=/\;P\4@QVXZ"OV#O\
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M&*?=U<A'!]^Z]T87W[KW7O?NO=>]^Z]U[W[KW6O%_P *IO\ MQS\N_\ M?\
MQN_^";ZA]^Z]U<[\3?\ LECXT?\ BO\ TU_[[K;GOW7NC >_=>Z][]U[K__0
MW^/?NO=>]^Z]U1-_PIB_[<>?/#_PVNF?_@D^FO?NO=67_!/_ +(A^&__ (JK
M\>?_ 'T>T/?NO=&J]^Z]U[W[KW7O?NO=>]^Z]U7'_,:^96^/B#M+J:38%/T+
M09SMS?M=LJ/>_P A^Q,UMW9NSSC]N5V>IDP_5_7.&W3WGWOO#<];21X^BP>T
M\8[4:2RY'(55-24I6?W7NJY8_P";;\GOE/\ 'C"5?Q,Z"Z_V_P!LU_P0[R^6
M_<-1V+VKN+;6.V;0;,WYV]\?MH;1Z-K_ /1K59G,[^WGVAU/F<Q05FZL-A*'
M#8C'T\.3IA65S1T7NO=,/QK_ )B_R%SL?7O2W6.*G[9^57?>,^&FT=O;G^2W
M;%72]'82LJ_Y9G7ORW[J[@J-H]==7+N7:D+TV22GFVW0Y/*S;DW7E?NDKL30
M+.*?W7NC6],?S8-W;^SW8_7^].@,!MGL?H[XS?,?M'MVBV]VG7[AVW3=S?##
MOS_05O#KO9^4KNO,)59C8&_2]/G\/N">*"MIZ*L2EJL:M5%.$]U[HO-;_.P[
MUJNLN^?D%M?XD]?Y#J'XW]%_"C>NZ-N9+O?+T/979?;WSOZKZ([%ZWV'L:K3
MJR7:VU=F]<5O<@H,[FLK]Q49!(XIJ2BBM+$ONO="KF/YF/R[VMO;<OQ8RWQ\
MZ!SOR\I?F;U+\5\+FL!VQOS'_'2EVIW_ /%OM7Y4;$[AS-1ENOY.R*VLV)M[
MJG(8C/;9@IJ=\E5)'4T62@CJ1#![KW07[2_G0=[[5VELONKY(?&_JS;_ $CO
M3JOY_P!;2P=/]K[BWCV12]J_RVJ7LBK[AJ?MMV;*VAMVHZT[=_T69:+:J-+#
MEL5(M,<CY5J7-+[KW4_8O\XKY)'8'8>4WS\2L%N#>L&8^*-)U75[1/R4ZHZ9
MK\[\J_D5L_X\)TEO?LKY$_''8=:>VNHZW>E+N&>KP6+R6)W1M])YX$Q3Q+'+
M[KW2EQWSI^=NZ?DY\2>A,UM;X_[)W)MK^8;W1\3_ )>4>SMW[NS&Q>SMG[?^
M!X^8/7^Z>J<AN+K>HW9MTQ[%W=%5UF,JY()QNK PX]ZQ\57S5E/[KW1H/E?\
MUODQLGN_LOI;XE]']2]I9'XU_&O;_P L/D#D>Y^S]Q=;T^;VGN[.=G8G9'2W
M4+;<V=NPCLW>%'T]GZQ\]F$3;V&$5%#,E0]9*U#[KW6#X?\ \P7LSYN?(G>^
M%ZJZBV7M7XJ=9]5_''L#-=C;\WQFCW5O:M^6'QNV/\C.M*':O6V"VK5;3VW2
M;+Q&[5Q^X#D<]4/432I)1<12*_NO= WDOYHW?&)[&[3WWEOC[UABOA5T/\[C
M\!NSM\#M7<V6[YJ]Q9?+==[;PW?NV=@TO7M+MA>NMN[T[&H\1EMN&OK,_4PK
M49&CE9*>.CJ_=>Z2FW_YJ_ROH=H]:]L;U^&^U=S;+^9/Q][W[M^!W5G2_:.7
MW9W[N/<?4'4M7WILOIONK$5^T*7:\6Z>\>H\?59>BJ]ISYC^!9*D?"O29*HF
MI:N;W7N@?QO\T?Y/]S[?^&E3UEO#XGUFX-T_S3>G?C-WW1]7YWN##Y)^FMU=
M4=L[WW)L[?O3OR#Z.VQWE\?NR:>NV34"&ES&-@DRR8JEJ*6K@I<C4QT/NO=*
M_'?SI^WMI]4[1^8'=_QEV1MGX>]SXOY68WIR'8';&7WCW[0;Y^+V+[IW)A*?
ML?"Y78^V=EQX+Y%;<Z4R)Q#8VID.TJZ:DBRTT\-1-4T/NO="#O/^9[\NOCM4
M9KK3Y*?%OI2N^0>[MH_&_LWH;:G3?>NYZCKS-;=^07RIZR^)^X.N^R-[;LZP
MCRFWM_\ 1F\>W<)D:G*4&+K,)N[&32FD&-G@:!O=>Z1?8O\ -T^0G5-#6]";
MZZ>Z:Q_S*QORD[+^/>1S^V)OD+VE\:J/9?6GQNZO^5V1[L_NWU=U+NSY"U@K
M.O>XL)@QMN#%.M+GA55%5F*>@BB:?W7NF3>7\Y/Y3#8TNY]E?##9VV<OU/\
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M]KUE/+5;4[ P>/IZ7*4DR/J%/#- \%5!#/'[KW16LE_)I^#L_5G7/3VW=O\
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M[MSO?"+D,#N#9NP-O=I8X[7R,5%%D,Y_&(YJ>GHI3$[I[KW0@]>_/3M?=/\
M)3_X<ERFU>NE[JA_E];U^6,NSJ*FW!CNJYNPMJ]+;@[&I\&M'7;GKMS4.RJS
M.8=(I(Y,Q)61TCL/N]8\OOW7NB\_'S^?S\7MT=#5G8'R=VUVS\;M^["^%?1/
MS+WO0;TZIS>#VGVOU[W!)M78T&]?C!",WN;=.^=B9CO3<\&U,",K%C<CDJNL
MI'BCFII?N_?NO=##DOYWOQ#VGU9NS?\ V?LKY*]4;ZZ]^0'7?QB[$^-.[.G'
MS7R5V3W'W'M'(;YZ:VYD>N^M=Q[^QN;I>V]M4*S8"LPN4RE+62U"0,\<Z3QP
M^Z]U-Q_\ZCXMS=I[!ZJSW6GRAV36;CW#\?NM.T-Y;NZ?I:+87Q?^07R>PD&<
MZ=^-/R.S>.W=E:W:/<F8CKZ.ER:XFDSNW=NU]?3TV7RU#+*%'NO=)*A_G$=9
M]?;;VMC.Q<3V+\BNY>V.WOG?L;I?K/XA?&[L ;FWA!\'^R8=K]B[).V^Q-^U
ML%-O?9V R<$E;F:[,XG;N8FI:J:D-*##2M[KW5EWQ=^2O4WS$^/O57R:Z,S5
M9G^J>XMK0;KVAD<EC:C#Y1*9JFJQN1Q>7Q55>6@S."S5!4T-9$&DC2IIG$<D
MB:7;W7NJAOYA7\WWM#X/_)#Y;]98SIO =H[%^/'\JG%?.;;=%A<?NJL[&SG;
M&X?DKE.A:'$[BEQN5EQ=#TEMJ@CI\SN&NBQZ5N+H(*JI-0T:K&ONO='@Z#^8
MVY\9_+0VY\Z_F+1T^V\CA/CQN'Y%=R8[8W3O8W5S8#;&"PN8WID,=ANHNSMU
M[PW_ $&2Q.UJ)852KRM1_%9H_NX#%3U,44?NO= %MG^>G\&LIA>Z]S;VC[VZ
M2VYTYT'UK\IL=ENZ.F\[LYN[/CQW#N+';(ZQ[6Z/PE/59C<^Z<)O?L;,4>V\
M;1Y"AQ&7J\S5Q11T;1MYO?NO=&K^'GS\ZL^8N7[0V+BNNN]>@.[>ESM.L[-^
M//R<Z]I^L^Y-K[8[!H:W(]>[X?#XK<.[]LYG9^]:3&57VM5CLM6/33TLM/6Q
MTE2OA/NO=("@_F?]-9_Y8;E^*.R>G?E+V/5;![6P?1/:'>_7/2]1O+H+J?N;
M<6UHMXXO8?8^<PN?J.Q=M0?P2J@:JW*^V'V9CY:A(ZO,0-K">Z]U,V!_-)^*
MW9<'QVJ-JUG8-3'\H/D?W7\6>K?N-DU$+3=H=!?W_/8#9T+6RC$[7A3K?(M2
MUX\HF4Q%DC!D\?NO=$^[!_G;[*W?\8OF#W5\5ND.^LE!TK\7/D'\AOCWW]W9
MT7N;#?#[Y(4_1,%;C\M7;(W_ (+=E#G:O Q[G@2*.CS2[1R6<I]3XHSH5E]^
MZ]T9KX _S0.L_F]E'ZLJ.O>WNF^_-O\ 0G3/?^:V;VOUO7]?XKL#K7MK#0?9
M]L=,G(9G-9;,]6OO"*KQ<$F73&9=)85\E)H996]U[HM_\T3^=+M'X3;5^6>Q
M>D.L^Q.Z_D;\9.B,)VGOK,XWJG<6^_CIT)G^R"%Z4P'R4W'MC=>UMT8!^SX(
MYZR@@Q@E5:"G>HKJO'4]I_?NO=/6[/YR73W06\_D#1_(+<TVY:7879_PRZ4V
M9U)T'\>NV]S]PX;M[Y7_ !HJN\-I]>YC)-N?<.#[GS/9%?B:A-NMMC&8Q<6L
M]-C\@L]0S5?OW7NA K_YT7Q=P?9^SNKMU]<?)G:%;62_&S;O=N[=P=4XV'8_
MQ![:^6V)H,IT9T3\HLU0;SR%7LWM3<4N6I*/(Q86EW%A=NUE7"F7R-"LB.?=
M>ZD5O\XKHRIW[W9LO8OQ_P#FCV?@>FW^0.V:?N[8?QPW3N'X_P#9G<?QFVYE
M\[VITAL+L'%5-=D_[X8RLP-;BZ;*Y7$8S:62RM'-3467J94"M[KW0!_&#^='
MMKNKJ_XP_(GN7^ ?&#K3M3X8?*3Y:=J]7;[ZP[2SO86W=I?'+=NR,-D^RMF]
MEXO)TFW*KJ%L9N9VQOW&V*C+;R,]--C%I[&FE]U[H5\!_/(^(#[ [QWSVKL;
MY._&W(]#=.;4^26>ZR^072M1LKM7>7QIWQNS'[&VM\@.M=I8G<.YANKKFOW7
MD4H*A344^9Q58#!D*"DG*1O[KW1F?A[_ #%^EOF?V'WQU)LO8_>W5/9_Q[.P
M<IN_8GR ZPJ>LMQ9SK[MC&9/,]6=K[/HY,IF%R>Q-^XS#U,E*M4]%F:)HO%D
M<?13,D;>Z]T7?M/^;%U1\=NY?F'L7M7<W^D:HZ6[Q^&WQWZGZ+Z4Z:W?1]X9
MCN3Y;]71[SV'UC7[Y[![#QW3?8VXNP:B*HR&,KJ>;:.'P&,A-+E*B6KT32>Z
M]U8?\=.]L?\ ([JO#]H4/6?=?3DM?D,WALMUK\@^L\SU5VCM3-[>RE3B<ICL
MWMW)O68ZOIQ4TQ>FR>(KLIA<A RRTE9.A)'NO=#G[]U[KWOW7NO>_=>Z][]U
M[K7B_P"%4W_;CGY=_P#:_P#C=_\ !-]0^_=>ZN=^)O\ V2Q\:/\ Q7_IK_WW
M6W/?NO=& ]^Z]U[W[KW7_]3?X]^Z]U[W[KW5$W_"F+_MQY\\/_#:Z9_^"3Z:
M]^Z]U9?\$_\ LB'X;_\ BJOQY_\ ?1[0]^Z]T:KW[KW7O?NO=>]^Z]U[W[KW
M16?F]\:!\R?B)\B_BJV]#UR._NIMW]7_ -^QMT;N.TSNK&2XY<[_ '8.=VQ_
M'ACVD#FE_B-%Y@-/F2^H>Z]T V]?Y>U-O'Y$_P KWO\ ;MFHQ\O\M?;?>VW:
M7:W]R8JM>Y%[M^/6-Z%EJZG-?WJIO[A-MQ,<,J$2DS JRYIKPV$_OW7NB5?&
M_P#D>U?QRVOU;@L%\L)\EE^J_A[\[?BGA]S/T!M&L::K^:7R?J/DA2=CU&TM
M^[R[&V%EHNL?N6P=1MW-8O,XS<L3-43-1J?M1[KW1BOY:?\ + J_Y?\ NOO;
M>U;V_LK<M1WA2=:T<_4WQZZ'C^*'Q<VA6]>;=_@60[ VS\><=VCVSM[#=L]F
MU)^[W)E<;6XW'5)2*&EQM)#$%/NO=5S;\_E-?)_Y7_-S^<9BM[=M[E^.?PN^
M9>__ (-4FZJ*AZ[V3OO*_)CJOJ7H[9M'O[&=8;SJ-Z46;Z.W-0[EP%1M^NR]
M9B<M!/15C&+'M+#%5)[KW1UJ_P#DS;4S7Q^^=/2&4[\W-193Y:?/?.?S ^L.
MR]J;$PV'S_QJ[3HZOJ/,]5XO&8;-9[=.#[,QW7V=ZAI/NGK4QT>9QU9/3>"C
MET58]U[I$[F_DW]K=G;0^40[@^;,FZNX?GKO+H7;?S0[0V?T%1=>8/=WP]Z,
MQN9P9^+?2/747:FY)>FJ[L/ 9^NH\MO.JSFY:T"OJ)%H&)A2#W7NB5_-;^5#
M\DL?\0_C/_+S^/VY.X>V<MM3Y/[Q?XN?*C;^(V%UU2_ _P"%&\L#6=3]E]*=
M\[ZW%V?D-Y=K1TOQ][8W)A<+6X/"M6[D2AI89Z*CFH*<U?NO=7C],=3?(#I[
MY.Q=>;/K<1M[^7%U5\*ND>INF>L#B=D0Y#!=V;*W9NK"5M7MS+XJ";?U3MK%
M],8G!8^J@RTM+CHZE:<XZ&5S72I[KW15OG5_)EZC^=WR\ZJ^46_^P:_#879O
M0W9O278_3?\ =0YS:W<DN=VWV%B^E-[;BJFW9B,?39KX][C[6SN;Q J,7DI9
MJZ>#Q3T0A8S>Z]T@OBK_ "1L!\8-Q?RN]V4OR*S.^MR_R[F^=&>WSG\UUTT&
M=^5'8WSHPM%CMZ;^W1F:WL7.Y'9.1VS6T@EC663<4]? D4$E1$8S*_NO=$WQ
M?_"9'9VU>L?CSMO;/R(ZGW-V=T]T)VC\:=V=B_(3X*=2?)3;&X^NM]_([L/Y
M%;7W?UCU)VEOO([<Z@[SZUR/9V5PU'N2>JW-1U^.FM5XMP%C'NO='%[N_DC8
M'M;;W\R?:FW/D G7NWOY@'QS^&WQWP6+H>E<)4T70N(^'^!RFWL1E<?BMN[W
MV5@-W8_=U%6PA<1046UJ/$+"8X3+&R+#[KW0D_SL_B_W/\D/Y778'QS^/NWL
M_OCM+(;R^*L>"I-M3X#%Y_\ AW7_ ,B>H-R;EW-CGW)74N"IZG;VV=NU>3T3
M2LO^3E0LALK>Z]T#>8_DD[I[%[6H?D3W=\R:WL;Y#57SP^#/RZWEO;%=!X/8
MVS\[UM\!,=O"@ZEZ!P77=!V1E(]J5^X:C?62KLYNS^)5WW-=*K0XB"&-(![K
MW2W^4W\G3-]^=J?+#+=>_+C<O1W0O\PBBZEH/G/TQ1]1[:WYN7L*/JG#XO9G
MWG2/:^9W/BQT7DM^]:X>'!YQZK ;LBE7554T5-4$,ONO=$ZZJ_E,_)WNSO/Y
MY8?NWM/(](_"[L7^:-LOY$M\>%ZKV=N>M^1W6W0N Z5W%U-E]G]OT>_H,WU5
MM;=&[=@T%%N2FJ<-DJ^OI-NP1T;XJ22JGJ?=>Z,)T!_(CVA\>/D-N3M/9G:?
M3</7*YGY3[IZ[P,'PBZ0A^2>#W%\G\?GZ3[??WS1R&2S';F]]I=,2;USR;4I
M,33[5R0QV3&/R61R%'3I&?=>Z%38/\JV3H'KS^5/+0]Q[A[$J_Y1VT^Z9X<'
MM?JG%T&XOD]_?[H+=G5%1M_!T&5[4I\3UQEZALWYZ:*JK\O3U;VI9IX%D:KC
M]U[H,_Y$/P([&^*&R?D9VWW'LOL#K;-=S]HU^S?C9T_VUN7;.[.R/CW\".K=
MT[XR_P 9>F-SU6T,UN7;&W]P4,W96>R60QN/R-9' *NEBGE:>G*1>Z]T[?,'
M^1QL+Y/?,#?/ROPN_P#IW;-7WEA.DMO=]8+NCX7](_+7<TE%TA7046.R/QSW
MIW74UN%^/FX-]]="7;.XYI-O;HI,A1M#4I2Q5E+#,ONO=*;/?RC>P<W\ZXOY
MB8^7-30]^8GL?"[/VQMJ'J"%NG\3_+SHL!783/\ P?K=F?Z0T&7R^ZLGEZS<
M$G8;21U5%GI8Y:?"K!"L+>Z]T7KX_?\ "<KHSIC!]J]19C?W6.Y?CSO'HCY"
M?'[9M'M/X==$=<_+#&;6[^RU3,VX>UOF@D>ZNQ>V-Y=9;9K'PV"J*3&[8HJB
MB"#*TN15/&WNO=#3NO\ E)?)GN+XJ[^^./R'_F/YSLW)PX_XP0?''=N"^,>R
MMA;5Z/W%\4MYX??.S.QMR==Q]A[DK>V-_P"^<I@X*?=,HS^ Q-=1?MTF/H9$
MAFB]U[H,<]_(V[=W6-\=A;I^>&/S'R5W'_,5^,_\R7;G:O\ LJV-HMA[9[6^
M.?657U=2;#K^HJ?O'S;BZYS6W\I4Q4B+N&AR6-A2F$U5D*B*6JJ?=>Z7?0W\
MBOKCH+YAY3Y ;>WUT[F>HZGN?OGOC']?9SX8=(5_R3AW9WY@,E0Y+95=\WJZ
M>N[-7J3KG<FY<SE=K4.(Q&%W%0_Q!:.JSE;20^.7W7N@LV/_ "4N_P#X_P"4
M^+^^MD?.+-]I8[^6OU?\T]K_  ,ZEJ_CIUW@]WX:+Y&].;OV%LS%;Z[)R7:-
M%M'L/>VP:NOQ-/29/)X?%82OH<8D-314CU-77M[KW5Q>T.GM^=P?!S;70?S/
MK,3O;LSM#XLXGJ7Y3U^(H<-18;=&]]Z=4P;1[HJL908.EI-O4U#ELYDLB\*4
M4$-&JN/#'''I1?=>ZIO^)G_"=/K/XU=K? GN3<7R*S_<&]?B".W-R=M9/,]>
M5F%JOEMV[NO.;TR/2G:O8E55=I;IFQ&9^-^)WW5X[ I4_P >G>""G\=52*LT
M<_NO="/A?Y&-/B>MMF]=2?)^HJH=I?&[^:W\>3E5Z:BIY,C#_,[[4K^RCNO[
M1NTJA:1^D8L@U%]EY)?[RNHG^XQ8_8]^Z]T=3?W\O&#>_P#*BA_E?IVY+BX*
M?X:[#^(T?=LFQ8\A.4V/UKMSKR+L"3KI=W4$;29'^[PK&Q:YM1$93$*MM/D/
MNO=$!WC_ ""U^0&R^]\7\P?F%N+OGL/L'XH]*?#7I[LG!=&[+ZR'4/4GQ_[9
MQG?>P\ENC9;[FWQMWM[?N;[@P-#D-RULW\%H<OCHY<=#144,VN/W7NK#?Y=O
MP%I/@KM?MFEK,OT%G-W]O[YQVZ,S-\;OA[U'\,.LL%@=O8"FP6U]H87KKK6L
MW/G,O#BG:NK'K]P[CSE8U3DIE@-+3Z8/?NO=!4/Y276$O\T'<W\QVO[&W%78
M?<?666QH^-)QU;3[$QWR#W1U_0=&;Q^2M+FJ?=24D6ZMR_'+%0;/FHXL+#/X
MWJ*MLA(T_A3W7N@ Z8_DC93K^MZ2V3V-\R-Y=J_&WX?;$^1VPOA?U-#U'M+9
M&]^L*#Y'[!W9U+DLEV[VW2[BST/>&6ZWZNWMD,3MQZ?;VU8X7D2JJTJYHQ?W
M7NB_[F_X3M5FZ-D?%^'.?)KHW?7<?QT^($/P-?LONK^7WU9WQL[+?'7:.\JS
M='3&<V+TOVIVEN/:O67R+ZGQ^3J\;%O%JG-467@JI#689[E#[KW0C?*[^0OF
MN\\/\M^L>FOF94?'GX]?-W;WQY_T]=/I\;=C[V$F_P#XVX?:.V]I;DZWW#M_
M>W55%UML_=6 V#AH\YMN@Q7@::A'\.J<=22/1^_=>ZM$_F,_#"'^8%\/.ROB
M94=C2]40]BY[IS-/OV#:B;VEQ ZE[LZY[C%,FVI-Q;5CK3GVZ_&.UFNB%+]W
MY],WB\,GNO=$3R?\EBDK\5O+&1?)"JICN[^=MM[^<D\[]313BAJL)6;,J9?C
MN(?])$/W5-61[1*KNHLAA:H#'#R"/3)[KW1SOY@'PCS'S3PGQDJ-H=Q1](]C
M?%+Y;]4?+?KO=F0Z[I^U=MY3<?66.W;@YMH;LV5+N[8E17X+<6$WG5QF>ERU
M'54E0D4J,P5HW]U[HF>)_DMP8JAV%11_).KD&R/YU&[_ .<%Y/\ 1+ AR<FZ
M9][R+\>-!['D%%#11;Q"/NO]YYC Q7$1>4"+W7NFCX%?R-.O/@9W_MKLC96^
M.F-P]7]6R=TS]0;>7X7=)8'Y,03=Q9RNR, [E^:M35;E[9[4AZSPN=RF&P'\
M.I-JRMBJX4V0DKH8(XS[KW1H/E9_+8A^3WR-W?W_ "=RS[)&[?Y<_P EOY?T
MVTHM@1[@-'#\B,UA\O\ Z5X\^V\\+YI-G_PQH_X&:(#(&16^_IM!5_=>Z(_V
M/_(.??>Q,5M'%_,C>&P<IA_Y/_QL_E1TN[-G]7_PS*U%-\=.X-O=N?Z6LDU/
MVC!4U6S>UO[OG ;FV(M1$M=@*ZJIOXW^[J7W7NH75'\@E.N=Q[5W _R*ZTQ=
M/@/YD'Q@_F,2;+Z7^(&UNB.L<?GOCOT]OOJ6LZ7V!UWM3M?(8+8NQ-U1;MIZ
MRBK?]R&1QAHI16'+U=7+D%]U[H8^FOY*]%U#\L]A?*6+Y'5>?EV3_,4_F)_/
MUMD3=3P8^/*3?/WJ/&]65'5*[B7L6M:ABZI_AB5T>;-#.^9#&#[&AXF'NO=%
MNSW_  G7PTW2_P 9=DX#Y!]1YCM7XV8[YB;.QW8'?OPBZ\^2?6>X]@_+;N[>
M'?$$HZ$[*[,FPF [:Z-WKN:*HVQNB++SPO-#4+7XRJI*PT</NO=67_$+^7)B
M/B/\B.R^\,#V?!N3"[Z^+7Q(^,>(Z]H^J]H]=8_:E%\6<%N_#G=E$NPJO$[&
MHHNP)]UM5M@\)MG 8G#S(ZTR/%(B0^Z]TF_F3_+DWQW]\C]H?++X]?)ZI^+7
M>%-\<>Q?A[V7N"KZ?PG=N)WY\<>Q]R4.]JK!X7!9O>&RX=D]C;2WO0+E<+G_
M "9.EBF)CK,96P?M'W7NB![W_P"$\=+O/XUYWX\/\N*C&QYG^63\:?Y<R;MB
MZ)BJ#3#X[_)K</R._P!,;X)NX(?N6WA-FUQ!V^*R(4"Q-5?Q*I,@IX_=>Z''
MYV?R0-H_,'Y+5OR8VUV=U%L7=&^NF=C=&=L4'=?PNZ0^82';_7^[&S>%W]T0
MW<]4N%Z4[=J]KY+);;KLC5XW=.$K,55Q,^(^ZI4G?W7NAEVY_+.[=ZE^3_8'
M9OQL^:>=Z$^,G=GR-Z[^4O=OQDP'2&T-P;@W)V)LK:.!V;N?:.R>[LSN>_7_
M $UV]B]EX)=PX([7RE9#%CY(,3D<93U)CB]U[HFO8W_"?+&;WK$RK=^]3[JJ
M^N_F%\LOE'\<]L]^_#;:W?\ U-L7;?S9,==WKTUW%U3N?MW$[<[ZH:+<V-QN
M7VCGR=MY/;M=0@NM:CA(_=>Z%C-_R4=Q[<CZ5W)\;_EU2?'[MK9_PIWK\">[
M-\8;XK=0S;/[=Z1[!WI6]HYW+[(Z4V'DNJ>LNBNRL;VEFLEF,7DL?1Y2CB%:
MT-915_[DLWNO='(VC_+UAVO_ "HJC^5^W;4E?!4_"O>/P]?NU=BK1RB/=W56
M<ZQD["7KH[OJT#T(S1K1BCG")#'X?O%U>4>Z]T0;N3_A/MUSWSA-O;6[$^1&
MX:C;>W?Y2_1?\LBCH\3UEAJ:L.YOCSW7L7O?K[Y(O/E=V9O&RI_>_8%)#7[,
MFHIJ2MH)IX),II?CW7NGO;/\C&CQ_7_6FW\EW'T-M'=VQOYB/Q=^=N5K?C3\
M#>G_ (N]8YG"?%M:I=L=&X_K7K?>#YM(,Y-E<A5R[DW!N7=%515F0E--1K3V
MIO?NO=*#?'\CG8N?^>VY_F1MOL#IBCVMV?W]TU\C^U.O>SOA1T9WOVTV].I:
M"AH\IM3ICY*]CSUN?Z6ZT[:K-O8C(9^BAP.5S%+DJ&2HPN4Q+U!\7NO="/TI
M_*+_ -$/=7QO[CF^0U1N>?X^]D_S1.QCA'ZN.,DWA4?S)^P=O[Y?&OFY^Q\U
M480]-I@VI34M#72;D>;S$8T*87]U[H4/Y>/\OWN'X!=5?%SX_P"+^7/^DCH'
MX]=#]B=:;EZT?H/:VT9>TNU-Y=MU/8^![I_OK)O/=N[]D1[,P&3KL$FVX*JM
MH*]:O[R>?S11HONO=!O\T/Y2$'R][X^4W>#=_3=>S_);^6'F/Y;XVVO5\>ZX
MME1Y;M[.=KGN,Y4]@[<?<CP29=:'^[_V^/U+$9OXDI<1I[KW1S>]/B8O='P)
M[1^#Z[^;;2=D?%;<WQE7LYMKKFGPHW#U=4]:KO5MFC<&'7)FC^X^]..&4IA+
MI\(JDOY1[KW5;7;O\BO9G=N1JFWE\C-V4.%/\LCXV?R^<13[3V#B\/N' ;S^
M+7?>'^1/6?R2QVX*[=.:H_N:;?FV\?Y=J/CFII:>.:.3(R+-IC]U[HYGPW^"
MV_.B.Z>]_E1\COD4OR@^4??FU^K>M<WOK!=28KH;KK:'4_3M'F/[I;-V3U=C
M=X=B5=)79?<.Y<EE\YDJ[/5[5E;41I2PT-/#X7]U[HM7<G\H?</<WSVV/\S<
MM\C-DX"EV%WWU1WE@I-I?%/8FR/EA38;J[ G$5/QPJ?F/UUO;9&6WE\:>PY0
MJYS";MVEN;,2XP-CX,M# ^I?=>Z0'57\E7?G5GR!Z%WW0?-$Y+X[_&CYA_)+
MY:]2_'67XYX"DRE/4_*+$]B4F^]B;K[=A[->?<%-@<CV+5MA:Z' 4*4U%+44
M]11U4DE/54?NO=<=I?R9.Z]K?%OMOX+C^85N;)_#S)_&3Y#_ !G^/_4U5\>=
MHQ9KKG$=XSY!MN;L[KW[3;_BR7?N8Z4HL@:; 1XRGV$L\2G[UYR[ZO=>Z.-T
M!_+LBZ+^7^)^5R]OS;I.(_E\=&? Z+8<FQ(L/Y8NF-Y93=K=I2;H7=V3*R;F
M.06#^"KC@M&8VD^^GUA(_=>Z*9\XOY+^\OD]O[YN;GZ1^9-=\9=K?S&NI.J.
MM_EWL^LZ'PG=-1NW-=$X&LVEUAN_8&X\IV+L6;KN-]FU"8;<6/6FK_XQCT)@
MJ,?5^*JA]U[KAO[^2%0;[^261^0TOR4K,;)7_.S^6I\V5VC'U'3U44$_\NOX
M_P!=T72];'-OV1"TL7;8KCE),O\ :*V"*BG6CKO^!'OW7NL_;/\ (\V%O[YZ
M[N^9VW]^=,4&$[;[8Z#[D[BV#VQ\*NC?D/V0-S]%T5!BZK$=#=^=G3U>2Z+V
MCV]C]OXD[FIQ@<]7)6T!J\368N66\?NO="MT3_+ [;Z"[*W5M[:7S=W4GP5W
M!VU\E>Y8?B)#TSM*GW5)F?E!2Y^IW=U[NGY$U>YLID]S]/;0WGO',9W 4";:
MH=P0UM3 M9FZU*1-?NO=%WV/_(9Q,?3?3?17<_R=K.S-C]4_ KY5_P O6JJ]
MK=-8_K3=.Y.I/D#O'K_='7^ZZ;(U/8N_<)@.P^DH=@P1+4G&UU'N&J$-144]
M,(YX*OW7NFKLK^1;V5\A^N/D?!\H/GA5]M?(3N/X:[,^!G77=F%^-^&ZYVQU
M3T#M;LW:?;^7GS?4&'[;R-/V7V=V'OW:-/69O,_QS"4VD+!0T-% GC;W7NK,
M>EOA%'T_\W?D]\R5[-DW"?DATW\:NI#UPVSH\4NS/]EXQV\L?_>!=VKN;(?Q
M\;O7=BO]F,90C'M3M^]4^4>+W7NBE=T_RC<UV5V3_,'[.VW\@]AXNK^>?:'P
MU["SG7W<'Q'ZN^273V-P?Q*ZNH.M*KK#LKK[M#<4]-V;M'M/[)<C+78:HV3N
M/ 54<!Q^2#Q-++[KW1J_Y;GP9_X;X^.M9T1_I;S';2Y+M+L+M")OX+7[-ZWZ
MV@W[D:>LI^I.@^M,GO#L*NZKZ/V3!2*F'P,N?S#T\\]5.U4[5!5?=>Z/Y[]U
M[KWOW7NO>_=>Z][]U[K7B_X53?\ ;CGY=_\ :_\ C=_\$WU#[]U[JYWXF_\
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M;^XI(-=!N&BV[GY\?519"GQ\V/9JI?=>ZJ-_F-?SN/E)\6_FO\N/CUU[V?\
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M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:\7_"J;_MQS\N_^U_\;O\
MX)OJ'W[KW5SOQ-_[)8^-'_BO_37_ +[K;GOW7NC >_=>Z][]U[K_TM_CW[KW
M7O?NO=43?\*8O^W'GSP_\-KIG_X)/IKW[KW5E_P3_P"R(?AO_P"*J_'G_P!]
M'M#W[KW1JO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=:\7_"J;_MQS\N_^U_\;O\ X)OJ'W[KW5SOQ-_[)8^-'_BO_37_
M +[K;GOW7NC >_=>Z][]U[K_T]_CW[KW7O?NO=43?\*8O^W'GSP_\-KIG_X)
M/IKW[KW5E_P3_P"R(?AO_P"*J_'G_P!]'M#W[KW1JO?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:\7_"J;_MQS\N_^U_\
M;O\ X)OJ'W[KW5SOQ-_[)8^-'_BO_37_ +[K;GOW7NC >_=>Z][]U[K_U-_C
MW[KW7O?NO=43?\*8O^W'GSP_\-KIG_X)/IKW[KW5E_P3_P"R(?AO_P"*J_'G
M_P!]'M#W[KW1JO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=:\7_"J;_MQS\N_^U_\;O\ X)OJ'W[KW5SOQ-_[)8^-'_BO
M_37_ +[K;GOW7NC >_=>Z][]U[K_U=_CW[KW7O?NO=43?\*8O^W'GSP_\-KI
MG_X)/IKW[KW5E_P3_P"R(?AO_P"*J_'G_P!]'M#W[KW1JO?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:\7_"J;_MQS\N_
M^U_\;O\ X)OJ'W[KW5SOQ-_[)8^-'_BO_37_ +[K;GOW7NC >_=>Z][]U[K_
MUM_CW[KW7O?NO=43?\*8O^W'GSP_\-KIG_X)/IKW[KW5E_P3_P"R(?AO_P"*
MJ_'G_P!]'M#W[KW1JO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=:\7_"J;_MQS\N_^U_\;O\ X)OJ'W[KW5SOQ-_[)8^-
M'_BO_37_ +[K;GOW7NC >_=>Z][]U[K_U]_CW[KW7O?NO=43?\*8O^W'GSP_
M\-KIG_X)/IKW[KW5E_P3_P"R(?AO_P"*J_'G_P!]'M#W[KW1JO?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:\7_"J;_MQ
MS\N_^U_\;O\ X)OJ'W[KW5SOQ-_[)8^-'_BO_37_ +[K;GOW7NC >_=>Z][]
MU[K_T-_CW[KW7O?NO=43?\*8O^W'GSP_\-KIG_X)/IKW[KW5E_P3_P"R(?AO
M_P"*J_'G_P!]'M#W[KW1JO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=:\7_"J;_MQS\N_^U_\;O\ X)OJ'W[KW5SOQ-_[
M)8^-'_BO_37_ +[K;GOW7NC >_=>Z][]U[K_T=_CW[KW7O?NO=43?\*8O^W'
MGSP_\-KIG_X)/IKW[KW5E_P3_P"R(?AO_P"*J_'G_P!]'M#W[KW1JO?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:\7_"J
M;_MQS\N_^U_\;O\ X)OJ'W[KW5SOQ-_[)8^-'_BO_37_ +[K;GOW7NC >_=>
MZ][]U[K_TM_CW[KW7O?NO=43?\*8O^W'GSP_\-KIG_X)/IKW[KW5E_P3_P"R
M(?AO_P"*J_'G_P!]'M#W[KW1JO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=:\7_"J;_MQS\N_^U_\;O\ X)OJ'W[KW5SO
MQ-_[)8^-'_BO_37_ +[K;GOW7NC >_=>Z][]U[K_T]_CW[KW26W3O?:6R(\1
M-N[/X[;T&>RE1AL54Y2;[:FJ<A28#.;JK(GJ6'@I8J/;>VJ^MFEF:.&&FI)'
M=E"^_=>ZUYOY_?R$ZG[_ /Y%G\PC(]7[AKLLF V_T%_%:#-[7W7LK.4U#N3O
M[I7.[5SPV]O7";?SD^U]WX.9:S$92.G:@R=-J>GFD"/I]U[JYCX)_P#9$/PW
M_P#%5?CS_P"^CVA[]U[HU7OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NM>+_A5-_VXY^7?_:_^-W_P3?4/OW7NKG?B;_V2
MQ\:/_%?^FO\ WW6W/?NO=& ]^Z]U[W[KW7__U-_CW[KW15_E]4=0R]88?;';
MVQMS=D0;^[!VKLCK[9NQZHX;?.6[,RQKZC;QVCNT[EV5#LC*4./H*ZHFRLN:
MQ<,-!%41R3,LI@F]U[K7-_G 8/KO9/\ )1_FL];[6VCOS8N\=B[?^(N+WKMC
MN/<.3[([BHL5+V_U W7\F?[DF[6[;P6_-DC;\+P;>IJ"MI#AEIZN*II5J)7E
ME]U[K8P^"?\ V1#\-_\ Q57X\_\ OH]H>_=>Z-5[]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K7B_X53?]N.?EW_VO_C=_
M\$WU#[]U[JYWXF_]DL?&C_Q7_IK_ -]UMSW[KW1@/?NO=>]^Z]U__]7?X]^Z
M]T4KYI;XV1LOIJ&#L/K;979VU]\;ZV;L&JQW:.4Q^V^H]MU6?R+2X[>O:6\L
MEA-RP[*VGMZMQZ-'D4H*JI7*R4<,"K-/'(GNO=:Z?\V[<>QJS^1W_->V;U]L
MWKG:>%V/4?&Z"NGZ'W#MSL'H+<6=SO<W2.3R.4V?VCCMB['W5NG>\,(@I]RT
M6=%?58AXJ)(:@TTT:+[KW6QO\$_^R(?AO_XJK\>?_?1[0]^Z]T:KW[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6O%_PJF_
M[<<_+O\ [7_QN_\ @F^H??NO=7._$W_LECXT?^*_]-?^^ZVY[]U[HP'OW7NO
M>_=>Z__6W^/?NO= QWOO??&P]C19/8'1NX/D'FLMN;;>U*K86W]P;+VT]/A=
MSY*/$Y7=6:R.^LGC,2=K[9@J/N,E'"*JL:D#F&FF*E/?NO=:_O\ />K-Y9'^
M1Y_,HJMZ],9#HFNCQ/Q\H,;L9NU]M]B;?_A-)W]T[)#EMNX':%4^W]AQUM75
M3K4PQT]/+7S1>>37Z2/=>ZN_^"?_ &1#\-__ !57X\_^^CVA[]U[HU7OW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM>+_A
M5-_VXY^7?_:_^-W_ ,$WU#[]U[JYWXF_]DL?&C_Q7_IK_P!]UMSW[KW1@/?N
MO=>]^Z]U_]??X]^Z]T6GY4?'VI^2?7>(V%#NS&;7@QN^,!O&N@W%M*IWWM+=
M%-@J?*1Q;=W5M*EW;LF3,8Q,A7P9&G#5Z)!D\?2SM'*(O&WNO=4(?SK/C76_
M&3^0#\_MH93=FVM_YC)8#X_5>:[ H=B9;:^^M^9C&=Y]%87(;P[:W1N+L3LG
M</9&_,_441GGR5360)#&RT\%/%!$BCW7NKV_@G_V1#\-_P#Q57X\_P#OH]H>
M_=>Z-5[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[K7B_X53?\ ;CGY=_\ :_\ C=_\$WU#[]U[JYWXF_\ 9+'QH_\ %?\
MIK_WW6W/?NO=& ]^Z]U[W[KW7__0W^/?NO=>]^Z]U1-_PIB_[<>?/#_PVNF?
M_@D^FO?NO=67_!/_ +(A^&__ (JK\>?_ 'T>T/?NO=&J]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UKQ?\*IO^W'/R[_[
M7_QN_P#@F^H??NO=7._$W_LECXT?^*_]-?\ ONMN>_=>Z,![]U[KWOW7NO_1
MW^/?NO= ?WSU)E.Z-N;5VC3[TW+L[;M/O_;VX-_0[1W1N_8V>WALS$09-ZO9
M]'O38.=VUO+;/WF9FH:MIZ"NIWE6B^WD+032HWNO=:W7\]W:O;/4?\J?^9[U
MQVIW-G.ZL1N;JKXW;BZ5R^<HVIMR8#K[KWY(=([7SE#V9/#7P[>SG8V2W%NZ
M-GS&(Q>.BR]#2Q25L*5L;RU/NO=;!?P3_P"R(?AO_P"*J_'G_P!]'M#W[KW1
MJO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=:\7_"J;_MQS\N_^U_\;O\ X)OJ'W[KW5SOQ-_[)8^-'_BO_37_ +[K;GOW
M7NC >_=>Z][]U[K_TM_CW[KW1)?GWN7-[4Z+HLKB.RJ7K>B;LG8U!N<#LFJZ
M>W#OW;5?6U-/6==;*[/QN W)F=E;IW!6O3RI644$,_V=)41FKH8GEK(/=>ZU
MT?YG]:^<_D!?S!ZVH^16%^43[:V#\9MMOO[(;BJ=^=@[8WCD>^.ELSV7M8=@
M93;>W\ENOJ?+5D>(R.V<FIJ*;-PF:N@D^UDI8H?=>ZV7O@G_ -D0_#?_ ,55
M^//_ +Z/:'OW7NC5>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>ZUXO^%4W_;CGY=_]K_XW?_!-]0^_=>ZN=^)O_9+'QH_\
M5_Z:_P#?=;<]^Z]T8#W[KW7O?NO=?__3W^/?NO=%J^44F;Q^S=E[EVWTOAN\
M,WM;M79E?28'/]HXSJ3$[4ILY_$MD9OL"OW'E\?E:+)T.V]O;KJUJ<3]M439
M*EJ)8H8I92D;>Z]U09_/'VDV+_DB_P S'<]?T_L#J',U>V?C%UO_  SKCM^7
MM;;\FVNH.]NI-O;;PBP)LS9&.V5/L_\ B550G'0TKR:0&E<'3&GNO=7O?!/_
M +(A^&__ (JK\>?_ 'T>T/?NO=&J]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UKQ?\*IO^W'/R[_[7_QN_P#@F^H??NO=
M7._$W_LECXT?^*_]-?\ ONMN>_=>Z,![]U[KWOW7NO_4W^/?NO=$Q^=.'V_7
M=/8/.;JZ:WWWWMS9'9>TMUYCKC8\>R*N*IH$@S& GW-O7&;YR5!!D-C;$3/_
M ,;JSBXZ[.451CX*V@I9IJ4 >Z]UK=_S+]O[&I_Y"'\U'<O6?6>3ZDV(,MT5
MU)M_;D?8'7?8^T=X0]#=_P#3^P).Y<3N7KRKJH,MNSLHQK_>&NKS)7UM7CHW
MDFJ"#(?=>ZV:/@G_ -D0_#?_ ,55^//_ +Z/:'OW7NC5>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUXO^%4W_;CGY=_]
MK_XW?_!-]0^_=>ZN=^)O_9+'QH_\5_Z:_P#?=;<]^Z]T8#W[KW7O?NO=?__5
MW^/?NO=%&^:&Y]U;.ZKPVX=A]A-L7?M)OK%TFRL8-M;PWF.RMQ9G ;FP=-U^
MNU-A8_,[HS57+39*7,4BQ4-;2TU;AH:JMA:A@J2ONO=:S/\ ,EPV4VU_(/\
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M?%[#[@[AR':/<?Q]Z\Z8V/5_&*DZ^[+/=7\:W+O"3Y1=0U?;FPX.R.KZC8N
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M]U[W[KW5$W_"F+_MQY\\/_#:Z9_^"3Z:]^Z]U9?\$_\ LB'X;_\ BJOQY_\
M?1[0]^Z]T:KW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW6O%_PJF_[<<_+O_M?_&[_ .";ZA]^Z]U<[\3?^R6/C1_XK_TU
M_P"^ZVY[]U[HP'OW7NO>_=>Z_]/?X]^Z]U[W[KW5(7_"D';6?W7_ "2_GOB]
MMXFNS61I>ONO]RU%'CX6GGAP&S.[^L-X;KRTB+RM#@-KX*LKZE_I'34TCGA?
M?NO=&#_EN?,+XL=B? +X<;EVG\@^GZ_&1?&[IG;=>L_86UL=D,/N;:?7FW-N
M[IVUF\7D<I2Y#$9_;F=Q\])64E1%'-#-&05M8GW7NCK_ .S$_'[_ )_ITY_Z
M,[9/_P!>_?NO=>_V8GX_?\_TZ<_]&=LG_P"O?OW7NO?[,3\?O^?Z=.?^C.V3
M_P#7OW[KW7O]F)^/W_/].G/_ $9VR?\ Z]^_=>Z]_LQ/Q^_Y_ITY_P"C.V3_
M /7OW[KW7O\ 9B?C]_S_ $Z<_P#1G;)_^O?OW7NO?[,3\?O^?Z=.?^C.V3_]
M>_?NO=>_V8GX_?\ /].G/_1G;)_^O?OW7NO?[,3\?O\ G^G3G_HSMD__ %[]
M^Z]U[_9B?C]_S_3IS_T9VR?_ *]^_=>Z]_LQ/Q^_Y_ITY_Z,[9/_ ->_?NO=
M>_V8GX_?\_TZ<_\ 1G;)_P#KW[]U[KW^S$_'[_G^G3G_ *,[9/\ ]>_?NO=>
M_P!F)^/W_/\ 3IS_ -&=LG_Z]^_=>Z]_LQ/Q^_Y_ITY_Z,[9/_U[]^Z]U[_9
MB?C]_P _TZ<_]&=LG_Z]^_=>Z]_LQ/Q^_P"?Z=.?^C.V3_\ 7OW[KW7O]F)^
M/W_/].G/_1G;)_\ KW[]U[KW^S$_'[_G^G3G_HSMD_\ U[]^Z]U[_9B?C]_S
M_3IS_P!&=LG_ .O?OW7NO?[,3\?O^?Z=.?\ HSMD_P#U[]^Z]U[_ &8GX_?\
M_P!.G/\ T9VR?_KW[]U[KW^S$_'[_G^G3G_HSMD__7OW[KW7O]F)^/W_ #_3
MIS_T9VR?_KW[]U[KW^S$_'[_ )_ITY_Z,[9/_P!>_?NO=>_V8GX_?\_TZ<_]
M&=LG_P"O?OW7NO?[,3\?O^?Z=.?^C.V3_P#7OW[KW7O]F)^/W_/].G/_ $9V
MR?\ Z]^_=>Z]_LQ/Q^_Y_ITY_P"C.V3_ /7OW[KW7O\ 9B?C]_S_ $Z<_P#1
MG;)_^O?OW7NO?[,3\?O^?Z=.?^C.V3_]>_?NO=>_V8GX_?\ /].G/_1G;)_^
MO?OW7NO?[,3\?O\ G^G3G_HSMD__ %[]^Z]U[_9B?C]_S_3IS_T9VR?_ *]^
M_=>Z]_LQ/Q^_Y_ITY_Z,[9/_ ->_?NO=>_V8GX_?\_TZ<_\ 1G;)_P#KW[]U
M[KW^S$_'[_G^G3G_ *,[9/\ ]>_?NO=>_P!F)^/W_/\ 3IS_ -&=LG_Z]^_=
M>Z]_LQ/Q^_Y_ITY_Z,[9/_U[]^Z]U[_9B?C]_P _TZ<_]&=LG_Z]^_=>Z]_L
MQ/Q^_P"?Z=.?^C.V3_\ 7OW[KW7O]F)^/W_/].G/_1G;)_\ KW[]U[KW^S$_
M'[_G^G3G_HSMD_\ U[]^Z]U[_9B?C]_S_3IS_P!&=LG_ .O?OW7NO?[,3\?O
M^?Z=.?\ HSMD_P#U[]^Z]U[_ &8GX_?\_P!.G/\ T9VR?_KW[]U[KW^S$_'[
M_G^G3G_HSMD__7OW[KW7O]F)^/W_ #_3IS_T9VR?_KW[]U[KW^S$_'[_ )_I
MTY_Z,[9/_P!>_?NO=>_V8GX_?\_TZ<_]&=LG_P"O?OW7NO?[,3\?O^?Z=.?^
MC.V3_P#7OW[KW7O]F)^/W_/].G/_ $9VR?\ Z]^_=>Z]_LQ/Q^_Y_ITY_P"C
M.V3_ /7OW[KW7O\ 9B?C]_S_ $Z<_P#1G;)_^O?OW7NO?[,3\?O^?Z=.?^C.
MV3_]>_?NO=>_V8GX_?\ /].G/_1G;)_^O?OW7NO?[,3\?O\ G^G3G_HSMD__
M %[]^Z]U[_9B?C]_S_3IS_T9VR?_ *]^_=>Z]_LQ/Q^_Y_ITY_Z,[9/_ ->_
M?NO=>_V8GX_?\_TZ<_\ 1G;)_P#KW[]U[KW^S$_'[_G^G3G_ *,[9/\ ]>_?
MNO=>_P!F)^/W_/\ 3IS_ -&=LG_Z]^_=>Z]_LQ/Q^_Y_ITY_Z,[9/_U[]^Z]
MU[_9B?C]_P _TZ<_]&=LG_Z]^_=>Z]_LQ/Q^_P"?Z=.?^C.V3_\ 7OW[KW7O
M]F)^/W_/].G/_1G;)_\ KW[]U[KW^S$_'[_G^G3G_HSMD_\ U[]^Z]U[_9B?
MC]_S_3IS_P!&=LG_ .O?OW7NO?[,3\?O^?Z=.?\ HSMD_P#U[]^Z]U[_ &8G
MX_?\_P!.G/\ T9VR?_KW[]U[KW^S$_'[_G^G3G_HSMD__7OW[KW7O]F)^/W_
M #_3IS_T9VR?_KW[]U[KW^S$_'[_ )_ITY_Z,[9/_P!>_?NO=>_V8GX_?\_T
MZ<_]&=LG_P"O?OW7NO?[,3\?O^?Z=.?^C.V3_P#7OW[KW7O]F)^/W_/].G/_
M $9VR?\ Z]^_=>Z]_LQ/Q^_Y_ITY_P"C.V3_ /7OW[KW7O\ 9B?C]_S_ $Z<
M_P#1G;)_^O?OW7NO?[,3\?O^?Z=.?^C.V3_]>_?NO=>_V8GX_?\ /].G/_1G
M;)_^O?OW7NO?[,3\?O\ G^G3G_HSMD__ %[]^Z]U[_9B?C]_S_3IS_T9VR?_
M *]^_=>Z]_LQ/Q^_Y_ITY_Z,[9/_ ->_?NO=>_V8GX_?\_TZ<_\ 1G;)_P#K
MW[]U[KW^S$_'[_G^G3G_ *,[9/\ ]>_?NO=:ZO\ PJ;^2WQ^R7\GKNKJ?"=R
M=<;F[,[IW_T3M?J_8>U-X8'<^[-Y9G;G=O7^^<[#A\#@:[(9.HI\3MO;E3-4
M3^(012&&)G$M1 DGNO=;$OQOV_F=I_'?H7:VXJ"HQ6X-M=+]6[?SN+JD\=5C
M<SAMCX+'9.@J8S<I44=;3/&X_#*??NO=#1[]U[KWOW7NO__4W^/?NO=>]^Z]
MU"R>,QN:QN0P^8Q]#EL1EJ&KQF5Q63I(*_&Y/&U\$E+78_(4-5'+2UE#64LK
M1RQ2*T<D;%6!!(]^Z]U0'O?_ (2Z?R2]];MS^\*OXCU>W*O<61J,K6879'=/
M=NT-I4-75R--4I@-JX7?]-A-N8YY7)CHJ&&GH:9;1P0Q1JJ#W7NDM_T"D_R1
M/^\8MZ?^E%]__P#VQ??NO=>_Z!2?Y(G_ 'C%O3_THOO_ /\ MB^_=>Z]_P!
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M^Z]U[_H%)_DB?]XQ;T_]*+[_ /\ [8OOW7NO?] I/\D3_O&+>G_I1??_ /\
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MOW7NO?\ 0*3_ "1/^\8MZ?\ I1??_P#]L7W[KW7O^@4G^2)_WC%O3_THOO\
M_P#MB^_=>Z]_T"D_R1/^\8MZ?^E%]_\ _P!L7W[KW7O^@4G^2)_WC%O3_P!*
M+[__ /MB^_=>Z]_T"D_R1/\ O&+>G_I1??\ _P#;%]^Z]U[_ *!2?Y(G_>,6
M]/\ THOO_P#^V+[]U[KW_0*3_)$_[QBWI_Z47W__ /;%]^Z]U[_H%)_DB?\
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MD3_O&+>G_I1??_\ ]L7W[KW7O^@4G^2)_P!XQ;T_]*+[_P#_ +8OOW7NO?\
M0*3_ "1/^\8MZ?\ I1??_P#]L7W[KW7O^@4G^2)_WC%O3_THOO\ _P#MB^_=
M>Z]_T"D_R1/^\8MZ?^E%]_\ _P!L7W[KW7O^@4G^2)_WC%O3_P!*+[__ /MB
M^_=>Z]_T"D_R1/\ O&+>G_I1??\ _P#;%]^Z]U[_ *!2?Y(G_>,6]/\ THOO
M_P#^V+[]U[KW_0*3_)$_[QBWI_Z47W__ /;%]^Z]U[_H%)_DB?\ >,6]/_2B
M^_\ _P"V+[]U[KW_ $"D_P D3_O&+>G_ *47W_\ _;%]^Z]U[_H%)_DB?]XQ
M;T_]*+[_ /\ [8OOW7NO?] I/\D3_O&+>G_I1??_ /\ ;%]^Z]U[_H%)_DB?
M]XQ;T_\ 2B^__P#[8OOW7NO?] I/\D3_ +QBWI_Z47W_ /\ VQ??NO=>_P"@
M4G^2)_WC%O3_ -*+[_\ _MB^_=>Z]_T"D_R1/^\8MZ?^E%]__P#VQ??NO=>_
MZ!2?Y(G_ 'C%O3_THOO_ /\ MB^_=>Z]_P! I/\ )$_[QBWI_P"E%]__ /VQ
M??NO=>_Z!2?Y(G_>,6]/_2B^_P#_ .V+[]U[KW_0*3_)$_[QBWI_Z47W_P#_
M &Q??NO=>_Z!2?Y(G_>,6]/_ $HOO_\ ^V+[]U[KW_0*3_)$_P"\8MZ?^E%]
M_P#_ -L7W[KW7O\ H%)_DB?]XQ;T_P#2B^__ /[8OOW7NO?] I/\D3_O&+>G
M_I1??_\ ]L7W[KW7O^@4G^2)_P!XQ;T_]*+[_P#_ +8OOW7NO?\ 0*3_ "1/
M^\8MZ?\ I1??_P#]L7W[KW7O^@4G^2)_WC%O3_THOO\ _P#MB^_=>Z]_T"D_
MR1/^\8MZ?^E%]_\ _P!L7W[KW0^_&;_A.U_*(^)?;^U^]NI?BG1S=E[&K:?+
M[)S'8G8O9W:6,VGGZ.9:F@W-AMK;^W?GMK1[FQ55%'/0Y"6CEJL=4Q)/2O#,
MHD]^Z]U=K[]U[KWOW7NO>_=>Z__5W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7__6W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
)Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g785934g25o54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g785934g25o54.jpg
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M8R!T>7!E.B @(" @(" @("!"87(@0VAA<G0F(WA!.R8C>$$[(" @(" @(.*
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M  ,! 0            D$!08'" (#"@$+_\0 5A    8"  $'!0D,!P<# P4
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M\WH#N.'\,9>@PEAL&X)YO0'<</X8R]!A+#8-P3S>@.XX?PQEZ#"6&P;@GF]
M=QP_AC+T&$L-@W!/-Z [CA_#&7H,)8;!N">;T!W'#^&,O082PV#<$\WH#N.'
M\,9>@PEAL&X)YO0'<</X8R]!A+#8-P3S>@.XX?PQEZ#"6&P;@GF] =QP_AC+
MT&$L-@W!/-Z [CA_#&7H,)8;!N">;T!W'#^&,O082PV#<$\WH#N.'\,9>@PE
MAL&X)YO0'<</X8R]!A+#8-P3S>@.XX?PQEZ#"6&P;@GF] =QP_AC+T&$L-@W
M!/-Z [CA_#&7H,)8;!N">;T!W'#^&,O082PV#<$\WH#N.'\,9>@PEAL&X)YO
M0'<</X8R]!A+#8-P3S>@.XX?PQEZ#"6&P;@GF] =QP_AC+T&$L-@W!/-Z [C
MA_#&7H,)8;!N"Q2\0D*WJ\HLWB(M!4G4N8JBP:)*%YTBT*;FG(D4Q><4QBCR
M"'*41 ?>$0PEAL&X+*Z]]X(/YGC/W)#"E7C")A$PB81,(F$3")A$PB81,(F$
M7-?$]OU30E1J2\-"-K+?-G[%JNI]<P<@Z68Q"]MM[E1!H^GG;9-9TA!Q:**S
MMZ#1(SETJ#6/14:F>=<;;/R6Y/#E!65C9YW4N'X5AM7B^)3QL$DS:.C:'/CI
MV.(8ZHE<YK(],Z#!I2.#]#0?A\:Q7[%T\!CC$U56U<%!1Q.<6QFHJ"0UTK@"
MX1, +GZ(TG'18"W2TFY.]L=^URB:T;3M>N5];0%0L<[?+3'5J;J+BOOHA..=
M-5FS)]<KAUZ%=M#372(I\Z5:KLHYND,FI(',WM&4V'XDX4N%4F)-Q.HK*:GH
M*26I@K&U,<QD8]KWQT5'S<['\Q8FT+FOE<>:$8#O9TU51@SUT](ZCBIYI:J=
ML,E.Z)\88YI:UU14!T;F\Y<9O:YK "_2-L<D^+'2$)5[3;9JR245'4B1H\;;
MF;JKV0T[7U=E-8Y[0W+Z :QCB5%A9VLM'J1SYLU<-RJJKLG9VS^.DVK.YBY(
MX[/5TE'!31325\=?+1R,JJ84]0,,?+'B#8ZA\K81)2OAD$C'O:X@->P.CEB>
M_P 9,=PV*">HEF>QE,^F9.UT$QEB-8UCJ4NB:QS]&=LC"QS6D7):XM>Q[6TL
M=Q>:-DIV/KA9VQL99_M(-+"A,4*[PR4?LM=DK(Q=7EW<G -6L6_G&2)G$.5X
MLF#LG+R]$*:P)5R<CL>C@DJ33TTD,>$_9O2AQ"AF=)A;9!%+5PLBJ'OEC@>=
M&<L!T#MNV\,Q_#'RMA$LS9'5WV.M)2U,896%I>R"1SXFM8Z1HTHPXC2&P@@5
M5>XL=(V:T1]1C;#,I2DG?[1JIHYE*;;HB"4V53TCN)ND><4E"M83S@3;HN%6
M;4K\R<B"!DV2RZRK9)>BIY(X[2TLE9)3P.BBPZEQ=[8JVCFG&&5A#8*[P:*=
MT_@Y<YH>\Q@QZ5WAK0XMF+'<-FG93LFD#WU<]"TOIZB.(UE."9*;GGQMBYVP
M):W3^':S226AWB[XMM$,X.RV5:X+#!5:KR%W=R2$!/ND9.FQ%L<T67M%<(VC
ME5[#"QEK:*Q3MW%(N>0JC&32(K#RT3(OI9R0Q]\]+2BC:*BKJXZ!D3JBG:8J
MV:C;7PTM272!M-/+2/$K&2EN8DB<6S0S1QG8[AC8IYC4'FH('5+GB*4A]/'.
MZFDGA 83-&R=I8YT8.MCP#')&]_XUXM=&.V5H>!9Y!FI4;-0JA+1LQ6+'7Y?
MMS:#5B]U\@VC9Z,C7"K:U-'Z+N.D#E28D9D</7KAHR0.X _DACS)*5G@L;Q6
M4N(5D,L-535$/,84Y[,1<Z2"65H?2/C+98Q>0O+6,:][@U&X]ACFSNYY[?!Y
MJ6"1DD,T4G.UH:ZE#62L8XB9K@YC[!@:'.<YK6DBLM_%/I2B)(+6JSO8?E@8
M2U2;=W7+"B_KE7L5Q3U_$3]GBU8TDG!Q[BXJ$@5BO6B;QB[Z0[]HV;H.%TJ*
M/DGCE>7-I*5DW_$3TD3F5-,Z.IJJ:B.(34]+*V4Q3R-H@:AIC>62,MS;W.<T
M&JHQO#:4 SSNC^U1SO#H90^&&:H%+'+,PL#XFFH(B(<T.:Z^DUH!(U/M/C 8
M5MQQ.U>N-BUZ?X>:K0Y)[<[U5+K,4)&<O"<@^2),LZ:Q<3XPC2+)#*M';,Q7
MDPO(OE(]FM'0ZCUUE\)Y&R53>2U54O-13\HZNOB914%710X@8*$QQDP/K7MI
M^??+S[7L?\"%L<8D>V28,985N/LA.-0P@12X3!2O=454%1)2B6I#W 2-IVF7
MFVL$9#FV=(7N+ 6LTG;F6XC]3QE@;5&7M:!)Y-]K^!FG+6+EQ@(:T;/8KO:+
M!2DJ=J=M%/[4BU56BVCY<#MTW$6G*JLEIF(*_P (WDUB\M.ZLAI'>#F/$*B!
MKY8?")Z7"Y&QU\\40<'31TCGM;*^-MG%LIA#VP3F/(G%Z%DK8))QSH=2Q2.#
M'\U'/6L+Z:)[R"&/G:"YC7&[06<X6F2/3M,1Q8:1F[PWUXPL,SYR.=CVK410
M=4RWL88FQZ;&EEYNIGL;R$1@1DDXXPN6G12*J#TA0ZNL<5FW3^TW)''8*%V(
MR4T'@S,-I,8)96T4DQPVME,,%6*9D[JCFC(-!]X@YA/P@+.T:(\=PV6I%(V6
M3GG5D] -*GJ&Q^&4[.<E@YYT8BTPSX3;/(<-1-Q?.-X[%>:IU1>;W$0JUFL,
M#795W6*RV346<6&Q),7"T7&$;H'(Z6;F72ZU)BT$SAM$-9!Z0H@V-R6&!8:S
M%L6H*":=M+35%3"RJJGD-;34SI&MEE+G L:X-.C%I_!=,Z-A^Z"N<3K'4-#4
MU4<9FEBAD=! T$F:8,<6, !#B"1I/T<Q&U[@/@K':EQ%:ZLVEM=;M5DRLJ]L
MAO4FD&Q1(M(R;FWVY\W@V5)8M&:2B[^?2LZRT JB@GT2+EF[=.56[!JY=(W5
M9R;Q*EQO$L#$7.5.&.K'SR$MCB;1T<;JB2ND>\AL=.:5HJ 7'2+7L8UKI'M8
M[Q@Q>DFPZDQ(OT8:P4[8F %\AJ*AXB;3-:T$OE$Q,1 %@6N<2&M<1A#/B^UQ
M/WO35*I["TV0-P,+S*LY=O69ULWA&M"D75<FV<BS<QZ;Y*596QN>+DTED$6<
M.T:NI.1>HM58TSZ]?R.Q*GP_&JZLDI*;[#24$3X755.]T[\0C;4P/C>R1T9A
M?1N$T3@XOF>]D44;GB41VS<?HY:G#J:G9/-]D&U,C9&P2@1-I7F&5KVN8'A[
M:@<V\%NC&UKGO<&EA=D-3XL]$74]/+ W!P=.]UZ_6FMN9"N66):.H35\J^AK
MT[=.9.):HQ8P#^/<D71DSM%G"()N61'+=4B@V]9R0Q^A\-\(HV@T%3A])5-C
MJ::9[)\5ACGH&,;%,]TOA$<C"UT0>UKB6O+7 @>T&.X94FGYJ=UJF&KGA<^&
M:-KHJ&1T54YQ>QHCYI[7 B31)'PFAP(*UAM+C+J+32NX[[IF4B[#<-8Z]JFR
MF<5:X"PH1$O5;KT3NK3J29', Y?1$]'%>"@HSDDGL8Z2*G+,FRW-:K97"N15
M8_',%P_&HI:>CQ3$:O#'S4E13.FAJZ&[*NG)+:AD<U/(6:0?$Z.5A)A>YOPQ
M95W*&!N&XA58>]DM114D%8V.>*41R05-G02@:43G1RLTK%KPYCA9[0?@FTQ'
M&4A6[IQ#H[C[(@-;Z:@N':59V*M5BUR4B@KNJKOY1[YS),GEA$8YE-(L8Z/D
M6L;&MFJ;L@2:BAE"KD]9N1;JJAY-G!>>J,3QN?E)$^FJJJDCB<,#JF11^"E\
M=/:1\!DDDC?+*YY83$&@%I\X^4(AJ,6&(<W%1X?%A#VRPPSO>#B,#GNYX-=+
M\!LNBQCVL8&APTR205VI%6)C/+S[.+%R5S7GR$4^5=Q[I)H5^[A8R>;]554Z
M!&5;!'3,:NJO'N5&Y5%CLC.4WC=RDAI$U-)3MIWRZ!;4QNEC#)&%_-LGEIW:
M;1I.A?SL$K0V1H=8!^B6.:7;&R5LIE:S2#HG!CBYI#=-T;)1HDV#QH2,)+21
M<EMPX. C2U;QO;7MMOH\!(0&N[2M9>([8NDIVITB)L4?;ZS4J<=!-';+P[RX
M6=%. 9&4.I/H/8ADV%/F$82P+ 8F=/Q;D+A-'1U]1'48C2-I>36&XY!65TU-
M)1U596AQ=A# RCI2:B0 "G<R9[KW,D.CFM-H>4M=43TL3XJ2<SXO5X;+3TS)
MF5$$%.0!7NTJB8")M[RAT;1F-&2^2ZAD.+75,W5]@N=?7*-=3U;TU:]QP+^9
MK]I=U>0J, [FJZI<BA$,@DYRKPULAG$?8&D(/G!T#=06#-3K3%=;58^2&+05
M>',Q&BE93U6-TF"U$<-12,JHZRH9!4BB///YJGJYJ.=LE.^?_A])PYQXT)&M
MS3\>H9(*MU)4,,L.'3XC$^2*=T#Z>)TD1J1H-TY8(YXRV5L9YT@'0;\)KCJ;
M<'&FA0>'MQ<JG(5FX[@C=):ZW!(L(^G7V0U^E&W@\2@R?R(E7AY>KQ5D6<R2
MU896&5:SK=HV25EV92@8ZF7P;D0[$.4;:*LCJJ+!I<<Q+!HY)*W#X\1,M )G
M21Q?!FAJIJ5K8FU4E-"^G<]Q;"\FP%CB'*-M+A)J8'PU->S#:3$'L93U3Z4,
MJ>;#'OSCD@CF)>86RO;*UH!D:!F>PK%LNKT>I0%JNLFA$-Y][58%@0B2ZQY&
MT7!RSCH.#CFZ8+*J.9*4>)-F_2F*@W3$[E\Y;LT'#I+3*?#*JNK*BDH8G3.I
MV5=1(2YK1'2T;7R3SR..BT-BB87NL-)QLR-CGN:P[!-604T$4U2\1B5\$3,B
M=.>H<UD4; +F[WN %\FB[GN#07#6(<6.DCP-#L*$_-O&6R;58*+4VL=2[?*S
M#RZ595\A.5=S#1D*[DV$LS7C7Z)4W;9)N[%L95FX<('164RO\T<<%1B%,ZG@
M9)AE)3U]6Z6NHXH64-6(W0539Y9V120O;+&XECRYFF ]K7!S19?9W#3%2RB6
M5S:R>:F@:RFJ'R.J8"\2P&-D;GMD:8WBS@ [1NTEI!-HE^+;5+W7-7N-%L:L
M](;+J5ZLFM(]"I6F9=R*-!9/5+)(3-?CF[.7CXFNR#3L^:.[6C3F=F*R8++N
ME4BF]8>2&+,Q*JHJ^F%/'A=904V*2.K*2!D1Q"1@IHX:B1SX9)JF-_.0AC9
M&?#D:UH*HDQZA=1P5%+*975L%3-1L$$\CGBE:XS/DB8&O9'"YNA(7%GPO@L)
M)%_?K#<=UV-PE0&\.K5:*O<[JI]>"L^S99W4F\RUCGKY-L:-[>0F%(Q0[0J1
MTPGRNBE4$Y7)A*!#1BN#4.&<KZC M*KFP^GQ:.A+^=A96.@=(R,N$O@[H1*
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MMF)XI3OAC$$YHQ&*6C+KNAF@F%;&7PS:#'Y6D7)IH8]L\T-03AE!A#6R4SC
M:2BE$CS+'S^D9IP+"2.2,T[PV2/2<,Z:.X%$&4?H1FIL-1>2T))PKZK78L-*
MI; CXQC>YZURU-CK.6UB=U29:MRD?KQ"OV=I84(F&BBR30QG#QZQ<52\O722
M<H'C#@V+E!%/'54)GB.'/EDP^GI(:V2E\# ;70U,,F(NJ*5],Z:>4Q/^"QCV
MPSDP&LPMIJRZ3"WQN@J>;>*IC&U4L\E.R?GR33/A>RD;%,V4,CCTVG2>YID$
MSGBVM,(F$3")A$PB81,(F$3"+#[]\$Y;] ^TF>$5XKWW@@_F>,_<D,(KQA$P
MBBCD^'SB>C5+RRH8=%65KZG=J\6TO*0\O,Y)EU'L<L! 7A\LXDJK?M>4;<3_
M %\_CW,ZU8V^4A^U74J20FZY&O7U=QE?7:W2!KZ+"X)&L^BW0O/1.=@;7Z;7
M.73G8@'??J6[[)JO>-UX@==;+<,DJU!5M]1V3U-.>C'*48RH$OO=O;I*/:-7
MBKDC#<$%<Z(1FP137D&K)J+&UE8K0K<%(N+6W]=P+;C^[6558DWV:M^9UG6/
MWZ@5W;E*J5O=I2AU"BQ?,6R0$ #)N8U=XH*G.,(G!5.39%*02B0H)BD80,4Q
MND$# 4A0;]%O2+_6%2]7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[
M#WM$^!.O;^$SVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[#
MWM$^!.O;^$SVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[#W
MM$^!.O;^$SVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[#WM
M$^!.O;^$SVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[#WM$
M^!.O;^$SVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[#WM$^
M!.O;^$SVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[#WM$^!
M.O;^$SVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[#WM$^!.
MO;^$SVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[#WM$^!.O
M;^$SVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[#WM$^!.O;
M^$SVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[#WM$^!.O;^
M$SVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[#WM$^!.O;^$
MSVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BG5[#WM$^!.O;^$S
MVC<>*=7L/>T3X$Z]OX3/:-QXIU>P][1/@3KV_A,]HW'BO<@A,E6(9S(QRR "
M/2)(Q#ANJ<.0>0"+'F')4Q W((B*"G* "4  1 P$SVC<>*]5A3L*L,^3JCN%
M8V$R9 C'5ACWTK#(J@LF*AGT?&R<.^<IF;@L0A6\DT,58R:ACG(0R1RE5S K
MXK%D645:+216C<LBLP06;,57P(D!VJR;.'#MPW:*. 4.W07=.5DD1(FJX6.4
MRAB*KPB81,(L/OWP3EOT#[29X17BO?>"#^9XS]R0PBO&$3")A$PB81,(F$3"
M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,
M(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB818??O@G+?H'VDSPBO%>^\$'
M\SQG[DAA%>,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(HX]U;0VK&;<O4%7]CS]<A(1S7FL=%1
M<93EFZ)7=/KTNZ4,M,U>6?JJK/I)TH85'AB%*8B:9"$( 9U# ,'P>?!</J*G
M#*>IJ)VU+I9I9JYKG:%;4PL&C!5PQ@-CB:!9@)-R225J.)5]=%7U,4-4^**/
MF0QC8Z=P&E!&]QO)"]Q)<XG-UAJ "UE[K6[?]\EQ\(US_P""9EOL'@']R4?Y
M_$__ +!67V3Q+^W2_FJ3_;)[K6[?]\EQ\(US_P""8^P> ?W)1_G\3_\ L$^R
M>)?VZ7\U2?[99YJ7:NVGVW]8P<WLRPV"#L$].1TO$2<72DFKMLWH%RFFX"M$
MU2,D$5$)*)8.2';O4N=T(I*@HBHHF;'8U@V"Q8+BM13X73TU134]/+#-%-7N
M>QSL1HH'?!FK)8G!T4TC"'1NMI7%G $7>'XA7RU])%+5R21222->QT=. X"G
MG>,V0,>+/8UWP7#58W!(,EN<J6X)A$PB81,(F$3")A$PB81,(F$6'W[X)RWZ
M!]I,\(KQ7OO!!_,\9^Y(817C")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"**[>?QX;0^<ZM_+RG
MYV#D[Y/X5YNL^DJQ:-BOC.L[8/9H5K#,PK!,(L[T_P#'EIC\K;%_*S8F8W'/
M)_'/D=-]+8:KW#/&5#YV7V2I4LN<96]IA$PB81,(F$3")A$PB81,(F$6'W[X
M)RWZ!]I,\(KQ7OO!!_,\9^Y(817C")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"**[>?QX;0^<ZM
M_+RGYV#D[Y/X5YNL^DJQ:-BOC.L[8/9H5K#,PK!,(L[T_P#'EIC\K;%_*S8F
M8W'/)_'/D=-]+8:KW#/&5#YV7V2I4LN<96]IA$PB81,(F$3")A$PB81,(F$6
M'W[X)RWZ!]I,\(KQ7OO!!_,\9^Y(817C")A%'I.<8FP&D!LY9AK$Z-MU==8.
M)NU7<0UGG)#7=)E86>FC;!LS&N Z<6:EO6L*1S6K315)0)IFX?K*U^/4@GB*
MU1:,L]?3;IV:_7T]U&D<\@"#T] VG;Z/X[;NO$J>J;OH^J6M?2EHNQI:N%_/
MHJ+E5,;;3G;T="N(I$.5(&\(]U0=>7*X%<R[">*9)5HM%G*_@#+?W6/JOZ5)
M.=NR^OI-LLNSU+K#(52H'<FT9*%2<"X YB H'0LGKDO-$QBARG;-UB%-RE'[
M@3 < Y!$O(8HC-K[/20/6HO;;N)]05+V_&_*>^$RWJ6+'JWCBEQU[CP3M^-^
M4]\)EO4L6/5O'%+CKW'@G;\;\I[X3+>I8L>K>.*7'7N/!.WXWY3WPF6]2Q8]
M6\<4N.O<>"=OQORGOA,MZEBQZMXXI<=>X\$[?C?E/?"9;U+%CU;QQ2XZ]QX)
MV_&_*>^$RWJ6+'JWCBEQU[CP3M^-^4]\)EO4L6/5O'%+CKW'@G;\;\I[X3+>
MI8L>K>.*7'7N/!.WXWY3WPF6]2Q8]6\<4N.O<>"=OQORGOA,MZEBQZMXXI<=
M>X\$[?C?E/?"9;U+%CU;QQ2XZ]QX)V_&_*>^$RWJ6+'JWCBEQU[CP3M^-^4]
M\)EO4L6/5O'%+CKW'@G;\;\I[X3+>I8L>K>.*7'7N/!.WXWY3WPF6]2Q8]6\
M<4N.O<>"=OQORGOA,MZEBQZMXXI<=>X\$[?C?E/?"9;U+%CU;QQ2XZ]QX)V_
M&_*>^$RWJ6+'JWCBEQU[CP3M^-^4]\)EO4L6/5O'%+CKW'@G;\;\I[X3+>I8
ML>K>.*7'7N/!.WXWY3WPF6]2Q8]6\<4N.O<>"=OQORGOA,MZEBQZMXXI<=>X
M\$[?C?E/?"9;U+%CU;QQ2XZ]QX)V_&_*>^$RWJ6+'JWCBEQU[CP3M^-^4]\)
MEO4L6/5O'%+CKW'@G;\;\I[X3+>I8L>K>.*7'7N/!.WXWY3WPF6]2Q8]6\<4
MN.O<>"=OQORGOA,MZEBQZMXXI<=>X\$[?C?E/?"9;U+%CU;QQ2XZ]QX)V_&_
M*>^$RWJ6+'JWCBEQU[CP48&ZW*3O=>SED14%,TI6 #I45FY^4NO:> \J3A-)
M4 Y0]X1( "'O@(A[^=?Y.^3^%>;K/I&L6CXKXSK.V#V:):WS,*P3"+-=3N$F
MN[--KK"<$T[;8.<*:2JY_NM7;"('-20(HJ?[HP<O,(;D#E,/(4!$,;CGD_CG
MR.F^EL-5[AGC*A\[+[)4J5+M^-^4]\)EO4LXU8]6\<5O5QU[CP3M^-^4]\)E
MO4L6/5O'%+CKW'@G;\;\I[X3+>I8L>K>.*7'7N/!.WXWY3WPF6]2Q8]6\<4N
M.O<>"=OQORGOA,MZEBQZMXXI<=>X\$[?C?E/?"9;U+%CU;QQ2XZ]QX+VH3#%
MRJ1!(SKI%!$"])'2*).4 $WW2JS5-(GO /()SE 1Y #WQ !6[-XXI?MW'@L4
MVG?V>KM?6F^OF2LDE78X'"$:BJ#<\E(NG*$=$1W6127*T(_E7C-HJ],@L1FD
ML=T=%4J0IF 7(&U"; G8N=[IQ+V*HVS8%,/5XAP^JUUX>Z)#2J;J069O7FZ#
MNQD9N68]&W58M(-%FXZC%H/W!WK@&R"TND+P3-IT<@=H<=WK4%QN1U@#IU[=
M7OO6>\/N_6V\8=N\/!*UZ2<ZVT_M(K 5S.DTJ[N*KNYJ';J+G10$7\9+0=FB
M'',3%%VTCXZ83%#M4T>Q@BW3?,C=[A2#?<#Z#[V[UT5D*4PBP^_?!.6_0/M)
MGA%>*]]X(/YGC/W)#"*\81,(M9)Z8U4DZ4?%H==%ZH\:/3.SL2JN ,PBG<$Q
M9D64,=1.'9PTA(QC:!3,2$092,B@G'E3?NP6FYVE18;![^^[+4KBQU=KB+E6
MDY'4>KL9AA*3DXTDFD,Q0=H3-D?S,G.2Q5DT2F&1DI"QV)VN],)G +3\V9-0
MG:S\'$7.WW]P-R6&Q9YA2F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3"**[>?QX;0^<ZM_+RGYV#D[Y/X5YNL^
MDJQ:-BOC.L[8/9H5K#,PK!,(L[T_\>6F/RML7\K-B9C<<\G\<^1TWTMAJO<,
M\94/G9?9*E2RYQE;VF$3")A$PB81,(K!:JQ"72N3=3LC(LC!6&-=14HS,HJB
M95H[2,F<47"!TW#5RD(@LT>-E4G3-RFDZ;*I+I)J%*" <BK$XUC1'QYQQ*5J
M*E9"T>;A[/*/F38TA8'=0.FM6)&26;I-R&D(!RD1W".6R38T,Z %8H&0E(!5
MSM]SK2PSRUZ_?U;.A5M:HM9J3Z:D8*,08NIU.#:.A01001;1%9C"Q%<@(ULV
M10;Q\%!L^L!&QK=(B#=9](.  RSU<YUTL![[/4LOPI3"+#[]\$Y;] ^TF>$5
MXKWW@@_F>,_<D,(KQA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%%=O/X\-H?.=6_EY3\[!R=\G
M\*\W6?258M&Q7QG6=L'LT*UAF85@F$6=Z?\ CRTQ^5MB_E9L3,;CGD_CGR.F
M^EL-5[AGC*A\[+[)4J67.,K>TPB81,(F$3")A$PB81,(F$3"+#[]\$Y;] ^T
MF>$5XKWW@@_F>,_<D,(KQA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%%=O/X\-H?.=6_EY3\[!
MR=\G\*\W6?258M&Q7QG6=L'LT*UAF85@F$6=Z?\ CRTQ^5MB_E9L3,;CGD_C
MGR.F^EL-5[AGC*A\[+[)4J67.,K>TPB81,(F$3")A$PB81,(F$3"+#[]\$Y;
M] ^TF>$5XKWW@@_F>,_<D,(KQA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%%=O/X\-H?.=6_EY
M3\[!R=\G\*\W6?258M&Q7QG6=L'LT*UAF85@F$6=Z?\ CRTQ^5MB_E9L3,;C
MGD_CGR.F^EL-5[AGC*A\[+[)4J67.,K>TPB81,(F$3")A$PB81,(F$3"+#[]
M\$Y;] ^TF>$5XKWW@@_F>,_<D,(KQA$PBPXNPZ"=I8WY+M4SL:>4I[6[)88D
M[:MD,FHJ0\XN5V*<64Y$5A(9Z9$#BBL4HB9%0"K'9KU=:BXSS&6M71Y:*U'S
M<96W\_#,K#-%4/$0;J29H2TF5)%VY.+"/56*Z=\C>/D'  @D<3(1[]4H"FR<
MF2*5?<(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3"**[>?QX;0^<ZM_+RGYV#D[Y/X5YNL^DJQ:-BOC.L[8/9
MH5K#,PK!,(L[T_\ 'EIC\K;%_*S8F8W'/)_'/D=-]+8:KW#/&5#YV7V2I4LN
M<96]IA$PB81,(F$3"+UJJI-TE5UU4T4$4SJK+*G*FDDDF43J*JJ'$I$TTR%$
MYSG$"E* F,(  CA%@J>UM7K+V%JCL>AJNJB,,6U-D[= *.*T:QG33KQ9]$D@
M*L0:>4613ABR!6YI115--B"YSE 9L=ASU=:BXVC?MU++XZ6BYA 743),)1L4
MR93.(YXW>H 95L@\2**K915,#*LW35VF FY3MG+=<O*DLF<T*;@ZC=5^$3"+
M#[]\$Y;] ^TF>$5XKWW@@_F>,_<D,(KQA$PBC=L/!;L.9I^Z:3 [&C*/4+],
M5Z>JE#136N%9@IIJQ7"SN$Y.=B&]ABJW*RRS66KU+26EHVER$:9>$=%2<LT8
MNL.S!.9 M?IU^GHOLO?TJC1-B!87MET9=>OT9V]*VQ8>'*[W/=]4VY8[1 M$
MX*6I)W<="]J]*K#ZHL.[)*F"V*Z0*CVE:8_:S!&ZI=(V8Q[F$>$B0DVS]'JE
M-\K=NOK ONM<>A2020??(DCT]!].W+LK(52M[MBLY4*HG*2#(H$ @I-.H=&8
M0,8W2&ZTQ=*<\0,!1Y% )S2%Y" ;G&,4'M(W?6"J7LEU^,$U]$/[(PECM/=P
M3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P
M3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P
M3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P
M3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P
M3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P
M3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P
M3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P
M3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P
M3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P
M3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P3LEU^,$U]$/[(PECM/=P
M48.ZD3M]U[.2.Y<.S!*5@17<]!TQN77M/$ -U=!NER%Y>0O(D \@!SA,/OYV
M#D[Y/X5YNL^DJQ:/BOC.L[8/9HEK?,PK!,(LUU.D9?=FFTB.%FICVVP<B[?H
M>F3Y-7;",/,ZPBNE]T "0W/2/]R8W-YIN:8,;CGD_CGR.F^EL-5[AGC*A\[+
M[)4J5'LEU^,$U]$/[(SC*WJQVGNX)V2Z_&":^B']D82QVGNX)V2Z_&":^B']
MD82QVGNX)V2Z_&":^B']D82QVGNX)V2Z_&":^B']D82QVGNX)V2Z_&":^B']
MD82QVGNX+W(1SA%8BIYF4<E((B*"_9G0J<H"'(?H(U%7D 1YP<Q4@\H!RB(<
MH"2W6>[@M<;XI\_?M/[ I]76*E.SD NU8(G7(U2DQ360=.(%=RH8J3=M8VB#
MB!<KKB""+>2547Y4BG 9!L03T(X$@@=*YYOW#]L39=ZGKPY;Z[@RHSVHY2CK
M(25E"?>US6UU6N8UFY-S5INQAE)9_/6N9>NHX+ N$VX@&JW2-H$SM](( M<]
M-]F8UC/U]RI().H9$6UY@=!RZ;_Q6<<-6EK)IL)&%DI=63@8;6&A]8Q"RO*D
M,[+ZIILC"66[D9=*L=DC/C)1$&V2=F!\+:H(B/2QP1CIS!-^VY._H]9]*J M
M?9D,^K*_J[;=BZIR%*818??O@G+?H'VDSPBO%>^\$'\SQG[DAA%>,(F$3")A
M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(HKMY_'AM#YSJW\O*?G8.3OD_A7FZSZ2K%HV*^,ZSM@]FA6L,
MS"L$PBSO3_QY:8_*VQ?RLV)F-QSR?QSY'3?2V&J]PSQE0^=E]DJ5++G&5O:8
M1,(F$3")A$PB81,(F$3")A%A]^^"<M^@?:3/"*\5[[P0?S/&?N2&$5XPB81,
M(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$3")A$PBBNWG\>&T/G.K?R\I^=@Y.^3^%>;K/I*L6C8KXSK.V#V:%
M:PS,*P3"+.]/_'EIC\K;%_*S8F8W'/)_'/D=-]+8:KW#/&5#YV7V2I4LN<96
M]IA$PB81,(F$3")A$PB81,(F$6'W[X)RWZ!]I,\(L(OS)L[U,DL[<6ADC%5L
MTT,C5KBYI#B//%U21=)N9.6;7G78+1!SD*T69.K3',!>N6+Q\\B6S)2>B9'O
ME?ZBH.KIWVMVYC+:J+AWD#2NN22 SBE@*ZGYXY'QK"E:$"%*[Z+JC.9)LS;Z
MKENV.0Q#=9O\PJ5T+GHF\,T%K"QXZ_?@.X#?=0V]L_?LUW'7<_4-Z9"J3")A
M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(HKMY_'AM#YSJW\O*?G8.3OD_A7FZSZ2K%HV*^,ZSM@]FA6L,
MS"L$PBSO3_QY:8_*VQ?RLV)F-QSR?QSY'3?2V&J]PSQE0^=E]DJ5++G&5O:8
M1,(F$3")A$PB81,(F$3")A%A]^^"<M^@?:3/"+7>R8F_SVJX>%UV<$I:3:Q3
M:17!]#QJR,/V$Z5.*#R<@[$T1Z>42BFCLZ$4>4+&N'IX=]#RA6DRPD6Z?1TY
M]WKX*EUR,O3V6*SG7<:[BX!1N^JK:GNE91^[5B6EC7M*!C.3D4ZTE*.46ZQ4
M# /5FD:""3>)9-FT:P22CVK5(D'WRLI&K5;JO>RSO"E,(F$3")A$PB81,(F$
M3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PBB
MNWG\>&T/G.K?R\I^=@Y.^3^%>;K/I*L6C8KXSK.V#V:%:PS,*P3"+.]/_'EI
MC\K;%_*S8F8W'/)_'/D=-]+8:KW#/&5#YV7V2I4LN<96]IA$PB81,(F$3")A
M$PB81:LV7?9JCH,W4;#UEZV64;).'-GM,Y7DU'#U\WC&,?#-:S0]@RLK*.I%
MVPCT&:L;'%>2,M#1D4O)R4AU-"1;I]]Y"@W'1Z_J!6Q(IVL_CF3UPW2;+.6Z
M:JB*#M-^V Q@Y>>T?)$3*\9JAR+,W)D6RJ[8Z2BS1HL91LE"E8]?O@G+?H'V
MDSPBP#8LW)0^J8YO%1[9^ZL,8RKO*Z;S+U-BF_KKQ4T@6/AM>[./(J-A:E K
M&1JCF'7Z0>T5@1+U=S(%S_#ZR/6H=J[<NG8=@-U[M()2?FR=R]D)Q9'G%8%C
MIR2L<RX1D&CJ0<R$N21M]+H,Z@282D6#<L"A5XBKP:$0W1J[!NR75%4=?O\
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MVE&ZY+LKBY) #CI+D:@>4.VCPWVZ%T;Y3JAL=33TFZ"'HW%92T7+[AQVLHF
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MPB\$$$6R*+9LBDW;MTDT&[=!,B2*"*1 321123 J:221"E(FF0I2$(4"E
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M1 ,UGEI-">2/*8"6,DX'B8 $C22322V  -R3T!97 XY!C6%$L> ,1HR3HNR
MGC))RU 9E?;_ -8;_AT?UI/]6?#2^@$ZPW_#H_K2?ZL(G6&_X=']:3_5A$ZP
MW_#H_K2?ZL(G6&_X=']:3_5A$ZPW_#H_K2?ZL(G6&_X=']:3_5A%#]9BF&[;
M&$"F$#;/V88H@ \ABGO=@,4P#R<@E,40,40]X2B @(@(9VVB<W['X9\)OBK"
M^D=&'TX/3T'+M7/JD'PJKR/QRKZ#_:95:.8?Y)O^$?\ MESIL_";^4.*\;'8
M=Q3F'^2;_A'_ +8TV?A-_*'%+'8=Q4<?E&&3QU4=;%;-'+@Q;%-B8$$%51*
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M6:_RMFBPCW3ER8L4\BH1@W+( X8,0;2 JQBYUVS<SULF0Z7,?+&,<"03>W4
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MS<;I6I"MR+1I)=,X6ZGT:?4Y!/G=&_:JG^[5:D('(0AC?=&#EY.0.41 !('
&FP/<5__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g785934g41g41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g785934g41g41.jpg
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M4R=UPM+Y:=L0897R,8"YS6,=9K7'8TVA2X=*Y@>\<90_'2*S<Z5RGPORQRG
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M9)0024U'3P2R&:9D3>?E.V6=PTII-6P/E+G = ('0H:H/!EHJ?2BYRYX.E8
MB!Y:KE#KX,(([([EX;L+%M1K99;CP#017K;:7'UL,NM>K_P&DNG_ (3N>UB&
M/4M7R5P+ (XJAM1A%37U$D[Q'S,W=TKI2Q@$A>WFKAH<YIYS6;1[%Y]+ADT&
M-XEBCI(G15\--$V-I?SD?<T;6!SB6AKM.Q) (T-EW;59\GT6CK?R%P[R=;Q:
M$'R3Q3:FK ?RS3T2D3<[_"@Q$M&@TJQ@^KFAM@EZ.C43<T=,SBWQHDYF(@X5
MBR$"QGUQ<JHZ/#L9PNC=7OPW%J1U-'A%:8IJ+#YY)HI7UU-)SA?SC-"4P01P
M0!KYF.FGG=3-=+T/P5T]7A]94-IFUE#.)75U/IQU%7&V.1C::9F@&Z)THQ)(
MZ24N;&\1QQ-F<UD$QG0!N$(S*W>O7*GUGGF(Z2-RYXXZY  !E#@&(*_NQK5E
MXMN@BQ8\V8KI$>(4ULD<C3CCI;J1AHQDJ22?[\OX0:*=T-#44594X!-R:HL
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MT^"JR9@EG0S\JY$ ,BD22Q4ND)#T<0ATE :7WTB(=2,E]Y+6G%0FY)S7("P
MR4F9%51;)]'9_P"Q97[B_E;M&\=JCMAW'L2M_1V ^Q8K[BQAVT[SVHW8-P[%
M6LBJCOEF*E9SCFVP\'8+'5)>2BE!1]EJ<8J:GH(E]]EMN5$AVUMD2K(6]^?D
M8X%UJ1-C$&#1KK9[@RTT;?3Z^O3J4.P[?%M6 W'L#SLL[@>^6R&MFI+CJK2R
M;;QCH3E8B(G(M4[?DO7FJV<FZ1T4JYR@ U:D(OB/DV EUPT2=%0$*Y&O#(,
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M3+2RB-CA#!1HP0(Q<"2XDG:5D/A1,(F$6EK7XQLWZ;WW]]9_-[L[Q2> 8?\
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M;=ILL+7UR6A1(]LK8")8T11FAEF"((V/ISS*RATN>3M]K2A!N=72>U0$ "Y
MU#;N5\Q,M%ST8!-0DB#+P\J(P?&2D84P='R 13:71BPS!EN,$C/M*2XT\RXM
MMQ"M*2K>MY%R50PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A%J?^5(^4#L/10JE%X'Z-U>:Y5Z?'2HD':)T8^)1$#G
MKC"R]N"2O,-X&>5H6-H-!:T1).$S"AXR6D0'6C'F*U#7&9@"Y-;<DG4T:R=G
MB'6>@*1?DT?D_:]T".%9**FK"[RETDN9)QSDWI3<]2ZR#K'RORO,K)/DW=RL
M@G4HJI5TN2D0:H 3YE2D$R=A-$9G;'-+>(YVD=E@-0&06QO"XIA$PB81:6M?
MC&S?IO??WUG\WNSO%)X!A_V&G6N'=\G\)JOM$JY<JB819$]$_P#*[/\ ZN"?
MWGALQ;EG\34GTG_I95[. ?#IO!#YYBV+YK!9>F$3")A$PB81,(H[Y.XY&Y0K
M;59,M-OJ8K<Q%S*SZ6?&1TH0_#$:- &?(E8>:9V$U(MB2*FFQFG5%@";V_YE
M+K+M!MT [U"+ZKGQ*)B.B-Q 18R[:X+/;L3LW&V>.EERC1!4%9@;1Q_=2IZ+
M64"1YV0G;7QC4)J>U,ZEA#R BQ]"L RLD(3=([.JV\:[<+^FZFB.O;?QZO'K
MMFIPH5(KO&E)JG'U1#5'UBEU^*K,"&MYPAUF+APV01-$$N[VZ42MIE+A13VU
M/$D+=?=5MQQ6]\=JY#4 ,E=N$5%LGT=G_L65^XOY6[1O':H[8=Q[%"7*S\H%
MQ+$G1A*AGVHVO,B.A!$*G!Y G4>V@F*E&N3>*V07E ^G@H%>M 6Y<HT6,9U)
MNDHK\S?SCO/W]1[/2./YK3D!V9W%O&=:OWAQYHGBR@DL;\MDFL19#;FWEDJ>
M2^.EWTA9;EHN[AKI&U[?=.7<;2LUQQ92I^6V]LYZ':=_KT#L&Y<AL''CXSX]
M:DK(JF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PBPUZ>/3=XEZ '1UM?/_ "LZ](J"6S7N.^/HIU.K7ROR9,M/IJG'E3&T
MV0\](S)3*WCS&A"T0<$)*SQ0[HL:ZTLN36EQ ''H Z2L&ODM^A%RU$6N]?*.
M]/!IB;Z>O2=CVEIKI#2E0_17X5(\V15>"** 2X1N$D1XW06[L0AQ9J"FD01!
M1LFW;+#;RKG#4UOO1_\ Z/2X_=D,MBW7X7!,(F$3")A%I:U^,;-^F]]_?6?S
M>[.\4G@&'_8:=:X=WR?PFJ^T2KERJ)A%D3T3_P KL_\ JX)_>>&S%N6?Q-2?
M2?\ I95[. ?#IO!#YYBV+YK!9>F$3")A$PB81,(HUY;Y+ XBHQUZE(B4FP09
M6KQ#H40L!!27;7:(>J!%.*D"Q&M!BGS0KQRF5$%I%2ZL80EQ.FMAK\OD%U";
M"Z@67Z95)BN2[1Q4JN3JK77;A5J-H4A306U3=UMG'%0J1DJV\UMV-K=H)Y%]
M<UR<#1-)E*_3;H3H1B3C08B3Y:.PWU6OVGB .*FEKM;IMV;<@;ZCY%D/Q9R)
M!\M\;T?DZM-F,P5\K$/:(P:0;;:D QY<)HO0)[;+K["#05N+$+TP^^/Z0RYY
MA]YKR'5PBQ(R5!N+CI5^Y%51;)]'9_[%E?N+^5NT;QVJ.V'<>Q07R!12++&\
M469F\1=)[$BC&C&2\$;-!ZE2TULH [RF+16Q8Y0S$,?%DD'>E-%Q,]*1:EC#
M'EM&4G6X6O<]&\ZMA_[ 7&Q(;KM8?</Y]FPE3M7D2"(2,3*S E@D-B-+)FP
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M'$)VDKO?\+XH#[_%CD>!2XS'$)VDKO?\+XH#[_%CD>!2XS'$)VDKO?\ "^*
M^_Q8Y'@4N,QQ"=I*[W_"^* ^_P 6.1X%+C,<0G:2N]_POB@/O\6.1X%+C,<0
MG:2N]_POB@/O\6.1X%+C,<0G:2N]_P +XH#[_%CD>!2XS'$)VDKO?\+XH#[_
M !8Y'@4N,QQ"^'+1666W'GK%!---(6XZZY+QZ&VVT)VI;CBU$:2A"$ZVI:U;
MTE*=;WO>M:WO%CD>!2XS'$+S27"RI^7;Z69/&T=/ZC?DC^AYR ,[R-.,2NHP
M7IS](&M/(*$IT.<A]A4CPK2'MMDGF N.#RP[S<N.^X?:*9+4F6)V G<NRXC
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MA#MZTAD4,1AH=AI.M)0VVE.OZ,BJJV$5%LGT=G_L65^XOY6[1O':H[8=Q[%
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M.M^5Y;:T+TE6O@Q3\%?(>FPS$*B'")&S0455-$XXEB;M&2.![V.T75A:[1<
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M'=F]"*C6H\8>0Y,D./)R^'*V@TK3S<C/\<Q9T,(VR-J$$./CW'Y36QR683<
M96\E[=JH%B3GT;[7XV636154HB%!)>6^[L_SCF];5YJ7EAV^O6M)_!9'-:9;
MUU:U\S;:=;WU[WKKWO>READ."X>ST;]:3\=G/B.$L,AP"=GHWZTGX[.?$<)8
M9#@$[/1OUI/QV<^(X2PR' )V>C?K2?CLY\1PEAD. 3L]&_6D_'9SXCA+#(<
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M9ZBQFA)IHQT%T6U7NMU(Q>] F OI(&&G7#!=^?\ -J?'0VZA3:U;31K/B)X
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M*?\ ]G0/_D/'M&Q#]8X1^TQ#_P#-3VQ4GZ-6_LZ?_DI_''I7]7O*?_V= _\
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M3VFW6=/:&-9?9T[IIYYK3FD>7IMUU&M^2XO6R6!VBZ^A82&!/-E0HB,#E))
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M'<>Q*W]'8#[%BON+&';3O/:C=@W#L5:R*IA$PB81,(F$3")A%#'2+_(-R_\
MJ\M7[()SW.3/Y0X+])4GGF+S\6^+*_P6;ZA6L;-N+!TPB8107_*F!=$^?N/$
M3_"A5Y6'953OKYJ_-5Y#FIB%A5Z&]6KI\SM.Q_1]ZV]Z:K3OE]?FV_)^?U)?
MP5OY6Q4>,-QMM"'TK8.YSAYJ2.9FF&ES@K(+Z6ELT-5MI7SQ\KQ@SIJ+N U&
MC,9.<[IYJ^G''JT.8?LMMTM>2[7\O!&_\LAW_=L?_P".LZ/Q"R?WG9_E#O\
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MIU#2G-+4VEQ&U:UU:4GKZ\^_"JQF'8E0USF.E;254-0Z,$-+Q%(UY:''2 )
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MY_B\RC\>^'_W>J_W^+_C+ROQ>U7ZQA_=W_Q4_D,>7?ZZZ%_T_.?XO'X]\/\
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MDQXERJM>M0H!JF5& C6&(#EV RU#..CJ)&:,2R^IAUUG;J%[:<6C:5;BY#6
MKJPB81,(F$3")A$PB81,(F$3"*'N3.7A^*W&S[#5IPFHIB;1(FV>*>BRM@OU
M:F6:^&#N0KAC$@L9Z&JAX3,CKR6MV Z$BO-*;/=-#H%^D='E-E";<+]'IO\
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M_P":\4.]_BPR' )<YGB4[26+O^:\4.]_BPR' )<YGB4[26+O^:\4.]_BPR'
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M_P":\4.]_BPR' )<YGB4[26+O^:\4.]_BPR' )<YGB4[26+O^:\4.]_BPR'
M)<YGB4[26+O^:\4.]_BPR' )<YGB4[26+O\ FO%#O?XL,AP"7.9XE.TEB[_F
MO%#O?XL,AP"7.9XE.TEB[_FO%#O?XL,AP"7.9XE=<NP3[HI+3LY+N-.#O-N-
FN21JT.(6VI*T+0I_:5(4G>TJ2K6]*UO>MZWK>+#(< ESF>)7_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
